Nitro Games signs approx. 2.1 million EUR development agreement

Nitro Games has signed another development services agreement with a European Game developer and publisher for an unannounced mobile shooter game. “We’re happy to see the collaboration project continuing. The game has progressed well, and the collaboration with the partner has been productive. This aligns well with our strategy.,” says Jussi Tähtinen, CEO & Co-Founder of Nitro Games. With this agreement, Nitro Games continues providing the partner with game development services for an unannounced mobile shooter game based on the partner IP. This agreement follows Nitro Games’ strategy, where in addition to developing games based on its own IP, the company also offers its services to selected customers. The order value of this new agreement is approx. 2.1 million EUR. This agreement is a continuation for earlier smaller orders by the same customer, bringing the total order value with this customer to approx. 4.1 million EUR. The agreement follows an industry-standard structure. The project under this new agreement continues uninterrupted and the work under this agreement is expected to be completed in early 2027. For more information: Jussi Tähtinen, CEO & Co-Founder Phone: +358 44 388 1071 Email: jussi@nitrogames.comThis company release contains information that Nitro Games Oyj is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication by aforementioned contact person on 8 July 2026 at 06:20 (EEST). Nitro Games in brief: Nitro Games is a game developer and publisher, backed by a multinational team of gaming professionals with expertise spanning game development, publishing, and live operations. Specializing in action and shooter games, Nitro Games is dedicated to creating high-quality experiences for a global audience. With recent titles like Autogun Heroes and NERF: Superblast, the company has built a strong portfolio of engaging and innovative games. Nitro Games also has a proven history of collaborating with leading brands and companies, offering tailored development and publishing services to select partners. Nitro Games’ shares are listed on Nasdaq First North Growth Market with the ticker NITRO. The Certified Adviser is FNCA Sweden AB. www.nitrogames.com Finnish Business ID: FI21348196

Ellos Group announces the outcome of the offering and trading on Nasdaq Stockholm commences today

Ellos Holding AB (publ) (“Ellos Group”, “Ellos Holding”, the “Group” or the “Company”), one of the leading Nordic online shopping destinations for fashion and home interior,[1] today announces the outcome of the offering of shares in the Company (the "Offering") in connection with the listing of the Company's shares on Nasdaq Stockholm (together with the Offering, the "Listing"). The Offering attracted very strong interest from both institutional investors in Sweden and certain jurisdictions abroad, as well as from the general public in Sweden and Norway. The Offering was oversubscribed several times. Trading on Nasdaq Stockholm commences today, 8 July 2026. The Offering in brief · The price in the Offering was, as previously announced, SEK 60 per share (the "Offering Price"), corresponding to a total market value of all outstanding shares in the Company of approximately SEK 1,485 million after the completion of the Offering (excluding the Overallotment Option). · The Offering comprised 5,000,000 newly issued shares in the Company (excluding the Overallotment Option), corresponding to SEK 300 million before deduction of costs related to the Offering, corresponding to approximately 20.2 percent of the total number of shares and votes in the Company after completion of the Offering. · In order to cover any overallotment in relation to the Offering, the Company has committed to issue a maximum of an additional 15 percent of the total number of shares in the Offering (the "Overallotment Option"), corresponding to 750,000 shares. · Provided that the Overallotment Option is exercised in full, the Offering will comprise a total of 5,750,000 newly issued shares, corresponding to SEK 345 million. · The Offering was oversubscribed several times and as previously announced, Martin Bjäringer through company and family, Carl Rosvall through company, Heimdal Førvaltning, Sissener, Storm Bond Fund (a related party to the chairman of the board, Morten Eivindssøn Astrup), and Tinden Holding (together, the “Cornerstone Investors”) have acquired shares in the Offering totalling an amount of approximately SEK 203 million. The Cornerstone Investors together hold 13.3 percent of the share capital and votes in the Company after completion of the Offering if the Overallotment Option is exercised in full. · In connection with the Listing, members of the board of directors and the executive group management have committed, for a period of 180 days for the board members, and 360 days for the executive group management, following the commencement of trading, not to, with certain exceptions, transfer or dispose of their respective shareholdings in the Company without the prior written consent of the Joint Global Coordinators (so-called lock-up undertakings). Existing shareholders in the Company representing approximately 85.7 percent of the shares in the Company prior to completion of the Offering have entered into similar lock-up undertakings for a period of 180 days following the commencement of trading in the Company’s shares on Nasdaq Stockholm, although limited to 90 percent of each shareholder’s shareholding in the Company at the time of the Offering, on certain terms. In addition, subject to certain customary exceptions, the Company has undertaken not to issue or otherwise transfer any securities for a period of 180 days following the commencement of trading in the Company's shares on Nasdaq Stockholm without the prior written consent of the Joint Global Coordinators. · Trading in the Ellos Group share on Nasdaq Stockholm commences today, 8 July 2026, under the trading symbol (ticker) “ELLOS”. Settlement is expected to take place on 10 July 2026. Hans Ohlsson, CEO of Ellos Group, comments: "Today marks the beginning of a new chapter for Ellos Group. Over the past several years, we have undertaken a significant transformation, delivering improved profitability, stronger cash flow and a more robust capital structure and today we have a leading position in fashion and home interior in the Nordics. Our listing on Nasdaq Stockholm provides a strong platform to continue developing our brands, growing the business, and creating long-term value for shareholders, customers, and partners. I would like to extend my sincere thanks to our owners and employees for the commitment that has brought us to this point, and to warmly welcome our new shareholders to the next phase of Ellos Group’s journey." Morten Eivindssøn Astrup, Chair of the Board of Directors of Ellos Group, comments: "Since we became a major shareholder around two years ago, Ellos Group has generated an EBITA of approximately SEK 400 million. As the company now lists with a market capitalisation of approximately SEK 1.5 billion, it stands as a robust business with nearly 3 million customers and a strong balance sheet that provides the flexibility to create shareholder value. I am confident that the listing will foster even greater loyalty among customers and employees over time, particularly now that they have the opportunity to become shareholders of the company. Significant opportunities exist – especially within AI – to streamline operations at Ellos Group while simultaneously enhancing the customer experience. We are entering the stock market with shareholders who declined an indicative offer for the company at a price nearly 30 percent above the listing price. Our task now is to prove that this was a wise decision." About Ellos Group Ellos Group is one of the leading Nordic online shopping destinations for fashion and home interior. The Group’s online stores Ellos, Jotex and Homeroom have strong market positions in the Nordic region in their core customer segment, midlife women. The product offering includes a selection of both own and external brands, with 61 percent of the Group’s total merchandise sales for the financial year ended 31 December 2025 being attributable to own brands[2] and 39 percent to external brands. The customer offering is supported in Sweden, Norway, Denmark and Finland by Ellos Group’s own integrated payment and financing solution, Elpy. Elpy enables Ellos Group to manage the entire customer journey, offering a smoother shopping experience that supports customer loyalty. Ellos Group’s operations are built on a single and scalable online platform, integrating group-wide functions such as sourcing, logistics, advanced data analytics and data-driven digital marketing, payment solutions and customer service. Ellos Group’s head office is located in Viared outside Borås, which is closely situated to the Group’s two warehouses with the capacity to deliver to most addresses in the Nordic region and northern Europe with short lead times. As of 31 December 2025, the number of employees in the Group was 509. For the financial year ended 31 December 2025, 74 percent of the Group’s net sales were attributable to Ellos, 21 percent to Jotex and 5 percent to Homeroom. For the same period, Ellos’ net sales amounted to SEK 2,549 million, Jotex’s net sales amounted to SEK 728 million and Homeroom’s net sales amounted to SEK 158 million. Stabilisation measures In connection with the Offering, Danske Bank will act as stabilisation manager (the “Stabilisation Manager”) and may, to the extent permitted in accordance with Swedish law, carry out transactions aimed to stabilise, maintain, or in other ways support the market price of the Company’s shares, for up to 30 days from the commencement of trading in the Company’s shares on Nasdaq Stockholm. The Stabilisation Manager may effect transactions in order to maintain the market price of shares at levels above those that might otherwise prevail in the open market. The Stabilisation Manager is, however, not required to carry out such transactions and there is no assurance that such activities will be undertaken. Such transactions may be affected on any securities market, including Nasdaq Stockholm, over-the-counter market or otherwise. Stabilisation transactions, if conducted, may be discontinued at any time without prior notice but must be ended no later than by the end of the abovementioned 30-day period. In no event will transactions be affected at levels above the Offering Price. No later than by the end of the seventh trading day after stabilisation transactions have been undertaken, it shall be made public that stabilising measures have been performed in accordance with article 5(4) in EU’s Market Abuse Regulation 596/2014. Within one week of the end of the stabilisation period, the Stabilisation Manager will make public whether or not stabilisation measures were undertaken, the date at which stabilisation started, the date at which stabilisation last occurred as well as the price range within which stabilisation was carried out for each of the dates during which stabilisation transactions were carried out. Except as required by law or regulation, the Stabilisation Manager will not disclose the extent of any stabilisation and/or overallotment transaction carried out in relation to the Offering. Advisors ABG Sundal Collier AB and Danske Bank A/S, Danmark, Sverige Filial are Joint Global Coordinators and Joint Bookrunners, and Pareto Securities AB and SB1 Markets, filial i Sverige are Joint Bookrunners, in the Offering. Advokatfirman Cederquist KB is legal adviser to the Company. Advokatfirmaet Schjødt AS, filial is legal adviser to the Joint Global Coordinators and the Joint Bookrunners. For further information, please contact: Johan Stigson, CFO and responsible for IR, Ellos Group Telephone: +46 (0)33 16 08 05 Email: press@ellosgroup.com www.ellosgroup.com The information was submitted for publication, through the agency of the contact person set out above, at 8 July 2026 07:00 CEST. Important information This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by Ellos Holding AB (publ) (the “Company”) in any jurisdiction where such offer or sale would be unlawful. An offering of the securities referred to in this announcement has been made by means of a prospectus. This announcement is an advertisement and is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the “Prospectus Regulation”). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus. In any EEA Member State other than Sweden and Norway, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Regulation. This document and the information contained herein are not for distribution in or into the United States of America. This document does not constitute an offer to sell, or a solicitation of an offer to purchase, any securities in the United States. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. In the United Kingdom, this document and any other materials in relation to the securities described herein are only being distributed to, and are only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” within the meaning of paragraph 15 of Schedule 1 of the Public Offers and Admissions to Trading Regulations 2024 who are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “Relevant Persons”). This communication must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so. Forward-looking statements This announcement contains certain forward-looking statements that reflect the Company’s current view on future events and anticipated financial and operational performance. Forward-looking statements are generally all statements other than statements as to historical facts or present facts or circumstances. Words such as “may”, “shall”, “will”, “assume”, “forecast”, “anticipate”, “should”, “expect”, “believe”, “estimate”, “plan”, “project”, “prepare”, “intend” or “could” or, in each case, their negative or similar expressions or comparable terminology, are forward-looking statements. The forward-looking statements speak only as of the date of this announcement. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurances that they will materialise or prove to be correct. Because these forward-looking statements are based on assumptions or estimates and are subject to risks and uncertainties, the actual results or outcome could differ materially from those set out in the forward-looking statements. Readers are advised to view the forward-looking statements contained in this announcement with caution. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by applicable law or the Nasdaq Nordic Main Market Rulebook for Issuers of Shares. Information to distributors Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended (“MiFID II”); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the “MiFID II Product Governance Requirements”), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any “manufacturer” (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the shares have been subject to a product approval process, which has determined that such shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the “Target Market Assessment”). Notwithstanding the Target Market Assessment, distributors should note that: the price of the shares may decline and investors could lose all or part of their investment; the shares offer no guaranteed income and no capital protection; and an investment in the shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering. Each distributor is responsible for undertaking its own target market assessment in respect of the shares and determining appropriate distribution channels. [1] The Group has the third largest online home interior market share in Sweden and the fourth largest online fashion market share in Sweden, according to market research from Arthur D. Little. [2] Merchandise sales of own brands divided by total merchandise sales. 

Norse Atlantic ASA: All-time-high unit revenue in June

Arendal, Norway, 8 July 2026, In June, Norse Atlantic Airways (“Norse” or “the Company”) delivered an all-time-high total unit revenue in own network (TRASK) of 7.0 US cents per available seat kilometer, an increase of 20% compared to the same month in 2025. Due to consistently high fuel prices, Norse continued to optimize route planning to save cost with total available capacity down 30% year-over-year. The Norse product remains attractive with a total load factor exceeding 98%, in line with the year-ago period. Eivind Roald, the CEO of Norse, comments: “Norse delivered record unit revenue in June, reflecting our attractive product and strong demand for direct transatlantic routes with solid load factor and higher average fares in our own network. ACMI/charter utilization also remained high, underscoring the strength of our balanced business model. With fuel prices trending downward and strong demand for our product, we see an opportunity to increase capacity in the coming months, and we will, from August, consider adding more capacity to our US network. Our ‘Airline on Demand’ strategy, which enables us to adapt quickly and capitalise on opportunities, has been highly successful in bringing Norwegian football fans to the US to support Norway in the World Cup.” (June traffic figures. Comparable figures for year-ago period shown in brackets)  · 98.1% load factor across network and ACMI/Charter operations (98.6%) · Total revenue per available seat kilometer in own network (TRASK) of 7.0 US cents, up 20% from 5.8 US cents · 231 flights in own scheduled network (589) · 249 ACMI/charter flights operated (59) · 125,015 passengers transported (214,419) across network and ACMI/charter operations, down 42% YoY · Norse completed 100% of scheduled flights in the Month (100%) · 81% of flights in own network departed within 15 minutes of scheduled departure time (70%) · On-time performance was negatively impacted by continued Air Traffic Control (ATC) delays, airport congestion and travel disruptions as a knock-on effect from the Middle East conflict Investor and media contact: Anders Hall Jomaas, CFO, anders.jomaas@flynorse.com  About Norse Atlantic ASA Norse Atlantic Airways is an airline committed to offering affordable fares on direct, long-haul flights to popular destinations, along with specialized charter and ACMI services for tailored travel needs and extensive cargo operations. Norse operates a modern fleet of 12 fuel-efficient Boeing 787 Dreamliners, serving a network of destinations across North America, Europe, Africa and Asia. This information is subject to disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Bravida awarded SEK 650 million installation contract in Borlänge by EcoDataCenter

The assignment includes installing the electricity supply, power, lighting and cooling systems. Bravida has installation projects for eight EcoDataCenter data centres in Borlänge and Falun, four of which have already been completed. “I am very proud of the longstanding collaboration we have with EcoDataCenter and that we have now been awarded another contract. Bravida possesses unique expertise in large projects and we are the leading partner for data centre projects. We are now also welcoming additional specialists to the assignment,” says Lars Täuber, Head of Division, Bravida Sweden.The projects contribute to new jobs in the region, where EcoDataCenter and Bravida are collaborating with the aim of recruiting around 150 people to the site in Kvarnsveden during the autumn. Construction engineers, project managers, electricians and industrial piping fitters are needed.“Our investments in Borlänge are a key element in meeting the needs of the entire society regarding increased digitalisation. Bravida's ability to deliver projects of this size is important for us, and we have been building data centres together in the Dalarna region since 2019,” says Peter Michelson, CEO of EcoDataCenter.The order has been registered in the third quarter of 2026. The assignment in Kvarnsveden will start immediately and is scheduled for completion in the first quarter of 2028. For more information, please contact:Liselotte StrayHead of Group Communicationsliselotte.stray@bravida.se+46 76 852 38 11

Ponsse launches EU-funded project – Refactory to be established in Iisalmi, Finland

Ponsse is launching the ExtendedLIFE project, funded by the EU’s LIFE Programme. The project aims to extend the service life of used forest machines and increase the reuse of machine components. As part of the project, Ponsse will establish a Refactory in Iisalmi, Finland, where used machines can be refurbished or dismantled and recycled on an industrial scale. “Our goal is to significantly extend the lifetime of forest machine components and improve the efficient use of materials. We aim to even double the service life of key components and achieve substantial environmental benefits in line with our sustainability targets,” says Katja Paananen, Chief Responsibility Officer at Ponsse. The ExtendedLIFE project develops new solutions that enable more efficient refurbishment, reuse and recycling of forest machine components. Ponsse has already established circular economy processes for forest machine components. In 2010, a remanufacturing unit was established in Iisalmi, where components are refurbished for reuse. The operation has gradually expanded. In 2025, the volume of refurbished or reused spare parts reached 222 tonnes. Through the ExtendedLIFE project, these operations will be further expanded and developed on an industrial scale. The project also includes the development of a digital marketplace for remanufactured components and training for personnel, dealers and value chain partners in circular economy and remanufacturing practices. “As a result of the development work, a new Refactory concept will be created, enabling forest machines to be refurbished, dismantled and recycled as efficiently as possible. The Refactory will be established near Ponsse’s service and logistics centre in Iisalmi during 2026. The project is expected to increase employment in Iisalmi in areas such as machine dismantling and installation work,” says Ville Ohukainen, Circular Economy Coordinator at Ponsse. Ponsse is utilising digital tools and AI-based solutions in the project to anticipate maintenance needs and direct components for refurbishment, reuse or recycling. “For Ponsse customers, the project will primarily be visible through improved availability of refurbished and remanufactured spare parts. This will provide more cost-effective options for machine maintenance and support the long service life of forest machines,” Ohukainen says. ExtendedLIFE project in brief ExtendedLIFE is a project funded by the EU’s LIFE Programme in which Ponsse develops the remanufacturing and recycling of forest machine components on an industrial scale. The aim is to extend component lifetimes and significantly reduce the use of materials and emissions. The project’s total budget is approximately EUR 5 million, of which 60% is funded by the EU’s LIFE Programme. Media contacts: Katja Paananen, Chief Responsibility Officer, Ponsse PlcEmail: katja.paananen@ponsse.com Ville Ohukainen, Circular Economy Coordinator, Ponsse Plc Email: ville.ohukainen@ponsse.com

The Board of Directors of Episurf has resolved on an issue of Class B shares as part of partial closing

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE. The Board of Directors of Episurf Medical AB (publ) ("Episurf" or the "Company") has, on 7 July 2026, as part of the Company's strategy to build a Nordic property platform with a focus on cash flow and return, completed a partial closing (the "Partial Closing") of the acquisition of all shares in Grännäs Fastighetsbolag Portfölj 1 AB and Fyrby 3 AB (together, the "Target Companies") from Grännäs Fastigheter Holding AB ("Grännäs Fastigheter"). In connection with the Partial Closing, the Board of Directors has today, on 8 July 2026, by virtue of the authorisation granted by the Company's Annual General Meeting held on 25 May 2026, resolved on an issue of Class B shares to Grännäs Fastigheter. On 7 July 2026, Episurf completed a closing of an acquisition of properties with an agreed property value of MSEK 301, as part of the first Partial Closing of the acquisition of the property portfolio which Episurf announced on 5 June 2026. The complete closing of the property portfolio will take place at a later date, in accordance with what has previously been communicated.[1] As part of the payment of the consideration to be paid for the Target Companies to Grännäs Fastigheter, in connection with the Partial Closing, the Board of Directors of Episurf has, on the date of this press release, by virtue of the authorisation granted by the Company's Annual General Meeting held on 25 May 2026, resolved to issue 868,702,560 Class B shares, at a subscription price of SEK 0.10 per Class B share, to Grännäs Fastigheter, by way of off-setting the promissory note of SEK 86,870,256 which was issued in connection with the Partial Closing (the "Issue"). The reason for the deviation from the shareholders' preferential rights is to enable the fulfilment of the Company's previously announced commitments as a result of the Partial Closing of the acquisition of the Target Companies from Grännäs Fastigheter. Through the Issue, the number of shares in Episurf will increase by 868,702,560 Class B shares, from a total of 9,819,726,833 shares to 10,688,429,393 shares, and the number of votes in Episurf will increase by 868,702,560, from 9,820,673,547 to 10,689,376,107. The Company's share capital will increase by SEK 8,687,025.60, from SEK 98,197,268.33 to SEK 106,884,293.93. For existing shareholders, this entails a dilution effect of approximately 8.13 per cent of the share capital as well as the votes in the Company. An exemption document in accordance with Article 1.5, first paragraph, ba and Annex IX of Regulation (EU) 2017/1129 of the European Parliament and of the Council regarding the admission to trading of the newly issued Class B shares in Episurf Medical AB on Nasdaq Stockholm will be registered with the Swedish Financial Supervisory Authority and published on Episurf's website (www.episurf.com) prior to the admission to trading on Nasdaq Stockholm of the newly issued Class B shares. Advisors Roschier Advokatbyrå AB is acting as legal advisor to Episurf in connection with the Issue. For further information, please contact: Jens Andersson, CEO, Episurf Medical Tel: +46 (0) 768 55 67 02 Email: jens.andersson@episurf.com The information was submitted for publication, through the agency of the contact person set out above, at 08:15 CEST on 8 July, 2026. About Episurf Medical AB Episurf Medical is a property company with exposure to a diversified portfolio of property assets. The Company’s objective is to create value growth through the acquisition and management of Nordic properties. The Company also has a medical technology operation based on the individualized implant Episealer® and associated surgical instruments, which are used to treat cartilage injuries in joints. Episurf Medical’s head office is in Stockholm, Sweden. THIS PRESS RELEASE HAS BEEN PUBLISHED IN SWEDISH AND IN ENGLISH. IN THE EVENT OF ANY DISCREPANCIES BETWEEN THE LANGUAGE VERSIONS, THE SWEDISH VERSION SHALL PREVAIL. Important information The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to legal restrictions, and persons in jurisdictions where this press release has been published or distributed should inform themselves about and comply with such legal restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer, or a solicitation of an offer to sell or a solicitation of an offer to purchase or subscribe for securities issued by the Company in any jurisdiction where such an offer or solicitation would be in violation of applicable rules or require additional registration or other measures. This announcement is not a prospectus, information memorandum or exemption document for the purposes of Regulation (EU) 2017/1129 (the "Prospectus Regulation") and has not been approved by any regulatory authority in any jurisdiction. This press release does not constitute an offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933 (the "Securities Act"), as amended, and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. The information in this press release may not be announced, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, within or into, Australia, Belarus, Canada, Hong Kong, Israel, Japan, New Zealand, Russia, Singapore, South Africa, South Korea, Switzerland, the United Kingdom, the United States or in any other jurisdiction where such announcement, publication or distribution of the information would not comply with applicable laws and regulations or where such actions are subject to legal restrictions or would require additional registration or other measures than what is required under Swedish law. Actions taken in violation of this instruction may constitute a crime against applicable securities laws and regulations. This press release does not identify, or purport to identify, the risks (direct or indirect) that may be associated with an investment in the Company. Any information in this press release is provided solely to describe the background to the Issue and does not claim to be complete or exhaustive. No assurance shall be given with regard to the information in this press release nor to its accuracy or completeness. This press release does not constitute a recommendation for any investors' decisions regarding the Issues or Episurf. Each investor or prospective investor should conduct his, her or its own investigation, analysis and evaluation of the business and information described in this press release and all publicly available information. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. Neither the contents of the Company's website nor any other website accessible through hyperlinks on the Company's website are incorporated into or form part of this press release, unless expressly stated otherwise. In the United Kingdom, this document and other materials relating to the securities referred to herein are distributed and directed only to, and an investment or investment activity related to this document is only available to and will only be available to, "qualified investors" (as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024) who are (i) persons who have professional experience in matters relating to investments and who fall within the definition of "professional investors" in Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth individuals referred to in Article 49(2)(a)-(d) of the Order (all such persons are collectively referred to as "relevant persons"). Any investment or investment action referred to in this announcement is only available to relevant persons in the United Kingdom and will only be carried out with relevant persons. Persons who are not relevant persons should not take any action based on this press release, nor should they act or rely on it. Forward-looking statements This press release contains forward-looking statements that relate to the Company's intentions, assessments or expectations regarding the Company's future results, financial position, liquidity, development, prospects, expected growth, strategies and opportunities and the markets in which the Company operates. Forward-looking statements are statements that do not refer to historical facts and can be identified through statements which includes, but is not limited to, terms such as "consider", "expects", "anticipates", "intends", "appreciates", "will", "can", "assumes", "should", "could" and, in any case, negations thereof, or similar expressions. The forward-looking statements in this press release are based on various assumptions, which in many cases are based on additional assumptions. Although the Company considers that the assumptions reflected in these forward-looking statements are reasonable, it cannot be guaranteed that the assumptions will occur or that they are correct. Since these assumptions are based on assumptions or estimates and are subject to risks and uncertainties, the actual result or outcome may, for many different reasons, differ materially from the forward-looking statements. Such risks, uncertainties, eventualities and other significant factors may cause actual events to deviate significantly from the expectations expressly or implicitly stated in this press release through the forward-looking statements. The Company does not guarantee that the assumptions underlying the forward-looking statements in this press release are correct and each recipient of this press release should not unduly rely on the forward-looking statements in this press release. The information, perceptions and forward-looking statements expressly or implicitly set forth herein are provided only as of the date of this press release and may change. Neither the Company nor anyone else undertakes to review, update, confirm or publicly announce any revision of any forward-looking statement to reflect events or circumstances that occur relating to the content of this press release. [1] For further information regarding Episurf's acquisition and closing of acquisition of the property portfolio, please refer to Episurf's press releases dated 5 June 2026 and 7 July 2026, respectively.

Safeture Signs Partner Agreement with Italian Security Risk Management Company Aries Risk

Through the partnership, Aries Risk will be able to offer Safeture’s digital platform as part of its services for organizations seeking to strengthen their Travel Risk Management capabilities and better protect employees, travelers, and mobile workforces. Aries Risk is a veteran-founded company, built by former members of elite military and police units, with deep operational experience in security risk management and protective services. The company supports clients with proactive strategies to identify, analyze, and mitigate threats, enabling organizations to operate safely and effectively in complex environments. By combining Aries Risk’s operational expertise with Safeture’s technology platform, the partnership will provide organizations with a more comprehensive approach to people risk management — spanning risk intelligence, employee location awareness, communication, incident response, and real-time support during critical events. “Aries Risk brings exactly the kind of hands-on security expertise and client understanding that makes a strong Safeture partner,” said Magnus Hultman, CEO of Safeture. “Together, we can help organizations in Italy and beyond take a more proactive, structured, and technology-enabled approach to protecting their people.” “Our mission is to use security risk management to support and enable business,” said Andy Costa, Managing Director at Aries Risk. “Safeture’s platform gives us a powerful digital foundation to help clients manage travel-related risks, communicate with employees, and respond faster when situations change.” Safeture’s platform helps organizations know where their people are, understand how global events may affect them, and communicate quickly during times of uncertainty. The solution helps companies meet their duty of care responsibilities while providing travelers with relevant information and assistance when they need it most. For additional information, visit safeture.com or contact: Safeture CEO Magnus Hultman: +46 706 00 81 66. Magnus.hultman@safeture.com About Safeture ABSafeture is a Sweden-based SaaS company that provides a market-leading People Risk Management platform to help organizations protect their people anywhere in the world. By combining real-time risk intelligence, location awareness, and instant mass communication, Safeture enables faster response, stronger duty of care, and better decision-making for global operations. Trusted by medical assistance providers, security companies, insurers, and multinational organizations, Safeture supports travel, facility, and workforce safety through a scalable, partner-centric platform. Safeture AB is listed on the Nasdaq First North Growth Market in Stockholm (ticker: SFTR). Redeye Nordic Growth AB is the company’s Certified Adviser. About Aries RiskAries Risk is an Italian security risk management company offering services within security risk management, travel security, risk consulting, security operations, and protective services. Founded by former members of elite military and police units, Aries Risk helps organizations identify, analyze, and mitigate risks while supporting safe and resilient operations.

VAROPreem agrees sale of Road B.V. to Hametha B.V.

· Growth: Under VAROPreem ownership since 2021, Road has grown substantially, with net revenues increasing by 17X during the period. During the last 5 years, the number of charging points increased by 1,350% resulting in 25 million customer transactions. · Platform: VAROPreem supported the development of a robust, scalable, digital and operational platform, strengthening Road’s position as one of the leading EV charging management platforms across Western Europe. Operational performance has been strong, with 99.98% uptime across locations. · Value creation: The transaction marks a successful exit for VAROPreem at a multiple of 13X EBITDA[1]. Founded in 2017 and headquartered in Amsterdam, Road provides a flexible, technology-agnostic EV charging management platform. Its portfolio includes E-Flux by Road, an all-in-one solution for businesses and charge point operators, and Road Private Label, a customisable platform for charge point operators, energy companies, mobility service providers and OEMs. Road serves more than 200,000 customers with around 120 employees and a strong presence across Western Europe. Since taking a majority stake in Road in 2021, VAROPreem has supported the company’s development from an emerging platform into a stronger and scalable business. Through continued investment in its EV charging back-end platform, new features and standardised processes, Road has become a trusted partner to customers across Europe. Dev Sanyal, Group Chief Executive Officer of VAROPreem, said: “Road has developed strongly under VAROPreem ownership. It demonstrates significant value creation through focussed growth and a disciplined operating platform. This allowed us to exit at a multiple of 13X planned 2027 EBITDA. The significant value uplift is a result of growth in the scale of our customer base and geographies in which we operate underpinned by technology solutions and a reliable platform. We are pleased to have reached an agreement with Hametha and wish the Road team continued success.” The transaction completed on 3rd July 2026. Hametha is a leading provider of integrated mobility and energy solutions based in Benelux.

Atlas Copco Group receives prestigious award for industrial assembly tool

Industrial Technique, a business area within Atlas Copco Group, has been awarded the Red Dot Design Award 2026 for the Atlas Copco XB range, a new generation of cordless assembly tools designed to deliver reliability, ergonomics, and ease of use in modern manufacturing environments. “In today’s fast-moving production environments, manufacturers need assembly tools that enable consistent quality while remaining intuitive to use,” said Håkan Andersson, Business Area President Industrial Technique. “The XB range has been developed with a strong focus on ergonomics, reliability, and ease of integration into daily operations. Receiving the Red Dot Design Award highlights the importance of user-centered design in modern industrial tools.” The Red Dot Design Award is presented annually to products that demonstrate outstanding design quality and innovation. Modern manufacturing environments require assembly tools that support efficient workflows, consistent quality, and long-term durability while remaining intuitive for operators to use. Combining speed, precision, and connectivity, the XB range helps industrial manufacturers aiming to transform their production processes towards smart factories maintain productivity and tightening accuracy across a wide range of standard assembly applications. The tools feature an ergonomic and durable design to support operator comfort during continuous use while ensuring dependable performance in demanding industrial settings. The Red Dot Award ceremony took place on July 7, 2026, in Essen, Germany.

Epidemic Group¹ publishes 2025 Annual and Sustainability Report: A transformative year investing significantly into AI and bringing the company back to profitable growth in 2026

Epidemic Group publishes its 2025 Annual and Sustainability Report, marking a pivotal year toward its mission to reimagine storytelling through music, sound, video, and AI. The year was characterised by transformational work to set the company up for success in 2026, including further broadening Epidemic's strategy beyond music licensing. The significant operational investments made in 2025 are now allowing Epidemic to deliver the next-generation creative platform to its customers, future-proof its organization, and implement an AI-first approach. Operational Highlights · Epidemic Sound launched several key AI services across 2025, including the soundtracking workflow Studio, AI music adaption tool Adapt, and discovery tool Assistant, giving both business and individual creator customers new AI-powered tools for soundtracking. In 1H 2026 additional AI-based services were launched including the audio recognition software Soundproof .  · Deepened platform integration by bringing Studio natively into Adobe Premiere Pro and DaVinci Resolve. · Strengthened the group's AI-native capabilities through acquisitions, including Plenty Labs, an AI-native operating system for social ads, and Blenda Labs , an AI-native video entertainment company, concluded in Q2 2026. · Implemented a streamlined operating model to help our teams deliver for our customers in a faster, more focused manner, supported by AI-enabled ways of working. Financial Highlights[2] · 2025: An investment year. Epidemic Group grew 3 percent in constant currency while investing at a meaningful level in its product portfolio and AI-native transformation, resulting in a negative adjusted EBITDA[3] margin for the year. · 2026: Return to accelerating, profitable growth. The group returned to double-digit revenue growth and a positive adjusted EBITDA margin in H1 2026, with momentum building through the year — revenue growth in constant currency accelerated from 10 percent in H1 to 14 percent in Q2, at a consistent 10 percent adjusted EBITDA margin. Stockholm, Sweden, 8 July 2026 — Epidemic Group today published its 2025 Annual Report and Sustainability Report. The year was characterized by transformational work to set the company up for success in 2026, which included both a broadened strategy and significant operational investments to move the Epidemic Group’s offering beyond a music catalog and deliver the next generation creative platform to its customers, and also to future proof the organization and implement an AI-first setup.  In constant currencies, Epidemic Group grew by 3 percent in 2025, reflecting a robust underlying business driven by continued solid growth in the B2B segment. Reported revenues amounted to SEK 1,828 (1,921[4]) million, representing year-on-year growth of -5 percent. This reported growth was negatively impacted by currency movements, especially the USD and EUR, and by Digital Rights Management revenues impacted negatively by a compensation model reset from a large platform partner. The gross margin amounted to 84 (84) percent and adj. EBITDA margin amounted to -3 (8) percent, as the group made a deliberate choice to invest at a meaningful level in its product portfolio and AI-native transformation. Thanks to the transformational work carried out in 2025, the company's financial performance showed significant improvement in 1H 2026 and in Q2 2026, with the group returning to profitable growth. Reported revenues in 1H 2026 amounted to SEK 948 (909) million, equivalent to a 10 percent increase in constant currencies. This figure accelerated further in Q2 2026, with reported revenues amounting to SEK 480 (430) million, equivalent to a 14 percent increase in constant currencies. This positive development was driven by growth in both the business and individual creator segments. The gross margin amounted to 86 (84) percent in 1H 2026 and 87 (85) percent in Q2 2026. The adj. EBITDA margin increased to 10 percent in 1H 2026 and 10 percent in Q2 2026, equivalent to SEK SEK 99 (-62) million and SEK 49 (-100) million, respectively.  Sara Börsvik, Interim CEO of Epidemic Group, said:  "In 2025, we took a significant step towards creating the Epidemic Group, which will become the leading creative platform for businesses and individual creators. This required substantial investment in the product portfolio throughout the year. It also required us to transform our organizational structure to make us an AI-native company.“While revenue came in below our expectations, the underlying business was robust, and we also invested in and delivered our most ambitious product strategy in the group’s history. The direction is clear. We're expanding from a music licensing business into a creative platform. Human creativity, adaptive AI technology, human-made music and SFX, combined with complete licensing peace of mind – that combination is unique. “The first half of 2026 started to see the early results of the hard work delivered in 2025, with the group returning to profitable growth. The strategic direction of the company is very clear, and with the new organizational set-up in place, we are in a perfect position to deliver the world’s best creative platform to our customers." Hjalmar Winbladh, co-founder and Chair of the Board, said: "The annual report sets out one chapter in a longer strategy. The group's product, technology, and platform capabilities expanded significantly across 2025 and have continued into 2026, most recently with the acquisition of Blenda Labs. What creative platforms will look like as AI matures is still being defined. The group has the foundation, the IP, the customer base, and now the AI-enabled tooling to lead the market in defining it." Patrick McBride, Managing Director, EQT Growth, said:  "We continue to be excited about Epidemic Group's vision and its leading position at the intersection of music, video, technology and AI. Given its unique rights model, differentiated creator relationships and distribution, and decades-long understanding of how the internet sounds, Epidemic has a truly exciting role to play in the future of storytelling. We continue to be confident in the team, the strategy, and the long-term opportunity ahead."Notes[1]Epidemic Sound Group AB is in the process of changing its name to Epidemic Group AB, following ratification by its board. The name change is pending registration with Bolagsverket.[2]H1 and Q2 2026 are unaudited.[3]Operating profit or loss excluding items affecting comparability.[4]The numbers in parentheses represent the corresponding period from the previous year.

Notice of extraordinary general meeting in Biosergen AB

Right to participate Shareholders wishing to participate in the extraordinary general meeting must: · be listed in the Company's share register kept by Euroclear Sweden AB as of 29 July 2026; and · have given a notice of their intent to participate to the Company no later than on 31 July 2026. The notification should be made by e-mail to mark.beveridge@biosergen.net or by post to BAHR Advokatbyrå AB, Att. My Gabrielsson, Birger Jarlsgatan 16, SE-114 34 Stockholm. The notification should specify the shareholder's complete name, personal identity number or company registration number, address, telephone number and the number of shares held by the shareholder. Trustee-registered shares Shareholders whose shares are registered in the name of a bank or other nominee or trustee must, to be able to exercise their voting rights at the extraordinary general meeting, request the trustee to register their shares in their own name with Euroclear Sweden AB (so-called "voting rights registration"). Such voting rights registration must be implemented by the trustee no later than 31 July 2026. Accordingly, shareholders must notify their trustee and request such voting rights registration well before this date. Proxy etc. A proxy representing a shareholder must bring a valid written power of attorney to the extraordinary general meeting that is dated and signed by the shareholder. The power of attorney shall not be dated more than one year before the date of the extraordinary general meeting, unless it specifically stipulates that it will remain valid and in effect for a longer period of time (but not longer than five years). Should the power of attorney be issued by a legal entity, a copy of a registration certificate (Sw. registreringsbevis) or equivalent document shall be presented at the meeting. In order to facilitate the preparations before the meeting, a copy of the power of attorney and other proof of authority should be attached to the notice of participation submitted in advance. A template power of attorney can be found at the Company's website (www.biosergen.net) and will be sent by mail to the shareholders who request it and state their address. Proposed agenda 1. Opening of the meeting. 2. Election of chairman of the meeting. 3. Preparation and approval of voting register. 4. Approval of the agenda. 5. Election of one or two persons to attest the minutes. 6. Determination of whether the meeting was duly convened. 7. Resolution on amendment of the articles of association and reduction of the share capital to enable the rights issue of shares pursuant to item 9. a)     The board of directors' proposal to resolve on amendment of § 4 of the articles of association. b)     The board of directors' proposal to resolve on reduction of the share capital. 8. Resolution on amendment of the articles of association. 9. Resolution on approval of the board of directors' resolution on a rights issue of shares.10. Resolution on approval of the merger plan.11. Resolution on authorisation for the board of directors to issue shares, convertibles and/or warrants.12. Closing of the meeting. Proposed resolutions Item 2: Election of chairman of the meeting The board of directors proposes that Emil Hedberg, member of the Swedish Bar Association, is elected as chairman of the meeting, or, in his absence, the person determined by the board of directors. Item 7: Resolution on amendment of the articles of association and reduction of the share capital to enable the rights issue of shares pursuant to item 9 General information regarding the board of directors' proposal under item 7 In order to enable the implementation of the board of directors' resolution on a new issue of shares pursuant to item 9, it is proposed that the general meeting resolves on a reduction of the share capital and an adjustment of the limits of the share capital in the articles of association. The matters under items 7 a) – b) constitute one proposal and shall be dealt with by the general meeting as a whole through one resolution. The resolution under this item 7 is conditional upon the general meeting also resolving in accordance with items 8, 9, 10 and 11 of this notice, and the general meeting of Flerie AB resolving to approve the merger plan adopted by the board of directors of Biosergen and Flerie AB, respectively, on 26 June 2026. Item 7 a) – The board of directors' proposal to resolve on amendment of § 4 of the articles of association In order to enable the share capital reduction under item 7 b), the board of directors proposes that the general meeting resolves to amend the limits of the share capital pursuant to § 4 of the articles of association as follows. § 4 of the articles of association is proposed to have the following wording. Proposed wording The share capital shall be not less than SEK 1,100,000 and not more than SEK 4,400,000. The number of shares shall be not less than 1,250,000 and not more than 5,000,000. Item 7 b) – The board of directors' proposal to resolve on reduction of the share capital The board of directors proposes that the general meeting resolves on a reduction of the Company's share capital by SEK 4,696,464.30. The reduction shall be carried out without cancellation of shares. The reduction amount shall be allocated to unrestricted equity. The reduction is carried out in order to reduce the quota value of the shares and to enable the issue proposed for approval under item 9. Following the reduction, the Company's share capital will amount to SEK 1,174,116.00 divided among a total of 2,348,232 shares (prior to the new issue of shares pursuant to item 9), each share with a quota value of SEK 0.50. The board of directors' report pursuant to Chapter 20, Section 13, fourth paragraph, of the Swedish Companies Act The effect of the board of directors' proposal is that the Company's share capital is reduced by SEK 4,696,464.30, from SEK 5,870,580.30 to SEK 1,174,116.00. The new issue of shares of approximately SEK 39.9 million, pursuant to item 9, which is covered by subscription and guarantee commitments of approximately SEK 39.9 million, entails that the share capital simultaneously increases by a total of SEK 39,919,944.00. The share capital reduction and the completion of the rights issue pursuant to item 9 are conditional upon each other. By completing the rights issue, the share capital of the Company will, in connection with the registration of the share capital reduction with the Swedish Companies Registration Office, simultaneously increase by at least the amount by which the share capital has been reduced. By completing the rights issue simultaneously with the reduction, the Company may execute the reduction resolution without permission from the Swedish Companies Registration Office or a general court, since the measures collectively entail that neither the Company's restricted equity nor its share capital is reduced. Authorisation The board of directors, the CEO, or anyone appointed by the board of directors or the CEO, shall be authorised to make such minor amendments to the above resolution as may be necessary in connection with the registration of the resolution with the Swedish Companies Registration Office or due to other formal requirements. Majority requirements A valid resolution under this item 7 requires the approval of shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting. Item 8: Resolution on amendment of the articles of association In order to enable the registration of the rights issue of shares resolved by the board of directors of the Company on 26 June 2026, the board of directors proposes that the general meeting resolves on an amendment of the limits of the share capital and the number of shares in the Company's articles of association. The resolution under this item 8 is conditional upon the general meeting also resolving in accordance with items 7, 9, 10 and 11 of this notice, and the general meeting of Flerie AB resolving to approve the merger plan adopted by the board of directors of Biosergen and Flerie AB, respectively, on 26 June 2026. Proposed wording of § 4: The share capital shall be not less than SEK 37,500,000 and not more than SEK 150,000,000. The number of shares shall be not less than 75,000,000 and not more than 300,000,000. Authorisation The board of directors, the CEO, or anyone appointed by the board of directors or the CEO, shall be authorised to make such minor amendments to the above resolution as may be necessary in connection with the registration of the resolution with the Swedish Companies Registration Office or due to other formal requirements. Majority requirements A valid resolution under this item 8 requires the approval of shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting. Item 9: Resolution on approval of the board of directors' resolution on a rights issue of shares The board of directors proposes that the general meeting resolves to approve the board of directors' resolution of 26 June 2026 on a new issue of shares with preferential rights for the Company's shareholders. The resolution under this item 9 is conditional upon the general meeting also resolving in accordance with items 7, 8, 10 and 11 of this notice, and the general meeting of Flerie AB resolving to approve the merger plan adopted by the board of directors of Biosergen and Flerie AB, respectively, on 26 June 2026. Otherwise, the following conditions shall apply. A maximum of 79,839,888 shares shall be issued, entailing an increase of the share capital by a maximum of SEK 39,919,944.00. The right to subscribe for shares shall, in accordance with the shareholders' preferential rights, vest with those who are registered as shareholders in the Company on 10 August 2026 (the "Record Date"). Each shareholder receives one (1) subscription right for each share held. One (1) subscription right entitles to subscription of thirty-four (34) shares. The subscription price for each share is SEK 0.50. The amount that exceeds the share's quota value shall be transferred to the unrestricted premium reserve. Subscription for shares, with preferential rights, is made with the support of subscription rights. The right to receive subscription rights to subscribe for shares with preferential rights, shall vest with persons registered as shareholders in the Company as of the Record Date in the share register kept by Euroclear Sweden AB. Subscription of shares with the support of subscription rights must be made by simultaneous cash payment during the period from, and including, 12 August 2026, until, and including, 26 August 2026. The board of directors has the right to extend the subscription and payment period. Subscription of shares without the support of subscription rights must be made on a special subscription list during the period commencing on, and including, 12 August 2026, until, and including, 26 August 2026. Payment for shares that are subscribed for without the support of subscription rights must be paid in cash in accordance with the instructions on the transaction note no later than the second banking day after notification of allocation is sent to the subscriber through transaction note. The board of directors has the right to extend the subscription and payment period. In the event all shares in the rights issue are not subscribed for with the support of subscription rights, the board of directors shall, within the maximum amount of the rights issue, resolve on the allotment of shares subscribed for without the support of subscription rights in accordance with the following principles: (i)                 Firstly, allocation shall be made to those who subscribed for shares with the support of subscription rights, regardless of whether the subscriber was a shareholder on the record date or not, and, in case of oversubscription, in relation to the number of subscription rights that each party has exercised for the subscription of shares, and, if this is not possible, by drawing lots. (ii)                Secondly, allocation shall be made to other subscribers who subscribed for shares without the support of subscription rights, and, in case of oversubscription, in relation to the subscribed amount, and, if this is not possible, by drawing lots. (iii)              Thirdly, allocation of any remaining shares shall be made to guarantors in accordance with signed guarantee commitments. In the event that allotment cannot be made in full, allotment shall be made in proportion to the amount guaranteed by each guarantor and, if this is not possible, by drawing lots. The new shares issued in the rights issue shall carry a right to dividends commencing on the first record date that occurs after the registration of the shares with the Swedish Companies Registration Office and the entry of the shares in the share register kept by Euroclear Sweden AB. Special majority requirements and conditions Flerie Invest AB, a wholly owned subsidiary of Flerie AB, has, within the framework of the rights issue, entered into a guarantee undertaking of up to SEK 18.9 million. The Swedish Securities Council has granted Flerie Invest AB an exemption from the mandatory bid obligation that may arise if Flerie Invest AB fulfils its guarantee undertaking by subscribing for shares in the rights issue, on the condition that the shareholders are informed, prior to the extraordinary general meeting, of the maximum capital and voting share that Flerie Invest AB may obtain by fulfilling its guarantee undertaking, and that the extraordinary general meeting's resolution on the rights issue is supported by shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting, disregarding shares held and represented at the meeting by Flerie Invest AB. The maximum capital and voting share that Flerie Invest AB may obtain by fulfilling its guarantee undertaking, provided that the rights issue is not fully subscribed, is approximately 46.0 percent of the shares and votes in the Company (calculated on the number of shares in the Company following the rights issue, excluding any shares issued as guarantee compensation). A valid resolution under this item 9 requires the approval of shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting. Authorisation The board of directors, the CEO, or anyone appointed by the board of directors or the CEO, shall be authorised to make such minor amendments to the above resolution as may be necessary in connection with the registration of the resolution with the Swedish Companies Registration Office or Euroclear Sweden AB or due to other formal requirements. Item 10: Resolution on approval of the merger plan In order to implement the proposed merger between Flerie AB and Biosergen (the "Merger"), the board of directors proposes that the meeting resolves to approve the merger plan. The resolution under this item 10 is conditional upon the general meeting also resolving in accordance with items 7, 8, 9 and 11 of this notice, and the general meeting of Flerie AB resolving to approve the merger plan adopted by the board of directors of Biosergen and Flerie AB, respectively, on 26 June 2026. The board of directors proposes that the meeting resolves to approve the merger plan, dated 26 June 2026, which has been jointly adopted by the boards of directors of Flerie AB and Biosergen. The merger plan was registered with the Swedish Companies Registration Office on 30 June 2026 and announced on 2 July 2026. According to the merger plan, the Merger shall be undertaken by way of absorption, with Flerie AB as the absorbing company and Biosergen as the transferring company. Following the completion of the Merger, Biosergen’s operations will be contributed to a new subsidiary of Flerie AB's wholly owned subsidiary Flerie Invest AB. According to the merger plan, the exchange ratio for the merger consideration has been determined in such a way that thirty-one (31) shares in Biosergen shall be exchanged for one (1) new ordinary share in Flerie AB. Registration of the Merger with the Swedish Companies Registration Office is conditional upon the conditions in the merger plan, inter alia that the extraordinary general meetings of both Flerie AB and Biosergen approve the merger plan. The Merger is expected to be registered with the Swedish Companies Registration Office during the last quarter of 2026 and will result in the dissolution of Biosergen, whereby all of Biosergen’s assets and liabilities will be transferred to Flerie AB. Settlement of the merger consideration will take place following the Swedish Companies Registration Office registration of the Merger. Authorisation The board of directors, the CEO, or anyone appointed by the board of directors or the CEO, shall be authorised to make such minor amendments to the above resolution as may be necessary in connection with the registration of the resolution with the Swedish Companies Registration Office or Euroclear Sweden AB or due to other formal requirements. Majority requirements A valid resolution under this item 10 requires the approval of shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting. Item 11: Resolution on authorisation for the board of directors to issue shares, convertibles and/or warrants The resolution under this item 11 is conditional upon the general meeting also resolving in accordance with items 7, 8, 9 and 10 of this notice, and the general meeting of Flerie AB resolving to approve the merger plan adopted by the board of directors of Biosergen and Flerie AB, respectively, on 26 June 2026. The board of directors proposes that the extraordinary general meeting resolves to authorise the board of directors, up until the next annual general meeting, at one or several occasions, to resolve on the issue of shares, convertibles and/or warrants, with or without deviation from the shareholders' preferential rights, to be paid in cash, through contribution in kind and/or through set-off. The number of shares that may be issued pursuant to the authorisation, and thereby the increase of the share capital, shall not be limited in any other way than what follows from the limits of the number of shares and the share capital set out in the articles of association in force from time to time. The reason for why the board of directors should be able to resolve on issues without preferential rights for the shareholders as set out above is primarily to be able to source new capital to broaden the Company's shareholder base, increase the Company's flexibility, make payment for guarantee undertakings in the form of shares or in connection with acquisitions. In case the authorisation is used for a new issue with deviation from the shareholders' preferential rights, the issue shall be made on customary market terms. If the board of directors deems it appropriate to enable delivery of shares in connection with an issue as set out above, this may be made at a subscription price corresponding to the quota value of the shares. Authorisation The board of directors, the CEO, or anyone appointed by the board of directors or the CEO, shall be authorised to make such minor amendments to the above resolution as may be necessary in connection with the registration of the resolution with the Swedish Companies Registration Office or Euroclear Sweden AB or due to other formal requirements. Majority requirements A valid resolution under this item 11 requires the approval of shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting. Disclosures at the extraordinary general meeting Shareholders present at the extraordinary general meeting have the right to request information in accordance with Chapter 7, Section 32 of the Swedish Companies Act (2005:551). Meeting documents Documents pursuant to the Swedish Companies Act and a merger document, including, inter alia, the merger plan will be available at the Company's office, Fogdevreten 2A, SE-171 65 Solna, Sweden and at the Company's website (www.biosergen.net) as from no later than three weeks before the extraordinary general meeting, and will also be sent to shareholders who request it and state their address. Copies of the documents will also be available at the extraordinary general meeting. Number of shares and votes in the Company As of the date of this notice to attend the extraordinary general meeting, the total number of shares and votes in the Company amounts to 2,348,232. Processing of personal data For information on how your personal data is processed, see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf. ______________________ Solna in July 2026 Biosergen AB The Board of Directors For further information about Biosergen, please contact: Tine Kold Olesen, CEO Telephone: +45 3135 5707 E-mail:tine.olesen@biosergen.net Mark Beveridge, CFO Telephone: +46 76 805 8288 E-mail:mark.beveridge@biosergen.net The Company's Certified Adviser is DNB Carnegie Investment Bank AB (publ). About Biosergen Biosergen is a clinical-stage biotechnology company in the therapeutic area of life-threatening fungal diseases. Biosergen aims to develop the drug candidate BSG005, including new formulations, into a new first-line treatment for resistant and/or difficult-to-treat invasive fungal infections. The company strives to set a new standard for combating these infections where current treatments are insufficient, thereby saving thousands of lives each year among cancer patients with compromised immune systems, transplant recipients and AIDS patients.

KONE publishes January-June 2026 Half-year Financial Report on Wednesday, July 22, 2026 at 08:30 a.m. EEST

KONE Corporation, press release, July 8, 2026 at 1.30 p.m. EEST KONE publishes January-June 2026 Half-year Financial Report on Wednesday, July 22, 2026 at 08:30 a.m. EEST Half-year Financial ReportKONE Corporation will publish its Half-year Financial Report for the January 1-June 30, 2026 accounting period on Wednesday, July 22, 2026 at 08:30 a.m. EEST. The report will be available on www.kone.com after publishing. Press and analyst eventsA Microsoft Teams call for the press, conducted in English, will be held on Wednesday, July 22, 2026 at 09:00 a.m. EEST. Journalists are kindly asked to sign up to media@kone.com by Monday, July 20, 2026, and they will receive a link to the call upon registration. A webcast for analysts, conducted in English, will begin at 10:30 a.m. EEST and will be available on kone.events.inderes.com/2026-q2. An on-demand version of the webcast will be available on www.kone.com/global/en/investors later the same day. Participants wishing to ask questions may join the telephone conference by registering through the following link: events.inderes.com/kone/2026-q2/dial-in For further information, please contact:Natalia Valtasaari, Vice President, Investor Relations, tel. +358 204 75 4705 About KONEAt KONE, our purpose is to shape the future of cities. As a global leader in the elevator and escalator industry, we move two billion people every day, making their journeys safe, convenient, and reliable with smart and sustainable People Flow®. In 2025, KONE had annual sales of EUR 11.2 billion, and at the end of the year over 60,000 employees in close to 70 countries. KONE class B shares are listed on the Nasdaq Helsinki Ltd. in Finland. www.kone.com

Jefast Borrower II AB (publ) announces that the condition for the early redemption of its bonds 2025/2027 with ISIN SE0025158504 has been fulfilled

Jefast Borrower II AB (publ) announces that the condition for the early redemption of its bonds 2025/2027 with ISIN SE0025158504 has been fulfilled Jefast Borrower II AB (publ) (“Jefast” and the “Company”) announced on 2June 2026 that it will redeem in full all of its outstanding bonds 2025/2027 with ISIN SE0025158504 issued on 24June 2025 (the “Bonds” and the “Early Redemption” respectively). The Early Redemption was conditional upon the successful closing of a financing transaction (the “Refinancing”) for the purpose of refinancing the Bonds. The Refinancing has been completed and the condition for the Early Redemption have thus been fulfilled. Consequently, the Early Redemption is no longer conditional and will therefore occur on 15July 2026 as previously announced. The redemption price of 103.50 per cent. of the nominal amount (i.e., SEK 1,293,750 per Bond) together with accrued but unpaid interest up to (an including) 15July 2026 will be paid to each person who is registered as owner of Bonds in the debt register maintained by Euroclear Sweden at end of business on the 8July 2026. More information regarding the Early Redemption can be found in the notice of early redemption available on Jefast’s and CSC (Sweden) AB’s respective websites. For further information, please contact: Cassandra Jertshagen, VD, cassandra@jefast.se, +46 42 36 12 01 This information constitutes inside information that the Company is required to disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 8July 2026 at 13:00 CEST.

Goldsky Announces MOU with Ocean Partners to Further Study Cobalt Recovery from the Rajapalot Project in Finland

VANCOUVER, BC, July 8, 2026 /CNW/ - Goldsky Resources Corp (TSX-V: GSKR, FNSE: GSKR SDB, OTCQX: GSKRF, FRA: HEG0) (“Goldsky Resources” or the “Company”) is pleased to announce that Goldsky and Ocean Partners (“Ocean Partners”) have entered into a Memorandum of Understanding ("MOU") to establish a framework  cooperation agreement to investigate the technical and economic viability of recovering cobalt from Goldsky’s Rajapalot gold-cobalt Project in Finland and to evaluate potential commercial arrangements relating to cobalt concentrate production, marketing and offtake. "We are  pleased to announce this MOU with Ocean Partners for our Rajapalot Project in Finland. The MOU has been designed to investigate the best technical flowsheet for cobalt recovery and a commercial solution for the sale of concentrate into the cobalt market. Our Rajapalot project has a strategic cobalt component that enables us to potentially qualify as a critical metal producer as defined  by the EU's Critical Raw Materials Act. This will be an important advantage for us from the perspective of permitting the Rajapalot Project into production ”, said Russell Bradford CEO. The Company is evaluating opportunities to recover cobalt from mineralized material associated with the Rajapalot Project in Finland. Ocean Partners has expertise in metals marketing, concentrate blending, offtake arrangements, project development and financing solutions and wishes to assess the potential for participation in the development of a cobalt recovery process and associated commercial arrangements. Costs relating to the phase 1 development including sample generation, transport, laboratory work and supervision will be allocated between the two parties. The Parties shall cooperate in good faith to investigate: 1. The metallurgical recovery of cobalt from Rajapalot mineralized material; 2. The technical and economic viability of a cobalt recovery circuit and processing facility; 3. Potential cobalt concentrate marketing and offtake opportunities; 4. Concentrate blending opportunities and associated commercial arrangements; and 5. Potential participation by Ocean Partners in future project development. This MOU is intended to facilitate cooperation and information sharing during the evaluation process and does not constitute a binding commitment to proceed with any transaction, construction project, financing arrangement or offtake agreement, nor does it create any binding obligations. Certified Adviser Augment Partners AB is the Company's Certified Adviser on Nasdaq First North Growth Market.Phone: +46 8-604 22 55Email: info@augment.se This information was submitted for publication, through the agency of the contact person set out above, on July 8, 2026, at 8:00 a.m. Eastern Time. ON BEHALF OF THE BOARD OF DIRECTORS Russell Bradford, CEO & Director Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No securities regulatory authority has reviewed or approved of the contents of this news release. Forward-looking Information: This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes statements that relate to future events or future performance and are often, but not always, identified by words such as “anticipate”, “expect”, “intend”, “plan”, “estimate”, “believe”, “potential”, “may”, “will”, “should”, “could”, or similar expressions. All statements, other than statements of historical fact, included herein, including, without limitation, statements regarding Agnico Eagle’s expected provision of transition services; statements regarding the anticipated benefits of the Transaction, the potential of Barsele, the terms of the NSR and the re-purchase rights thereof, the Company’s exploration plan at Barsele, including the expectations for the Company’s upcoming drill campaign, the Company’s growth prospects and strategic objectives, the renewal of the Barsele exploration and exploitation permits, and any other statements regarding future plans, expectations, estimates, assumptions or projections, constitute forward-looking information. Although Goldsky Resources believes that the expectations reflected in such forward-looking statements and/or information are reasonable, undue reliance should not be placed on forward-looking statements since the Company can give no assurance that such expectations will prove to be correct. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements, including the risks, uncertainties and other factors identified in the Company’s periodic filings with Canadian securities regulators, and assumptions made with regard to: availability of financing; assumptions regarding commodity prices, exploration success, costs, and general business and economic conditions. Forward-looking statements are subject to business and economic risks and uncertainties and other factors that could cause actual results of operations to differ materially from those contained in the forward-looking statements. Important factors that could cause actual results to differ materially from the Company’s expectations include risks that the Transaction may not provide the anticipated benefits; risks associated with the business of Goldsky Resources; risks related to exploration and potential development of Barsele; business and economic conditions in the mining industry generally; fluctuations in commodity prices and currency exchange rates; uncertainties relating to interpretation of drill results and the geology, continuity and grade of mineral deposits; the need for cooperation of government agencies and indigenous groups in the exploration and development of Barsele and the issuance of required permits; the need to obtain additional financing to develop Barsele and uncertainty as to the availability and terms of future financing; the possibility of delay in exploration or development programs and uncertainty of meeting anticipated program milestones; uncertainty as to timely availability of permits and other governmental approvals; and other risk factors as identified in Goldsky Resources’ filings with Canadian securities regulators on SEDAR+ (available at www.sedarplus.ca). Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to Goldsky Resources. The forward-looking information contained in this news release is made as of the date hereof and Goldsky Resources does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws or Nasdaq First North Growth Market Rulebook for Issuers of Shares. The foregoing statements expressly qualify any forward-looking information contained herein. View PDF version 

Anko van der Werff to leave SAS at the beginning of 2027

Van der Werff will remain in his current role until departure, ensuring stability and continuity as SAS continues to execute its strategic priorities and deliver reliable operations and a high-quality experience for customers, colleagues and stakeholders. SAS will continue operating according to its established plan, with full focus on ongoing delivery and strategic progress. The Board will now initiate the process of appointing his successor. Since Anko van der Werff joined SAS in 2021, SAS has undergone a significant transformation, completed a comprehensive restructuring and substantially strengthened both its financial and operational position. The relentless focus on operational performance and reliability has positioned SAS as the most punctual airline in the world. Customer experience has been enhanced across service delivery and onboard experience, supported by continued investment in products, connectivity and fleet, including the recently announced record order of up to 40 Airbus widebody aircraft, the largest fleet investment in SAS’ history, reinforcing long-term operational excellence and reliability. During this period, SAS has joined SkyTeam, strengthening its position within a leading global airline alliance and opening a new chapter for the company through broader international connectivity and closer cooperation with partner airlines. Looking ahead, SAS remains fully focused on executing its strategy and building on the progress achieved in recent years. Key priorities include deepening cooperation with SkyTeam partners, further strengthening operational excellence and reliability, and delivering a consistent and high-quality travel experience for customers across its network. 2026 also marks SAS’ 80th anniversary, reflecting eight decades of connecting Scandinavia with the world and the world with Scandinavia. Comment from Kåre Schultz, Chairman of the Board of SAS “On behalf of the Board, I would like to thank Anko for his strong leadership and commitment during a highly demanding transformation period. He has played a central role in building a stronger and more competitive SAS with a clear direction and important opportunities ahead. We respect his decision, while naturally regretting his departure. Importantly, he will remain in his role until the beginning of 2027, ensuring stability and continuity as SAS continues to execute its strategy.” Comment from Anko van der Werff, President & CEO of SAS  “This has not been an easy decision. I have greatly valued my time at SAS and the opportunity to work alongside so many dedicated colleagues.  Over the past years, we have navigated a highly demanding period together and made substantial progress in strengthening the company. Many of the key building blocks are now in place, and SAS is well positioned for the next phase of its development.  Until I leave at the beginning of 2027, my focus remains on SAS. There are important priorities ahead, and I remain fully committed to delivering reliable operations and a high-quality experience for customers, colleagues and stakeholders every day.” 

Ahlstrom expands its global offering for Pressure Sensitive Adhesive (PSA) labeling with new release paper manufactured in Brazil

AHLSTROM OYJ, PRESS RELEASE, JULY 8, 2026, at 16:00 EEST Ahlstrom, a global leader in fiber‑based specialty materials, announces the launch of MaxLiner™, a new high transparency and high-density release paper for pressure‑sensitive adhesive (PSA) labeling. Produced at the company’s plant in Jacareí, Brazil, the new product further expands and strengthens Ahlstrom’s global and regional footprint for release liner solutions. MaxLiner ™ offers the South American market a locally available supply of a key component used in PSA labeling. With this addition, Ahlstrom complements its existing regional offering – already including clay-coated release papers as well as coated and uncoated label papers. With a broader range of release and label papers manufactured in Brazil, customers will benefit from reliable supply continuity, and shorter lead times. Leveraging Ahlstrom’s extensive global release liner expertise, MaxLiner ™ meets the requirements of hold-out, density and transparency necessary for silicone coating, lamination and further steps of PSA label printing, die-cutting and dispensing. Like other Ahlstrom labeling materials, the product is manufactured with responsibly sourced, certified renewable fibers and can be supplied with chain-of-custody forestry management certification, meeting customers’ sustainable sourcing requirements. With production now established in South America, alongside existing glassine and SCK capabilities in Europe and North America, the company further reinforces its position as a global partner to the PSA industry. “MaxLiner™ is a tangible demonstration of Ahlstrom’s continued commitment to the PSA industry and our strong focus on South America,” said Marco Martinez, Head of Product, Sustainability and Marketing, Release Liners. “With this addition, our Brazilian unit can offer a more complete range of release and label papers, supporting our local customers’ growth with dependable, high-performance solutions, as well as highly responsive service. The development also reflects Ahlstrom’s continuous innovation efforts and ambition to advance new sustainable solutions.” In addition to labeling applications, Ahlstrom’s global release liner solutions serve a wide range of end‑use segments, including composites, graphics, industrial, food, medical, and tape, and are manufactured in Europe, North and South America, supporting the needs of both global and regional customers worldwide. For more information about MaxLiner™, please contact: Liliane Nickel, Sales Manager, Release Liners, liliane.nickel@ahlstrom.com For more information on our release and label paper solutions, please visit: https://www.ahlstrom.com/products/release-and-label-papers/

Publication of a Prospectus

Regulatory Announcement Royal Bank of CanadaJuly 8, 2026 Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. Royal Bank of Canada today issued GBP950,000,000 Floating Rate Senior Notes due July 2027, Series 79008 (the "Notes") pursuant to its Programme for the Issuance of Securities (the "Programme"). The following document constitutes the final terms dated July 6, 2026 (the "Final Terms") relating to the admission to trading of the Notes for purpose of Article 8 of Regulation (EU) 2017/1129 and as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 and must be read in conjunction with the Prospectus dated July 9, 2025, as supplemented by the 1[st] Supplementary Notes Base Prospectus dated August 28, 2025, the 2[nd] Supplementary Notes Base Prospectus dated December 10, 2025, the 3[rd] Supplementary Notes Base Prospectus dated February 27, 2026 and the 4[th] Supplementary Notes Base Prospectus dated May 29, 2026 relating to the Programme (together, the "Prospectus").  Full information on Royal Bank of Canada and the offer of the Notes is only available on the basis of the combination of the Final Terms and the Prospectus. DISCLAIMER - INTENDED ADDRESSEES Please note that the information contained in the Prospectus and the Final Terms, may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed.  Prior to relying on the information contained in the Final Terms you must ascertain from the Prospectus, as supplemented by these Final Terms, whether or not you are part of the intended addressees of the information contained therein. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and are subject to US tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered in or into the United States or to or for the account or benefit of US persons (as defined in Regulation S under the Securities Act). No public offering of the Notes is being made in the United States. This announcement does not constitute an offer to sell or a solicitation to buy securities in the United States or in any other jurisdiction where such offer or solicitation would be unlawful. Your right to access this service is conditional upon complying with the above requirement. UK MIFIR professionals / ECPs-only - Manufacturer target market (UK MIFIR product governance) is eligible counterparties and professional clients only (all distribution channels). To view the full document, please paste the following URLs into the address bar of your browser. http://www.rns-pdf.londonstockexchange.com/rns/5720L_1-2026-7-8.pdf For further information, please contact Paul BurdSenior CounselRoyal Bank of CanadaTelephone Number: (437) 925-9253Fax Number: (416) 955-2032Email:  paul.burd@rbc.com END This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

OKEA second quarter 2026 trading update

Second quarter 2026 production and sales: Unit Q2 2026 Q1 2026 Q2 2025Total operating MUSD 334 239 206income*Realised crude oil USD/boe 116.9 79.5 68.4priceRealised NGL price USD/boe 55.3 46.4 41.2Realised liquids USD/boe 104.2 74.2 63.1priceRealised gas price USD/boe 88.1 76.5 71.4Net production Kboepd 27.0 34.9 31.7Third-party volumes Kboepd -0.2 -0.2 0.0available for saleOver/underlift/Inven Kboepd 7.6 4.4 1.3tory adjustmentsNet sold volume** Kboepd 34.4 39.1 33.0Net sold volumes - Kboepd 20.2 23.7 19.2crude oilNet sold volumes - Kboepd 5.3 4.4 4.7NGLNet sold volumes - Kboepd 9.0 11.0 9.1gas**Cash and interestbearing debt: Unit 30.06.2026 31.03.2026 30.06.2025Total cash*** MUSD 355 269 464Interest bearing MUSD 296 295 422bonds *    Total operating income includes a net hedging gain of USD 14 million **   Includes delivered compensation volumes to Duva and Nova (tie-in to Gjøa) *** Total cash including money market funds Expected impairments As a result of reduced forward prices, impairment charges on Statfjord asset in the range of USD 80-100 million and impairment of technical goodwill on Draugen in the range of USD 5-10 million are expected recognised in the second quarter. The related post-tax impact is expected at USD 25-30 million. The information contained in this statement is based on a preliminary assessment of the company’s financial and operational results for the second quarter 2026 and may be subject to change.  Second quarter 2026 financial report to be published on 16 July. OKEA will release its second quarter 2026 results on Thursday 16 July at 06:00 CEST. A presentation of the results and a Q&A session will be held on the same day through a webcast and audio conference starting 10:00 CEST (OKEA Webcast Q 2 202 6 (royalcast.co m) . The presentation will be held by Svein J. Liknes (CEO) and Birte Norheim (CFO).

Vår Energi: Second quarter 2026 trading update

Average production in the first half of 2026 was 391 kboepd. Vår Energi’s net production of oil, liquids and natural gas averaged 376 kboepd in the second quarter of 2026, a decrease of 7% from the first quarter of 2026 and an increase of 31% compared to the second quarter of 2025. With the majority of the planned turnaround activities for the year executed successfully in the second quarter, and planned project start-up’s and infill wells ramping up in the second half of 2026, the Company is on track to deliver full year 2026 production within guided range of 390 to 410 kboepd. The production split in the second quarter was 67% oil and NGLs (liquids) and 33% gas. Total volumes produced were 34.2 mmboe whereas volumes sold in the quarter amounted to 35.4 mmboe. The overlift position is mainly due to timing of crude liftings in the quarter. Vår Energi obtained an average realised price (volume-weighted) of USD 101 per boe in the quarter. The realised crude price was USD 110 per barrel representing a premium of USD 6 per barrel compared to dated Brent. The realised gas price of USD 91 per boe is around USD 1 per boe above the average spot market reference price. []Production (kboepd)[1] Q2 2026 Q1 2026 Q2 2025 1H 2026 1H 2025Crude oil 235 262 180 249 170Gas 123 122 92 122 94NGL 18 22 16 20 16Total 376 406 288 391 280 Realised prices (USD/boe)Crude oil price 110 80 68 95 72Gas price 91 73 79 82 83NGL price 62 50 43 58 47Average (volume weighted) 101 77 70 89 74 Sales volumes (mmboe)Crude oil 22.2 23.1 17.1 45.4 32.1Gas 10.5 10.1 7.7 20.6 15.8NGL 2.7 1.4 1.2 4.1 1.9Total 35.4 34.6 26.0 70.1 49.8 Total production (mmboe) 34.2 36.5 26.2 70.7 50.7 ¹ Produced figures are including fuel gas not for sale Other items As a result of the Company’s history of mergers and acquisitions, Vår Energi has several assets valued at fair value in the balance sheet. Changes in assumptions, cost and production profiles can result in impairments and reversals. There are no expected impairments in the quarter. The following items impacted the free cash flow in the second quarter: three cash tax payments totaling approximately NOK 8 billion (approximately USD 850 million) and a dividend payment for the first quarter of USD 300 million, paid in June. This information is based on a preliminary assessment of the Company's second quarter 2026 financial results and may be subject to change until the financial statements have been finally approved and published by the Company. Q2 2026 webcast Vår Energi will release its quarterly results on 21 July at 07:00 CEST. A webcast followed by Q&A will be held at 10:00 CEST, hosted by CEO Nick Walker and CFO Carlo Santopadre. You can follow the webcast with supporting slides, available on: https://events.streamhub.no/vaar-energi/quarterly-reports/AU4OtQqpy5OQnygbSUxS Contact Investor relations Ida Marie Fjellheim, VP Investor Relations +47 90509291 ida.fjellheim@varenergi.no About Vår Energi Vår Energi is a leading independent upstream oil and gas company on the Norwegian Continental Shelf (NCS). To learn more, please visit varenergi.no. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act

Sivers Semiconductors Updates Financial Reporting Calendar

Press Release Kista, Sweden – July 9, 2026 – Sivers Semiconductors AB (STO:SIVE), Sivers Semiconductors AB (publ), today announced updates to its financial reporting calendar as the Company continues to strengthen its financial reporting processes and prepare for future regulatory and US PCAOB audit requirements associated with the dual-listing objective. Updated Reporting Dates: · Q2 2026 Interim Report: August 27, 2026 · Q3 2026 Interim Report: November 26, 2026 · Q4 2026 Interim Report: February 25, 2027 This decision reflects management's commitment to maintaining the highest standards of financial reporting accuracy, transparency, and compliance as the Company continues to mature its internal controls and reporting processes. "As we continue to scale our business, pursue the dual-listing objective, and execute on our long-term strategy, it is important that our financial reporting processes evolve accordingly,” said Vickram Vathulya President & CEO.” Taking the additional time to complete our reporting process ensures compliance with the US PCAOB audit standards, as well as the quality, rigor, and transparency expected by shareholders and the broader investment community." For more information, please contact: Heine Thorsgaard CFO, Sivers Semiconductors Tel: +46 (0)8 703 68 00 Email: ir@sivers-semiconductors.com About Sivers Semiconductors We are Critical Enablers of a Greener Data Economy with Energy Efficient Photonics & Wireless Solutions. Our differentiated high precision laser and RF beamformer technologies help our customers in key markets such as AI Data Centers, SATCOM, Defense and Telecom solve essential performance challenges while enabling a much greener footprint. Visit us at: www.sivers-semiconductors.com (SIVE:ST).

BlueNord Announces Second Quarter and First Half 2026 Results and Declares Cash Dividend for the Quarter

Oslo, 9 July 2026: BlueNord ASA (“BlueNord” or the “Company”) has today announced its financial results for the second quarter and first half of 2026, delivering record net cash flow from operating activities in a period of significant market volatility. As a result, BlueNord has declared a cash dividend of USD 174 million for Q2 2026, at the top end of our distribution policy range and the Company’s largest quarterly distribution to date. Highlights: · Successful completion of the planned Tyra shutdown in June, with the full work scope executed and the hub currently producing at record rates above 28 mboepd net to BlueNord · Net hydrocarbon production of 37.2 mboepd for Q2, reflecting the planned work scope on Tyra and Gorm · Revenues of USD 277 million for the quarter and USD 594 million for the first half of 2026 · EBITDA of USD 147 million for the quarter and USD 348 million for the first half of 2026 · Record net operating cash flow of USD 249 million compared to USD 141 million in previous quarter, bringing net operating cash flow for the first half to USD 390 million · Declared cash dividend for the quarter of USD 174 million, the largest quarterly distribution to date, with paid and declared distributions now totalling USD 780 million · Successful issuance of a USD 400 million 5-year senior unsecured bond in May, refinancing BNOR16 at significantly improved terms, reducing the Company’s borrowing cost and providing increased distribution flexibility · Strong liquidity position of USD 546 million at quarter end OperationalBlueNord delivered a total net production of 37.2 mboepd in the second quarter of 2026, reflecting the planned maintenance shutdowns at both the Tyra and Gorm hubs during the quarter. The Tyra hub produced 19.3 mboepd, with the planned June shutdown successfully completed and the full work scope executed. Following the restart, Tyra exited the quarter producing at record gas rates above 250 mmscf/d and is currently producing above 28 mboepd net to BlueNord. The Company expects steady-state performance to be delivered for the second half of 2026. The base assets (Dan, Gorm and Halfdan hubs) averaged 17.9 mboepd, with the annual full-field shutdown at Gorm completed during May. With the planned Q2 maintenance activity now complete, the Company currently delivers a total production above 47 mboepd providing strong momentum into the third quarter, where production is guided at 42.0-49.0 mboepd. FinancialsRevenue for the quarter was USD 277 million, reflecting lower production during the shutdown period, partially offset by strong commodity prices. EBITDA was USD 147 million, with net operating cash flow reaching a record USD 249 million. Unit operating costs were temporarily higher as a result of the planned shutdown activity and are expected to return to target levels in the second half of 2026. The Company’s hedge portfolio provides downside protection through to the end of 2026. During the quarter, the Company successfully issued BNOR18, a USD 400 million 5-year senior unsecured bond maturing in 2031. The transaction was multiple times oversubscribed and attractively priced at 7.875 percent, with net proceeds used primarily to refinance the USD 300 million BNOR16 senior unsecured bond, reducing the Company’s cost of borrowing and extending its maturity profile. The terms of the new bond, including its distribution covenants, provide increased flexibility. Reflecting the strong cash generation in Q2, the Company has declared a cash dividend for the second quarter of USD 174 million, at the top end of the distribution policy range of 50-70% of operating cash flow and a record quarterly dividend, bringing total paid and declared distributions to date to USD 780 million. “The second quarter of 2026 demonstrates the resilience of BlueNord’s business, with record quarterly net operating cashflow and dividend delivered in a period of significant market volatility. The planned Tyra shutdown was completed with the full work scope successfully executed, and the hub is now producing at record rates, providing strong momentum into a second half in which we expect higher operational efficiency and further production growth.While oil prices have been volatile, gas prices have remained consistently high and, with gas now representing a substantial share of our production, the Company is well positioned to capture this strength. Our forward outlook benefits from the hedge portfolio we strengthened during the first quarter to cover the majority of expected volumes through to the end of 2026, protecting the cashflow that underpins our distributions while retaining exposure to further upside. During the quarter we also completed the refinancing of BNOR16, reducing our cost of borrowing and providing additional flexibility ahead of the new distribution policy we intend to communicate later this year. As operational performance strengthens into the second half, our priority remains unchanged: converting this into cash and returning it to our shareholders,” said Euan Shirlaw, Chief Executive Officer of BlueNord. The report and investor presentation may be downloaded from the Company’s website www.bluenord.com or www.newsweb.no. The Company will host a webcast today at 10:00 CEST. To join webcast: https: //qcnl.tv/p/Hr1IcAJVGmuiYeouvVvs9w Contact:Cathrine F. Torgersen, Chief Corporate Affairs OfficerPhone: +47 915 28 501Email: cathrine.torgersen@bluenord.com This information is considered to be inside information pursuant to the EU Market Abuse Regulation, and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. The stock exchange announcement was published by Cathrine Torgersen, Chief Corporate Affairs Officer, BlueNord ASA, at the date and time as set out above. 

Cruise passengers embrace “zebra striping” – Aperol Spritz faces a challenger

The arrival of summer and the opening of the sun decks are influencing passengers’ drink choices, with consumption shifting towards lighter options. White wine, lager beer and especially long drinks are overtaking stronger alternatives. Fresh, summery cocktails are also popular choices. Spritz drinks remain a staple of the summer season: in addition to Aperol, elderflower-based Hugo and rhubarb spritz are among the most popular options. Early this summer, it is already clear that this year’s standout drink on Viking Line is Raspberry Fields, created by the company’s restaurant team. The cocktail combines rum, raspberry, lemon and Swedish craft soda. “Raspberry Fields is a long, red and refreshing cocktail – exactly the kind our passengers enjoy at sea. It has taken its place alongside Aperol Spritz, which is quite an achievement, as Aperol has in recent years been something of a symbol of summer and holidays,” says Ossi Ruusunen, Beverage Manager at Viking Line. TikTok favourites and classic drinks side by side Although new drink trends are constantly emerging, classic cocktails continue to hold their ground. “Here, classic cocktails may have an even stronger position than in many land-based restaurants. A cruise has its own distinct atmosphere, and that is reflected in our guests’ drink choices as well. Perhaps most surprisingly, Irish Coffee remains among the most popular cocktails all year round. It is followed by Whisky Sour, Dry Martini and Negroni, which has emerged as a trending favourite,” says Ossi Ruusunen. Generational differences can also be seen in passengers’ drink choices. Younger travellers consume alcohol more moderately than older generations but are highly quality-conscious and actively follow international drink trends. “This is particularly evident in the growing popularity of Espresso Martini and Spicy Margarita. Over the past year, we have sold more of these than ever before.” Zebra striping trend also seen on board One of the most significant changes in onboard restaurants in recent years has been the sharp increase in demand for alcohol-free beverages. During the summer months, as many as one in four cocktails ordered from the drinks menu on Viking Line is alcohol-free. “It is no longer just about avoiding alcohol, but about seeking quality and flavour experiences. The same trend can be seen in alcohol-free wines, where demand continues to grow year by year. I see this development as very positive, as it challenges the entire industry to create ever better alcohol-free products. Mediocrity is no longer enough – not even in the alcohol-free category”, says Ossi Ruusunen. The latest trend in drinking habits is so-called zebra striping – alternating between alcoholic and alcohol-free beverages during the same evening. “Guests might choose an alcohol-free sparkling wine, sparkling tea or a mocktail as an aperitif, and later have wine with their meal. People no longer see drinking as an either-or choice”. Summer 2026 onboard drink trends • Light, refreshing summer cocktails such as Raspberry Fields, Aperol Spritz and Hugo Spritz• Social media favourites such as Espresso Martini and Spicy Margarita• Classic cocktails such as Irish Coffee and Negroni• Alcohol-free wines and cocktails• High-quality lager beers, including speciality beers• Long drinks – this year especially Hartwall Original Long Drink Summer Mandarin and the new sugar-free Strawberry Light, available exclusively on board For further information: Ossi Ruusunen, Beverage Manager ossi.ruusunen@vikingline.com, +358 50 555 4308 Johanna Boijer-Svahnström, Director of Communicationsjohanna.boijer@vikingline.com, tel +358 18 270 00

VAROPreem acquires the world’s largest Raw Tall Oil bio-refinery, strengthening Europe's renewable fuels supply chain

Key highlights  · Industrial scale: World's largest manufacturing facility for Raw Tall Oil in Piteå, Sweden, with the capacity to process approximately 400 thousand tonnes annually. · Distinctive technology: Nearly two decades of proprietary R&D, supported by VAROPreem Sunpine’s registered IP portfolio to deliver one of the most competitive feedstock for the production of renewable fuels such as HVO and SAF. · Strategic value chain: Full ownership enables VAROPreem greater optimisation across the integrated renewable fuels value chain, from processing sustainable raw materials through to the renewable fuels that customers use today. VAROPreem Sunpine occupies a unique position in one of Europe's most important renewable fuel value chains. Its ISCC-certified product delivers greenhouse gas reductions of up to 99.7% compared with fossil fuels, while using a renewable feedstock that does not compete with food production or require dedicated agricultural land. Operating from its world-scale bio-refinery in Piteå, Sweden, VAROPreem Sunpine processes Raw Tall Oil - a renewable by-product of the pulp and paper industry - using proprietary technology. VAROPreem Sunpine’s main product is then further refined into renewable fuels such as HVO and SAF in VAROPreem manufacturing facilities. For VAROPreem, full ownership of VAROPreem Sunpine secures access to a scarce and highly traceable renewable feedstock, adds distinctive technology and world-scale manufacturing capability, and reinforces Europe's renewable fuels supply chain at a time when energy security, industrial competitiveness and lower-carbon fuels are becoming increasingly important. The acquisition brings VAROPreem Sunpine's capabilities into VAROPreem's broader refining, trading, logistics and customer supply businesses. Together, these capabilities strengthen VAROPreem's ability to connect more of the renewable fuels value chain, from sustainable raw materials and specialist processing through to renewable fuels for customers across Europe. The acquisition comes as Europe seeks to scale renewable fuels while maintaining energy security and industrial competitiveness. Demand for advanced biofuels is expected to grow across road transport, aviation and marine, supported by regulation including RED III, ReFuelEU Aviation and FuelEU Maritime. VAROPreem Sunpine's access to domestic raw materials is a core part of what makes the business distinctive. It takes a residual stream from Sweden's forest industry and creates a fuel for transport and manufacturing, with surplus heat used in district heating. This strengthens both supply resilience for VAROPreem's refineries in Sweden and the company’s ability to supply practical low-carbon solutions that work with existing vehicles, fleets and fuel infrastructure. VAROPreem intends to continue to invest in the business to strengthen operational flexibility and create further growth potential. The acquisition supports VAROPreem's ‘twin-engine’ strategy, supplying both conventional and sustainable energies to mobility and industrial customers. By adding VAROPreem Sunpine's Swedish renewable fuels capability, VAROPreem is strengthening its ability to deliver lower-carbon solutions while maintaining the secure and reliable energy supply customers need today. Dev Sanyal, Group Chief Executive Officer of VAROPreem, said: “This is much more than an acquisition. Over almost two decades, Sunpine has built one of Europe’s most distinctive advanced renewable fuels businesses, combining proprietary technology, world-class industrial scale with access to one of the highest quality renewable feedstocks. This is about creating long-term value. It combines technology, circularity and manufacturing excellence to strengthen Europe's renewable fuels industry while reinforcing VAROPreem's position as one of Europe's leading energy companies. By combining Sunpine with VAROPreem, we are strengthening one of Europe’s most strategic renewable fuels businesses.” David Öquist, Chief Executive Officer of Sunpine, said: “Sunpine has spent twenty years developing the technology and expertise needed to convert Raw Tall Oil into advanced biofuel feedstocks. Joining VAROPreem opens an exciting new chapter for our company. Together, we will be able to build on Sunpine’s strong foundations, support future growth and bring our technology and expertise to a broader market. We look forward to working with VAROPreem to continue developing sustainable solutions based on forestry residues.” Notes to editors About Sunpine former shareholders Sunpine was previously a joint venture between VAROPreem (25.1%), Sveaskog Förvaltnings Aktiebolag (25.1%), Södra Skogsägarna ekonomisk förening (25.1%) and Lawter Europe BV (24.7%). Sveaskog is a state-owned company and Sweden’s largest forest owner, owning 14% of Sweden’s forest land. Södra is Sweden’s largest forest owners’ association and an international forest industry group that refines the forest raw material supplied by its members. Lawter Europe BV is part of Lawter, a pine chemicals company within Japan-based Harima Chemicals Group, specialising in bio-based pine chemical products.

Update on CARDIO-TTRansform Phase III trial

[This announcement contains inside information] 9 July 2026 Update on CARDIO-TTRansform Phase III trial forWainua(eplontersen) in adults with transthyretin-mediated amyloid cardiomyopathy The CARDIO-TTRansform Phase III trial1for AstraZeneca and Ionis'Wainua(eplontersen) in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy endpoint of the composite outcome of cardiovascular (CV) mortality and recurrent CV clinical events up to 140 weeks compared with placebo.Wainuawas generally well tolerated, with a safety profile consistent with previous results.2 In this contemporary patient population treated with standard of care, including a majority on a stabiliser,3,4addingWainuadid not provide a statistically significant benefit on the composite outcome of CV mortality and recurrent CV events. In a prespecified subgroup analysis of patients treated withWainuamonotherapy as compared to placebo, fewer primary composite events (CV mortality and recurrent CV events) were observed and this result was nominally significant. In patients who were on stabiliser therapy at baseline, no treatment effect was observed. Sharon Barr, Executive Vice President, BioPharmaceuticals R&D, said: "The CARDIO-TTRansform trial was designed to examine the role ofWainua, a gene silencer treatment, on top of today's standard of care in reducing recurring cardiovascular events and mortality. Although the trial did not meet its primary objective, we believe the results support greater scientific understanding of treatment approaches for the hundreds of thousands of patients worldwide suffering from this progressive and often fatal condition." CARDIO-TTRansform is a Phase III, multicentre, randomised, double-blinded, placebo-controlled trial1to evaluate the safety and efficacy ofWainuacompared to placebo in participants with ATTR-CM receiving available standard of care: 57% of patients in each arm received a stabiliser treatment at baseline, and a further 24% in each arm initiated a stabiliser during the trial.3 AstraZeneca and Ionis will analyse the full data set to further understand the results, whichwill be shared with the scientific communityat the European Society of Cardiology (ESC) Congress in August 2026. Notes Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) ATTR-CM is a systemic, progressive, debilitating and fatal disease that predominantly affects the heart and is an underrecognised cause of HF.5,6ATTR-CM, which can be inherited (hereditary, ATTRv) or develop with age (wild-type, ATTRwt), occurs when amyloid fibrils consisting of misfolded TTR protein build up in the heart, disrupting cardiac structure and function and making it harder for the heart to pump blood throughout the body.5-7Patients commonly present with non-specific symptoms such as shortness of breath, swelling, heart palpitations, dizziness, weakness and fatigue, which can contribute to misdiagnosis and delays in care.5,7With an estimated 300,000 to 500,000 people living with ATTR-CM worldwide,9greater awareness, earlier diagnosis and appropriate targeted treatment are critical to improving outcomes and quality of life for patients.10,11 CARDIO-TTRansform Trial CARDIO-TTRansformis a global, randomised, double-blind, placebo-controlled Phase III trial evaluating the efficacy and safety ofWainua(eplontersen) in adults with wild-type or hereditary ATTR-CM who are receiving available standard of care.1,3,4As the largest enrolled ATTR-CM trial to date, CARDIO-TTRansform enrolled 1,432 participants across 130 study sites in 20 countries, who were randomised 1:1 to receive eplontersen 45 mg or placebo by subcutaneous injection every four weeks.3The primary endpoint is a composite of CV mortality and recurrent CV clinical events through Week 140.4Secondary endpoints include changes from baseline in the 6-minute walk test and Kansas City Cardiomyopathy Questionnaire overall summary score at Week 140, total recurrent CV clinical events up to Week 140, all-cause mortality up to Weeks 140 and 160, the primary endpoint in the subgroup of patients receiving a TTR stabiliser at baseline and CV mortality through Weeks 140 and 160.4 Wainua(eplontersen) Wainuais a once-monthly RNA-targeted silencer that can be self-administered via an autoinjector or as a pre-filled syringe by healthcare professionaladministration in the US.12-14It provides upstream suppression of serum TTR production at its source inthe liver.12,13Wainuahas now been approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults, commonly referred to as hATTR-PN or ATTRv-PN, in over 20 countries, including in the EU asWainzua.15 As part of a global development and commercialisation agreement, AstraZeneca and Ionis are jointly developing and commercialisingWainuain the US. Outside the US, AstraZeneca has exclusive rest of world commercialisation and development rights. AstraZeneca in CVRMCardiovascular, Renal and Metabolism (CVRM), part of BioPharmaceuticals, forms one of AstraZeneca's main disease areas and is a key growth driver for the Company. By following the science to understand more clearly the underlying links between the heart, kidneys, liver and pancreas, AstraZeneca is investing in a portfolio of medicines for organ protection by slowing or stopping disease progression and ultimately paving the way towards regenerative therapies. The Company's ambition is to improve and save the lives of millions of people, by better understanding the interconnections between CVRM diseases and targeting the mechanisms that drive them, so we can detect, diagnose and treat people earlier and more effectively. AstraZeneca  AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Disease, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visitastrazeneca.com and follow the Company on Social Media@AstraZeneca . Contacts For details on how to contact the Investor Relations Team, please clickhere . For Media contacts, clickhere . References: 1. ClinicalTrials.gov. CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM). Available at: https://clinicaltrials.gov/study/NCT04136171. Accessed July 2026. 2. AstraZeneca 2023. Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis. Available at: https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-acquires-cincor-for-cardiorenal-asset.html. Accessed July 2026. 3. Maurer MS, et al. Design and baseline characteristics of the CARDIO-TTRansform phase 3 randomised controlled trial of eplontersen for participants with transthyretin amyloidosis with cardiomyopathy (ATTR-CM). Presented at: Heart Failure Congress 2026. Heart Failure Congress 2026; 2026 9-12 May 2026; Barcelona, Spain. 4. Masri A, et al. Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy. Circulation: Heart Failure. 2026;19(6):e014205. 5. Gertz MA. Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges. Am J Manag Care. 2017;23(7 Suppl):S107-s12. 6. Ando Y, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31. 7. Brunjes DL, et al. Transthyretin Cardiac Amyloidosis in Older Americans. J Card Fail. 2016;22(12):996-1003. 8. Rintell D, et al. Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups. Orphanet J Rare Dis. 2021;16(1):70. 9. Ionis Pharmaceuticals I. SEC Filing Details 202210. Kittleson MM, et al. Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance. J Am Coll Cardiol. 2026;87(5):549-65.11. Maurer MS, et al. Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Adv Ther. 2024;41(7):2723-42.12. Coelho T, et al. Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L(Rx) (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy. Neurol Ther. 2021;10(1):375-89.13. Coelho T, et al. Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy.JAMA.2023;330(15):1448–1458.14. AstraZeneca. Wainua (eplontersen) 45 mg solution for injection in pre-filled pen: summary of product characteristics. European Medicines Agency. 2026 [Available from: https://www.ema.europa.eu/en/documents/product-information/wainzua-epar-product-information_en.pdf.15. AstraZeneca 2024. Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis. Available at: https://www.astrazeneca.com/media-centre/press-releases/2024/wainzua-recommended-for-approval-in-the-eu.html. Accessed July 2026. Matthew Bowden Company Secretary AstraZeneca PLC This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.comor visitwww.rns.com.

Nordisk Bergteknik recruits Fredrik Karlsson as new CFO

"We are very pleased to be able to welcome Fredrik Karlsson as Nordisk Bergteknik's new CFO. Fredrik will bring the important combination of broad financial expertise with extensive operational experience from several different roles, not least in project management within construction and project-based businesses. Together with solid business acumen and strong leadership qualities, he will be a significant asset to Nordisk Bergteknik in the years ahead", says Andreas Christoffersson, CEO of Nordisk Bergteknik AB. Fredrik Karlsson, born in 1980, brings experience from both entrepreneurial environments and larger organisations, where he has been part of building finance functions, implementing systems and establishing structures for reporting and governance. He has among other things spent one and a half decades in various roles at Serneke, and prior to that worked within audit. "I truly look forward to taking on the role as Nordisk Bergteknik's new CFO. Above all, it is the combination of a decentralised and entrepreneurial culture within a listed group, and the opportunity to work close to the business in a smaller, tight-knit context, that attracts me", says Fredrik Karlsson, incoming CFO of Nordisk Bergteknik. Current CFO Johan Lundqvist, who has been active within Nordisk Bergteknik since its founding in 2016, will leave his position at the end of the third quarter to support the Group in an advisory capacity, with particular focus on the Norwegian operations. "Johan Lundqvist has a deep knowledge of our entire business and will contribute with valuable continuity, as well as supporting the Group's Norwegian operations on financial and operational matters during a transition period", says Andreas Christoffersson, CEO of Nordisk Bergteknik AB. For further information, contact: Andreas Christoffersson, CEO, +46 70-621 19 28, andreas.christoffersson@bergteknikgroup.com Johan Lundqvist, CFO, +46 76-392 71 21, johan.lundqvist@bergteknikgroup.com About Nordisk Bergteknik Nordisk Bergteknik has a clear growth strategy with the objective to contribute to the development of a future sustainable society. Our companies are specialists within rock handling and foundation solutions, and through compassion and skill they are able to combine demand with the surrounding natural conditions. To be involved at an early stage in building modern societal functions is our everyday life, our home ground and our future.

BiBB signs exclusive distribution agreement with Palex Medical Spain

Comment from Fredrik Lindblad, CEO of BiBB:"Signing our first European commercial distribution agreement represents an important milestone for BiBB. Palex Medical Spain combines a strong commercial organization with extensive experience in advanced endoscopy and a well-established presence in the Spanish healthcare market. We look forward to introducing EndoDrill[®] GI together with Palex and to supporting clinicians with a new approach to tissue acquisition through high-quality core tissue samples.” The agreement includes exclusivity rights and mutually agreed commercial targets. The agreement covers EndoDrill[®] GI only and does not include other products within the EndoDrill[®] portfolio. Additional EndoDrill® products may be added to the agreement as they become commercially available. Palex Group is one of Europe's leading healthcare distribution groups, operating across 11 European regions. The Group employs more than 2,100 people and is headquartered in Barcelona, Spain. Palex Spain is the Group's largest operating company, employing close to 1,000 people and serving healthcare providers throughout Spain. Commercial launch preparations in Spain have commenced. EndoDrill[®] GI has already been successfully used in patient cases at several leading EUS centers in Madrid and Valladolid together with Palex. The positive clinical experience generated through these procedures has provided an important foundation for the commercial launch. The parties have subsequently initiated market development activities, including clinical engagement, target account identification and launch planning. María Jesús Barrenechea , CBO Spain of Palex:”The introduction of BiBBInstruments’ EndoDrill[®] technology represents an important step forward in our commitment to advanced, patient-centred care. By enabling high-quality core biopsies through a powered, rotating tissue acquisition system, this state-of-the-art technology has the potential to improve the reliability of tissue sampling and support more accurate diagnosis and treatment planning. For patients, this may translate into better-informed clinical decisions and a more efficient diagnostic pathway. For healthcare professionals, EndoDrill[®] provides an innovative tool designed to enhance precision and confidence in endoscopic tissue acquisition procedures.” Spain represents an important European market for endoscopic ultrasound, with approximately 100 hospitals performing EUS procedures. The agreement with Palex Medical Spain is intended to support further commercial expansion within the Palex network. BiBB is currently engaged in discussions regarding additional European territories. About Palex Group and Palex Medical SpainPalex Group is a leading European healthcare and medical technology distribution group providing advanced solutions and services to hospitals, healthcare professionals and research institutions. The Group operates through a network of specialized companies with expertise spanning endoscopy, surgery, interventional medicine and hospital solutions. Palex Spain is the largest operating company within Palex Group, one of Europe's leading healthcare distribution groups. The company employs close to 1,000 people and maintains a dedicated endoscopy organization serving leading hospitals throughout Spain. About EndoDrill[®] GIEndoDrill[®] GI is the world's first market-cleared powered biopsy instrument for endoscopic ultrasound (EUS), with both FDA 510(k) clearance and CE marking. Unlike conventional manual biopsy needles, EndoDrill[®] uses a powered rotating needle tip designed to obtain intact core tissue samples to facilitate histopathology and molecular analysis. The system is currently being commercialized in the United States through distribution partner TaeWoong Medical USA. The European commercial launch is scheduled to commence in Spain during 2026 through distribution partner Palex Medical Spain, representing the first step in BiBB's planned expansion across Europe. For more information, please contact:Fredrik Lindblad, CEOEmail: fredrik.lindblad@bibbinstruments.comPhone: +46 70 899 94 86www.bibbinstruments.com  This is a translation of the Swedish press release. In the event of any discrepancy, the Swedish language version shall prevail. The information was submitted for publication, through the agency of the contact person set out above, at the time stated by the Company’s news distributor upon publication of this press release. About BiBBInstruments AB BiBBInstruments AB is a cancer diagnostics company developing and manufacturing EndoDrill®, the world’s first series of market-cleared powered endoscopic biopsy instruments. EndoDrill® is designed to obtain core tissue samples (core needle biopsies, CNB) with high diagnostic accuracy and aims to improve the diagnosis of cancers in organs such as the stomach, pancreas, liver, lungs, and urinary bladder. The product portfolio targets the global market for ultrasound-guided endoscopic biopsy instruments (EUS/EBUS), one of the most advanced and fastest-growing segments within modern endoscopy. BiBB received FDA 510(k) clearance for its first instrument, EndoDrill® GI, in 2023 and CE marking under the European Medical Device Regulation (MDR) in 2024 for all three product variants – EndoDrill® GI, EndoDrill® EBUS, and EndoDrill® URO. As such, EndoDrill® is the first powered biopsy system cleared in both the United States and Europe. The U.S. launch of EndoDrill® GI commenced during the second half of 2025 in collaboration with TaeWoong Medical USA. The EndoDrill® system consists of sterile single-use instruments and a proprietary drive system. BiBB was founded in 2013 by Dr. Charles Walther, cancer researcher at Lund University and senior consultant pathologist at Skåne University Hospital. The Company is headquartered at Medicon Village in Lund, Sweden, and its shares are listed on Spotlight Stock Market (ticker: BIBB).

AFRY supports modernization of Austria’s Franz-Josefs-Bahn

The Franz-Josefs-Bahn is an important regional rail corridor connecting Vienna with northern Austria and the Czech border. The line is currently undergoing a long-term program to modernize and strengthen its role in modern, efficient transport. The program includes upgrades to tracks, overhead line systems, and supporting infrastructure, as well as targeted improvements to stations and rail assets. These measures are designed to enhance operational reliability, increase capacity, and improve the experience for both passenger and freight transport. “This is an important step in strengthening rail infrastructure and improving service quality for passengers and freight customers. We are pleased to collaborate with AFRY, whose expertise supports the efficient implementation of this project,” said Friedrich Dallhammer, Project manager construction technology, ÖBB-Infrastruktur AG. Within the project, AFRY is responsible for site supervision and construction oversight. In this role, AFRY manages quality assurance, contract and time management, as well as project management and billing, ensuring efficient and high-quality delivery of infrastructure upgrades along key sections of the line. “Projects like this are central to advancing sustainable mobility. We are proud to support ÖBB-Infrastruktur AG with our expertise in project supervision and delivery, contributing to a more reliable and future-proof rail system,” said Ernst Zeller, Head of Segment Hydro, AFRY. AFRY is carrying out the assignment on behalf of ÖBB-Infrastruktur AG, with the project running until 31 December 2028.For further information, please contact: Mia Brunila, Head of Global Divisional Communications, AFRY+358 44 041 1418mia.brunila@afry.com Andreas Wutschl, Director and Head of Hydro Site Services Austria, AFRY+436 64 828 68 49andreas.wutschl@afry.com AFRY provides engineering, project management, and advisory services that enable the energy and industrial transition and strengthen resilience in society.With 18,000 experts worldwide, we combine a global reach with local insights and deep sector knowledge to make a lasting impact for generations to come. Making future

Vattenfall InCharge acquires Nima Energy´s ultra-fast charging business

The acquisition will significantly enhance Vattenfall’s charging footprint in key metropolitan areas, including Stockholm and Malmö.  "More drivers are switching to electric vehicles and expect charging to be available wherever they travel. This acquisition will give our customers increased access to fast and reliable charging in more locations while strengthening our position in Sweden’s fastest-growing charging markets," says Henrik Nordström, Director Vattenfall E-Mobility Sweden. Nima Energy currently operates 178 high-power charging points at 16 locations in Sweden, offering charging capacities of up to 300–400 kW. In addition, 254 ultra-fast charging points across 36 new locations are planned for development. The acquisition also supports Vattenfall’s long-term ambition to develop a leading and profitable charging business in Europe under the Vattenfall InCharge brand. Vattenfall InCharge has today more than 48,500 charging points across Sweden, Netherlands and Germany, of which 7,500 charging points in Sweden. "This acquisition is an important step in executing our European growth strategy. By combining Nima’s strong local footprint with Vattenfall’s scale, expertise and long-term commitment to fossil-free mobility, we can accelerate expansion and improve the charging experience for customers across Sweden," says Fabian Hagmann, Vice President BU E-Mobility, Vattenfall.  Founded in 2020, Nima Energy has built a strong reputation within ultra-fast charging. “It has been an extraordinary journey to build Nima Energy into the company it is today. We are immensely proud of the team, the network and the market position we have created together. We also firmly believe that the next phase can be even more exciting, and that Vattenfall is the right long-term owner to support Nima Energy reach its full potential” says Marcus Landelin, CEO and Co-founder of Nima Energy. “Nima has built an impressive ultra-fast charging network in attractive locations across Sweden, making it a strong addition to Vattenfall InCharge’s existing infrastructure. We are pleased to welcome Nima’s talented employees and look forward to continuing to provide Nima’s customers with the high level of service they expect. Together, we can accelerate the expansion of charging infrastructure and support the growing transition to electric mobility across Sweden,” says Henrik Nordström. The integration planning will commence following signing, with operational integration beginning after closing of the transaction. Financial details of the transaction are not disclosed. About Vattenfall InChargeVattenfall InCharge is a leading provider of charging solutions for electric vehicles, offering public charging infrastructure and charging services across several European markets. With approximately 48,500 publicly accessible charge points across Europe, including around 7,500 in Sweden, the company operates one of the region’s most extensive charging networks. Vattenfall InCharge is focused on building a high-performing, customer-centric charging ecosystem that enables the transition to fossil-free transport and supports the rapidly growing demand for electric mobility.About Nima EnergyNima Energy develops and operates high-capacity fast-charging infrastructure for electric vehicles in Sweden, with a focus on cities and key transport routes. The company serves both professional drivers, including taxis and fleets, and private EV drivers. Nima Energy operates 170 charging points across 15 sites in Sweden and has a strong pipeline of new sites expected to be developed and constructed in the coming years.  For more information, please contact:Vattenfall’s Press Office, +46 8 739 50 10, press@vattenfall.com

Wetteri discontinues sales of Seres, Skywell and DFSK vehicles

Wetteri PlcMedia Release9 July 2026 at 11 a.m. Wetteri discontinues sales of Seres, Skywell and DFSK vehicles Wetteri has decided to discontinue the sale of the Chinese car brands Seres, Skywell and DFSK as part of the optimization of its dealership network and brand portfolio. The company currently represents these brands at its locations in Oulu and Kuopio. "Wetteri’s objective is to strengthen its position particularly in high-volume brands and to focus its operations on growth centres and key market areas. This change allows us to allocate resources more efficiently to the development of our core brands and to expand their presence into new locations", says Aarne Simula, CEO of Wetteri. Following the change, Wetteri will continue to operate one of Finland’s broadest multi-brand passenger car networks, comprising 19 full-service sales and aftersales dealerships and 14 authorised service centres across 16 locations. Further information: Heidi Väkevä / Wetteri Communicationstel. +358 50336 975, viestinta@wetteri.fi Wetteri Plc – A car dealership from the north, across Finland Wetteri Plc is a full-service car dealership with more than 60 years of history in the Finnish car trade. Its business consists of three segments: passenger cars, maintenance services and heavy equipment. The company has grown from a local car dealership in Oulu into a national operator with 19 locations in Finland. Wetteri employs around 800 automotive professionals. Our goal is to deliver unrivalled car trade services and to be an excellent partner for our customers throughout the entire automotive life cycle. We are a key player in the Finnish car market on the journey towards zero-emission driving. Wetteri is listed on Nasdaq Helsinki. More information: sijoittajat.wetteri.fi/en/.

Provet Launches The First All-in-One Veterinary PIMS Built for AI Agents

HELSINKI, FINLAND — Provet, the veterinary practice management software used by more than 55,000 veterinary professionals across 45 countries, today unveiled the next era of Provet by launching the first and only all-in-one veterinary practice management system (PIMS) built for AI Agents to help with booking, treating, billing, and managing. Unlike third-party solutions or PIMS with bolt-on AI modules, Provet Agents are natively built into the Provet platform with full context on the clinic’s records, performance, operations, customer communications, inventory, and permissions. Provet’s AI Agents understand what is happening within a clinic, surfacing important information and - with a human's approval - can take action. Provet brings the core tools of the practice into one place and adds intelligence across every workflow, so teams spend less time managing software and more time delivering care and growing the practice. "Practice management software has always been manual. You enter the data, then dig through records to get it back. Now we're changing that. Today we launch AI Agents that enter data for you, surface what matters in the moment, and answer on demand," said Charles MacBain, CEO of Nordhealth and Provet.MacBain added, “In 2005, Provet was the first cloud-based PIMS. In 2015, Provet was the first with an open API because the industry deserved a platform built on openness and choice. Today, our AI Agents mark the beginning of a new era for veterinary practice management: giving every role more time for care, and equipping veterinary professionals with the tools to deliver better care for pets and their parents." Provet's new agentic AI capabilities Ask Provet Agent answers operational questions in plain language - the way a practice manager might ask a colleague - using live practice data about invoices, payments, debt, items and health plans, with more data sources to follow. Clinical AI Agent, using Provet’s AI Scribe, captures every measurement, diagnosis, medication, and charge spoken during the consultation. The chart and invoice are ready to confirm in one click - no missed charges, forgotten notes, or notes written after hours. Provet MCP (coming soon) will connect your practice to external AI Agents, including tools like Claude, ChatGPT, and Gemini. Those AI Agents can securely access Provet data and bring back useful practice context, so you can work in your AI tool of choice. "Saving five minutes per consult adds up when you have 20 to 30 a day," said Dr. Punit Rawal, veterinarian at Fauna Veterinary Clinic. "It helps me get home for my kids' bath time." Seven core principles, one intelligent platform To mark the start of Provet's agentic PIMS journey, the company has updated its core principles to reflect its growth and transformation from a cloud-based software provider to an agentic PIMS partner. The updated platform reflects seven core principles: 1. Intelligent. AI built into every workflow, not bolted on. History summarized before every consult, notes and charge capture by Scribe, discharge plans in plain language, business questions answered by Ask Provet. 2. All-in-one. EMR, scribe, payments, messaging, reporting, health plans, inpatient treatment sheets, online booking, and client engagement in one workspace. One login. One bill. One team behind it. 3. Open. A documented REST API. 150+ integrations. 100% data ownership. Build on top of Provet. Leave with your data whenever you want. 4. Simple and powerful. Simple enough to onboard a new nurse in one day. Powerful enough for the most complex cases and groups. 5. Scalable. From single-vet GP clinics to multi-site specialty and enterprise groups with 500+ sites, Provet fits each clinic’s workflow and grows with the business. Migrations done on time, on budget, with data intact. 6. Secure. The only global PIMS that's ISO 27001:2022 certified, with 99.99% uptime and an in-house security team. 7. Independent. Provet sells software. Not lab equipment, not pharmacy distribution, not insurance policies, not supplies. Customers keep their leverage with labs, suppliers, and partners, while Provet stays focused on building the best all-in-one veterinary platform. With a customer base of more than 3,000 clinics across 45 countries, including some of the largest veterinary groups in the world and independent practices, Provet enters its next era as the leading independent veterinary PIMS. For further information and to see Provet in action, please visit provet.com/next 

SIBS signs agreement for the delivery of 200 student housing units in Sweden

SIBS AB (publ) is pleased to announce that it has signed an agreement for the design and turnkey delivery of 200 student accommodation units in Sweden. The project will be based on SIBS´s standardized product concept for student housing, with building configurations optimized for modular production and assembly. The project will be developed by a Swedish developer, on land with an approved zoning plan in place. SIBS will lead the design work through to building start permit, at which point the agreement is set to convert into a turnkey production contract. Having delivered close to 4,000 homes in Sweden through own or joint developments, this agreement marks SIBS's first external delivery outside of Sveaviken Bostad in the Swedish market, underlining the strength of its standardized product offering to a broader customer base. Design work is ongoing, with production start targeted for the fourth quarter of 2026, subject to building permit approval and financing. For more information, please contact: Carl Saidac Director Europe, SIBS AB cs@sibs.se This information is the kind of insideinformation that SIBS AB (publ) isobliged to make public in accordancewith the EU Market Abuse Regulation andthe Swedish Securities Market Act. Theinformation was submitted forpublication, through the contact personat SIBS AB above, at 11.30 CEST on 9July 2026.SIBS was founded in 2016 and is todayone of the world’s leading modularbuilding manufacturers. With an annualscalable capacity of up to around 6,000homes, or 12,000 modules, SIBS deliverssustainable, high-quality buildingsadapted to local conditions. Thecompany’s industrialized platformenables awide range of applications, fromresidential housing to communitybuildings.SIBS has the entire integrated valuechain for industrial constructionwithinthe group, including design andconfiguration in its own buildingsystem,industrial production in its ownfactories, and onsite assembly andfinalization. Through digitalizationand advanced technology, SIBS sets anewstandard in the construction industry.SIBS’ bond is listed on NasdaqStockholm. Read more at www.sibs.se.

InCoax shows how shared 5G FWA can reach every apartment using existing coax

Five years into 5G, mmWave remains one of the clearest examples of the gap between technical promise and everyday broadband value. The technology can deliver very high capacity in trials and targeted deployments, but it has not become the broad breakthrough many expected. That may be because the industry has been looking for the wrong application. High-band 5G is not ideal for wide-area coverage or deep indoor reach through walls, low-emissivity windows and floor slabs. Its strength is high capacity over short distances, especially where demand is concentrated. That makes fixed wireless access one of the most relevant roles for 5G mmWave. In dense urban areas, where many homes are concentrated within a small footprint and civil works can be costly or slow, mmWave FWA can bring multi-gigabit capacity to buildings faster than a full fiber build. The recent U.S. auction of 5G spectrum underlines that licensed wireless capacity remains strategically important. But more spectrum alone does not create broadband services. Operators also need a cost-effective way to carry capacity from the building entry point to each subscriber. This is the deployment gap InCoax is addressing. Reaching the building is not the same as connecting the apartments inside it. New fiber or Ethernet inside an existing MDU can be expensive, time consuming and disruptive for residents. InCoax uses the coaxial infrastructure already present in many MDUs as a managed broadband access network. Its MoCA Access-based platform carries capacity from the building entry point to individual apartments, supporting per-subscriber separation, quality of service and operational control without new in-building cabling. (Figure 1: 5G FWA spectrum across 5G NR bands FR1 and FR2, with FR3 lower high-band under study.) The Broadband Forum’s TR-507 architecture provides a framework for this model. A single 5G FWA connection into the property acts as shared backhaul for the building. InCoax MoCA Access then distributes that capacity over existing coax to each apartment. (Figure 2: InCoax MoCA Access extends a shared 5G FWA connection over existing in-building coax infrastructure, from the DPU/control unit to apartment NTE/modems.) This building-centered approach was demonstrated at Network X in Paris, where Nokia and InCoax presented a multi-tenant 5G FWA solution based on TR-507 and MoCA Access over coax. The implementation received the “FWA Solution of the Year” award, highlighting that the concept is not only a technical architecture but a practical deployment model for real MDU environments. For operators, the value is direct. Shared mmWave FWA can bring high-capacity broadband to a property quickly. InCoax MoCA Access can then distribute that capacity through infrastructure that is already installed. This reduces the need for full in-building rewiring, shortens deployment time and creates a faster route to customers in apartment buildings, student housing and other dense living environments. The model also preserves a migration path. The same in-building MoCA Access platform can initially be fed by 5G FWA and later by fiber once fiber reaches the address. Operators can therefore accelerate service availability today without creating a dead-end architecture for tomorrow. Craig Thomas, CEO and President of Broadband Forum, describes the industry challenge and the role of TR-507 in connecting 5G FWA to the in-building network this way: “The industry has learned that the real challenge for high-band 5G is not reaching the street, but the last stretch inside the building. TR-507 answers that challenge by treating 5G FWA as shared backhaul to the MDU and using established in-building media such as coax to reach every apartment. The work demonstrated together with InCoax and Nokia shows how this approach can turn 5G FWA into a scalable broadband option for apartment buildings, rather than a technology that stops at the façade.” Jakob Tobieson, CEO of InCoax Networks, sees the same issue as a practical deployment problem rather than a limitation in 5G radio performance alone: “The missing piece in many 5G FWA deployments is not radio capacity alone, but a practical way to take that capacity from the outside to every apartment. By reusing existing coax with MoCA Access, InCoax makes shared 5G FWA deployable in MDUs without the delay and disruption of rewiring. That is where we believe our technology can help turn 5G into real broadband service.” The wider implication is clear. Fixed wireless access is already one of 5G’s most commercially relevant use cases, but dense MDU markets remain hard to serve because full fiber upgrades inside existing buildings can take years. A building-centric architecture where 5G FWA feeds the property and InCoax MoCA Access reuses the existing coax network removes much of that delay. In that light, the search for a dramatic 5G breakthrough may have overlooked a simpler answer. One of the most meaningful roles for 5G mmWave may be shared, high-capacity broadband access to dense buildings. It addresses a clear market problem, fits operator economics and can be deployed without waiting for fiber to reach every apartment. Sometimes the most important shift in a technology cycle is not a brand-new application.Sometimes it is a better way to apply the tools that are already available. For a deeper technical description of the architecture, including the role of TR-507, MoCA Access and in-building coax, download the whitepaper Extending 5G FWA to MDUs over coax with InCoax and BBF TR-507 . For more on InCoax work on sustainability and cost savings in brownfield buildings, download the whitepaper Enhancing MDU broadband sustainability with MoCA Access technology . The information was submitted for publication, through the agency of the contact person set out below, at 11.30 CEST on July 9, 2026. For additional information, please contact:Jakob Tobieson, CEO, InCoax Networks ABjakob.tobieson@incoax.com+46 (0) 764 955 260 About InCoax Networks ABInCoax Networks AB (publ) re-purposes existing property coaxial networks in fiber and fixed wireless access (FWA) extension deployments for Communication Service Providers (CSP) globally. The technology is a high performance, future proof, reliable and cost-effective complement, that reduces installation time and improves take-up rate, to boost digital inclusion and Internet access for all.www.incoax.com To keep updated on corporate information, visit incoax.com. Vator Securities AB, tel. +46 8-5800 6599, ca@vatorsec.se, is acting as the company’s Certified Adviser.

Metapic launches new tracking technology and creator app, as growth accelerates across Europe

Stockholm, 9th July — Metapic, the leading European creator commerce platform, today announced two strategic milestones that mark its evolution from a performance-focused platform into a 360°, full-funnel social commerce partner, designed to help brands see the full value of creator activity, not only the sales that happen at the end of a campaign. The company is launching proprietary tracking technology that measures the media value generated by creator content across social platforms. Instagram is the first platform to go live, with TikTok and Snapchat to follow as the rollout continues. Metapic is also beta-testing a new creator app, with public release currently expected in September. The news follows a period of rapid growth for Metapic. Revenue grew at a 46% CAGR between 2022 and 2025, close to 50% compound annual growth over three years, while the platform expanded to more than 18 European markets. Measuring what was previously invisible Creator campaigns often influence shoppers long before a click or purchase is recorded. A post may build awareness, drive reach, generate engagement, and keep a brand visible in social feeds, even when the final sale happens later or through another channel. Until now, much of that media value has been difficult for brands to measure consistently. Metapic's new tracking technology gives brands a clearer view of that activity. It is designed to capture creator-led media value across platforms, including metrics such as impressions, reach, views, engagement, estimated earned media value, clicks, orders, and conversion outcomes. By bringing these metrics together, Metapic helps brands compare awareness and performance in one place. A campaign can now be assessed not only by the revenue it directly generates, but also by the attention, reach, and measurable media value it creates before conversion. A creator app to close the loop Metapic is also beta-testing a new creator app that will make it easier for creators to access campaign opportunities, understand what brands need, and act on performance insights. The app is intended to give creators a more direct way to manage their work with Metapic, while giving brands a more connected journey from briefing to content, measurement, and sales. Together, the tracking technology and creator app strengthen Metapic's position across the full creator commerce journey, from planning and creator selection to content performance, media value measurement, and conversion. "These two launches are a deliberate step in our strategy. We are moving from being a performance platform to becoming a true 360° full-funnel partner for brands and creators. Clients need to understand the full value creators deliver, from awareness and engagement through to sales" said Juergen Burkhart, Co-CEO of Metapic. "With our new tracking technology, creator app, new market launches, and continued expansion across Europe, we are building Metapic into a broader social commerce partner for brands and creators." A dedicated AI roadmap that is already paying off Metapic also shared further progress on its AI roadmap, which is already being used to improve creator recommendations, campaign briefs, posting guidance, and brand fit. The strategy is built on a proprietary dataset of more than 2 million content pieces, covering stories, clicks, and orders. The dataset grows by more than 50,000 new content pieces each month, giving Metapic a stronger base for understanding which creators, content formats, timing, and messages are most likely to perform for each brand. "Most brands still brief creators on instinct. We brief on data and AI," said Niklas Schwake, Co-CEO of Metapic. "Our models can tell which creator will convert for one sportswear brand and why the very same creator underperforms for a competitor selling a similar product. That predictive edge is the result of a deliberate, multi-year investment in our AI capabilities and it is now driving real performance for our partners." Metapic was clear about where AI does and does not belong: the company is not building AI creators. It is committed to real people producing authentic content, with AI making them sharper through better briefs, better timing, and better brand fit. The combination of a human creator network and a proprietary AI data engine is, in Metapic's view, the next evolution of creator commerce. Built for scale The new capabilities arrive alongside fresh market launches and continued geographical expansion across Europe. The combination of proprietary technology, an expanding product surface, and a widening market footprint keeps Metapic's growth expectations high heading into the next phase of the business. For further information, please contact Matthias StadelmeyerCEONYORDA ABEmail: ir@nyorda.com About Metapic Metapic is the leading European creator commerce platform, connecting a large network of creators with leading brands across 18+ markets. Part of the NYORDA Group, Metapic enables brands to activate creators at scale and creators to monetise their influence through performance-driven and, increasingly, full-funnel social commerce solutions. About NYORDA AB NYORDA AB, formerly Tradedoubler AB, is a Swedish public limited liability company listed on Nasdaq Stockholm. NYORDA is the umbrella group brand for Tradedoubler, Metapic, Appiness, Retail Bridge Media and EmnaAI. NYORDA exists to help brands grow in a new era of digital discovery. As search, social, commerce, apps, retail media and AI-powered environments reshape how consumers find, compare and choose brands, NYORDA brings together specialist businesses that help brands increase visibility, strengthen relevance and drive measurable growth. Together, the Group’s businesses support brands across affiliate and partner marketing, influencer marketing, app marketing, retail media and AI-driven search visibility. NYORDA is driving the future of brand discovery by helping brands grow across a changing digital marketing ecosystem.

New Features and Vehicles for Transport Fever 3 Showcased in Latest “First Look” Video

STOCKHOLM and SCHAFFHAUSEN, Switzerland - July 9, 2026 - Urban Games and Paradox Interactive today released a new deep-dive video of Transport Fever 3, the upcoming sequel to Urban Games’ award-winning Transport Fever game series. In the fifth episode of Urban Games’ “First Look,” players can learn new details about the game’s dynamic environments and biomes, industrial challenges and gameplay options, road and line management, and modding options which will include cross-platform mods from day one. All of these features, alongside many more as requested by the community, will be included when Transport Fever 3 launches in 2026 on PC, Mac, Linux, PlayStation®5, and Xbox Series X|S. See the growing world of Transport Fever 3 and its new environments and vehicles in “First Look” Episode Five right here: https://www.youtube.com/watch?v=tdmumafIwwY Transport Fever 3 challenges players to design, build, and manage transport empires spanning railways, roads, shipping lanes, and air routes across 4 distinctive environments, each with a unique set of challenges and gameplay possibilities. The game’s dynamic, fully simulated world evolves in response to player actions, with settlements and industries that grow and thrive as players improve the flow of people and goods using over 300 authentic trains, buses, trams, trucks, ships, planes, and, for the first time, helicopters. Players can delve into the details of the game’s extensive features through the first four “First Look” episodes, available here . A detailed breakdown of the features highlighted in Episode Five is available in the press kit here . In addition to the new episode, press materials including high-quality screenshots, B-roll footage, and more can be found in the official press kit. For more information, visit www.transportfever3.com and the game’s official YouTube , X , Facebook , and Instagram  pages.

Invesco Ltd: Form 8.3 - Segro PLC; Public dealing disclosure

FORM 8.3 PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of Invesco Ltd. discloser:(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.(c) Name of Segro PLC offeror/offere e in relation to whose relevant securities this form relates: Use a separate form for each offeror/offere e(d) If an exempt fund manager connected with an offeror/offere e, state this and specify identity of offeror/offere e:(e) Date position 08.07.2026 held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure(f) In addition Yes: Prologis, Inc. to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there arepositions orrights tosubscribe todisclose inmore than oneclass ofrelevantsecurities ofthe offeror orofferee namedin 1(c), copytable 2(a) or(b) (asappropriate)for eachadditionalclass ofrelevantsecurity.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of 10p ordinary, ISIN:relevant GB00B5ZN1N88, LEI:security: 213800XC35KGM9NFC641 Interests Short Positions Number % Number %(1) Relevant 3,733,166* 0.27 securities owned and/or controlled:(2) Cash-settled derivatives:(3) Stock-settled derivatives (including options) and agreements to purchase/sell: Total 3,733,166* 0.27*The change inthe holding of732 sharessince the lastdisclosure on08.07.2026 isdue to thetransfer in ofa discretionaryholding at 8.65GBP.All interestsand all shortpositionsshould bedisclosed. Details of anyopen stock-settledderivativepositions(includingtradedoptions), oragreements topurchase orsell relevantsecurities,should be givenon aSupplementalForm 8 (OpenPositions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class ofrelevantsecurity inrelation towhichsubscriptionright exists:Details,includingnature of therightsconcerned andrelevantpercentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where therehave beendealings inmore than oneclass ofrelevantsecurities ofthe offeror orofferee namedin 1(c), copytable 3(a),(b), (c) or (d)(asappropriate)for eachadditionalclass ofrelevantsecurity dealtin. The currency ofall prices andother monetaryamounts shouldbe stated.(a) Purchases and sales Class of Purchase/sale Number of Price perrelevant securities unitsecurity10p ordinary Purchase 85 8.65 GBPGB00B5ZN1N8810p ordinary Sale 1,160 8.74 GBPGB00B5ZN1N88 (b) Cash-settled derivative transactions Class of Product Nature of Number of Pricerelevant description dealing reference persecurity e.g. CFD e.g. securities unit opening/clo sing a long/short position, increasing/ reducing a long/short position (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type e.g. Expiry date Optionrelevant description purchasing, securities price per American, moneysecurity e.g. call selling, to which unit European etc. paid/ option varying option received etc. relates per unit (ii) Exercise Class of Product Exercising/ Number of Exerciserelevant description exercised securities pricesecurity e.g. call against per unit option (d) Other dealings (including subscribing for new securities) Class of Nature of Details Price perrelevant dealing e.g. unit (ifsecurity subscription, applicable) conversion 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of anyindemnity oroptionarrangement, orany agreementorunderstanding,formal orinformal,relating torelevantsecuritieswhich may be aninducement todeal or refrainfrom dealingentered into bythe personmaking thedisclosure andany party tothe offer orany personacting inconcert with aparty to theoffer: Irrevocablecommitments andletters ofintent shouldnot beincluded. Ifthere are nosuchagreements,arrangements orunderstandings,state “none”None (b) Agreements, arrangements, or understandings relating to options or derivatives Details of anyagreement,arrangement orunderstanding,formal orinformal,between theperson makingthe disclosureand any otherperson relatingto: (i) the votingrights of anyrelevantsecuritiesunder anyoption; or (ii) the votingrights orfutureacquisition ordisposal of anyrelevantsecurities towhich anyderivative isreferenced: If there are nosuchagreements,arrangements orunderstandings,state “none”None Is a NOSupplementalForm 8 (OpenPositions)attached? Date of 09.07.2026disclosureContact name Philippa HolmesTelephone +441491417447number Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Bravida repurchases shares 3 – 9 July, 2026, and concludes the company's share buyback program

Pursuant to authorization from the 2026 Annual General Meeting, Bravida's Board of Directors initiated a share buyback program of up to SEK 100 million, running from 8 May to 9 July 2026. The program aims to optimize the company's capital structure and increase shareholder value. During the period from 8 May up to and including 9 July 2026, 863,100 own ordinary shares (ISIN:SE0007491303) have been repurchased. Full information about completed transactions is available on www.bravidagroup.com .  During the period 3 – 9 July 2026, 55,107 own ordinary shares have been repurchased as follows: Date Aggregate volume Weighted Total transaction value (SEK) (number of average price shares) (SEK)3 July, 10,283 125.8549 1,294,16620266 July, 11,737 127.3342 1,494,52220267 July, 11,365 126.6824 1,439,74520268 July, 12,000 124.1709 1,490,05120269 July, 9,722 124,3778 1,209,2012026Total 55,107 6,927,685 As of 9 July 2026, the number of outstanding shares in Bravida Holding AB (publ) is 207,126,598, of which 204,756,409 are ordinary shares with one vote each and 2,370,189 are Class C shares with 1/10 of a vote each. Following the completion of the above repurchases, Bravida holds up to and including 9 July 2026 876,014 of its own ordinary shares and 2,370,189 of its own Class C shares. All repurchases have been carried out independently and without influence from Bravida, by Skandinaviska Enskilda Banken AB on Nasdaq Stockholm. The buyback program is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). For more information, please contact: Ann-Charlotte JohanssonInterim Head of Investor Relations E-mail: ann-charlotte.johansson@bravida.seMobile: +46 70 751 98 31

Citycon Oyj: Managers' Transactions – G City Ltd.

Person subject to the notification requirementName: G City Ltd.Position: Closely associated person(X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer Name: Chaim KatzmanPosition: Member of the BoardIssuer: Citycon OyjLEI: 549300P8N0P6KDGTJ206Notification type: INITIAL NOTIFICATIONReference number: 165340/6/8 ____________________________________________Transaction date: 2026-07-02Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 38 Unit price: 2.9 EUR (2): Volume: 47 Unit price: 2.9 EUR (3): Volume: 26 Unit price: 2.9 EUR (4): Volume: 1222 Unit price: 2.9 EUR (5): Volume: 396 Unit price: 2.9 EUR (6): Volume: 700 Unit price: 2.9 EUR (7): Volume: 3 Unit price: 2.9 EUR (8): Volume: 79 Unit price: 2.9 EUR (9): Volume: 80 Unit price: 2.9 EUR (10): Volume: 79 Unit price: 2.9 EUR (11): Volume: 275 Unit price: 2.9 EUR (12): Volume: 1378 Unit price: 2.9 EUR (13): Volume: 1222 Unit price: 2.9 EUR (14): Volume: 498 Unit price: 2.9 EUR (15): Volume: 1096 Unit price: 2.9 EUR (16): Volume: 79 Unit price: 2.9 EUR (17): Volume: 79 Unit price: 2.9 EUR (18): Volume: 79 Unit price: 2.895 EUR (19): Volume: 39 Unit price: 2.895 EUR (20): Volume: 10 Unit price: 2.895 EUR (21): Volume: 19 Unit price: 2.895 EUR (22): Volume: 749 Unit price: 2.895 EUR (23): Volume: 723 Unit price: 2.895 EUR (24): Volume: 340 Unit price: 2.895 EUR (25): Volume: 150 Unit price: 2.895 EUR (26): Volume: 150 Unit price: 2.895 EUR (27): Volume: 2500 Unit price: 2.895 EUR (28): Volume: 67 Unit price: 2.895 EUR (29): Volume: 100 Unit price: 2.895 EUR (30): Volume: 12406 Unit price: 2.895 EUR (31): Volume: 1456 Unit price: 2.895 EUR (32): Volume: 10833 Unit price: 2.895 EUR (33): Volume: 100 Unit price: 2.895 EUR (34): Volume: 1430 Unit price: 2.895 EUR (35): Volume: 191 Unit price: 2.895 EUR (36): Volume: 40 Unit price: 2.895 EUR  Aggregated transactions (36): Volume: 38679 Volume weighted average price: 2.89594 EUR ____________________________________________Transaction date: 2026-07-02Venue: CEUXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 9 Unit price: 2.895 EUR (2): Volume: 5 Unit price: 2.895 EUR (3): Volume: 1 Unit price: 2.895 EUR (4): Volume: 5 Unit price: 2.895 EUR (5): Volume: 49 Unit price: 2.895 EUR (6): Volume: 10 Unit price: 2.895 EUR (7): Volume: 19 Unit price: 2.895 EUR (8): Volume: 1 Unit price: 2.895 EUR (9): Volume: 2 Unit price: 2.895 EUR (10): Volume: 20 Unit price: 2.895 EUR (11): Volume: 19 Unit price: 2.895 EUR (12): Volume: 7 Unit price: 2.895 EUR (13): Volume: 33 Unit price: 2.895 EUR (14): Volume: 75 Unit price: 2.895 EUR (15): Volume: 39 Unit price: 2.895 EUR (16): Volume: 118 Unit price: 2.895 EUR (17): Volume: 80 Unit price: 2.895 EUR (18): Volume: 95 Unit price: 2.895 EUR (19): Volume: 92 Unit price: 2.895 EUR (20): Volume: 132 Unit price: 2.895 EUR (21): Volume: 33 Unit price: 2.895 EUR (22): Volume: 33 Unit price: 2.895 EUR (23): Volume: 41 Unit price: 2.895 EUR (24): Volume: 33 Unit price: 2.895 EUR (25): Volume: 53 Unit price: 2.895 EUR (26): Volume: 34 Unit price: 2.895 EUR (27): Volume: 34 Unit price: 2.895 EUR (28): Volume: 34 Unit price: 2.895 EUR (29): Volume: 34 Unit price: 2.895 EUR (30): Volume: 34 Unit price: 2.895 EUR (31): Volume: 122 Unit price: 2.895 EUR (32): Volume: 146 Unit price: 2.895 EUR (33): Volume: 46 Unit price: 2.895 EUR (34): Volume: 46 Unit price: 2.895 EUR (35): Volume: 963 Unit price: 2.895 EUR (36): Volume: 2590 Unit price: 2.895 EUR  Aggregated transactions (36): Volume: 5087 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-02Venue: TQEXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 113 Unit price: 2.895 EUR  Aggregated transactions (1): Volume: 113 Volume weighted average price: 2.895 EUR ____________________________________________ Transaction date: 2026-07-03Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 149 Unit price: 2.895 EUR (2): Volume: 25000 Unit price: 2.895 EUR (3): Volume: 1727 Unit price: 2.895 EUR (4): Volume: 8908 Unit price: 2.895 EUR (5): Volume: 12999 Unit price: 2.895 EUR (6): Volume: 2631 Unit price: 2.895 EUR (7): Volume: 20 Unit price: 2.895 EUR (8): Volume: 230 Unit price: 2.895 EUR (9): Volume: 212 Unit price: 2.895 EUR  Aggregated transactions (9): Volume: 51876 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-03Venue: CEUXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 75 Unit price: 2.895 EUR (2): Volume: 35 Unit price: 2.895 EUR (3): Volume: 441 Unit price: 2.895 EUR (4): Volume: 123 Unit price: 2.895 EUR (5): Volume: 416 Unit price: 2.895 EUR (6): Volume: 997 Unit price: 2.895 EUR (7): Volume: 147 Unit price: 2.895 EUR  Aggregated transactions (7): Volume: 2234 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-03Venue: TQEXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 181 Unit price: 2.895 EUR  Aggregated transactions (1): Volume: 181 Volume weighted average price: 2.895 EUR CITYCON OYJ For further information, please contact:Anni TorkkoDirector, Group Corporate Analysis & IRTel. +358 45 358 0570anni.torkko@citycon.com 

EQT to acquire Copia Power, a leading integrated power and AI infrastructure platform

EQT is pleased to announce that EQT Infrastructure VII (“EQT”) has agreed to acquire Copia Power (“Copia” or the “Company”) from global investment firm Carlyle (NASDAQ: CG).  Copia develops integrated energy campuses that bring generation, high-voltage transmission, and data center load together at the same interconnection position, providing a differentiated approach that enables AI infrastructure growth on an accelerated timeline. Today, the Company has over 2.6 GW of energy generation and storage assets in operation or under construction and is actively developing over 9 GW of grid-connected data centers supported by Copia’s portfolio of gigawatt-scale energy campuses, comprising more than 25 GW of solar and storage and 7 GW of natural gas generation assets. The transaction aligns with EQT’s focus on investing behind the infrastructure underpinning global demand for artificial intelligence and supporting energy security. The rapid adoption of AI is driving a new era of infrastructure investment, with global demand for compute capacity accelerating at an unprecedented pace. Data center and energy investment is expected to reach into the trillions of dollars over the coming years, and energy has become the primary bottleneck to data center growth. As a result, digital and energy infrastructure must increasingly scale together. Copia’s integrated model addresses that constraint, giving utilities a single route to add generation and load on an accelerated timeline, and providing hyperscalers and other customers a path to firm, grid-connected power in markets where interconnection queues have become a key hurdle, while supporting ratepayer affordability through the promotion of bring-your-own generation models.  The acquisition of Copia further expands EQT's growing portfolio of AI infrastructure investments in the U.S., which spans data centers, energy, and fiber connectivity through companies including EdgeConneX, Zayo, Cypress Creek Energy, and Scale. EQT is actively encouraging collaboration across this portfolio — connecting power generation, digital infrastructure, and connectivity capabilities to deliver integrated solutions for hyperscalers and utilities. Copia's integrated campus model is a natural complement to these capabilities, and EQT sees meaningful opportunity for Copia to contribute to these collaborations as demand for AI infrastructure accelerates. EQT will support Copia’s management team in scaling the platform, advancing priority development projects, and expanding its integrated campuses strategy throughout the U.S.  Ray Henger, CEO of Copia Power, said: “We are excited to partner with EQT as we enter Copia's next phase of growth. Since our founding, we have focused on solving one of the most important challenges facing the U.S. power market: bringing generation, transmission and large-scale load together in a way that accelerates delivery for customers and utilities. EQT's deep infrastructure experience and long-term perspective bring the ideal partner as we continue to scale our platform and develop the energy infrastructure needed to support AI and electrification."  Alex Darden, Partner and Head of EQT Infrastructure Americas, said: "The rapid adoption of AI is transforming infrastructure demand, making energy an increasingly critical enabler of digital infrastructure. Copia has built a differentiated platform at the intersection of these two themes, and we believe it is exceptionally well positioned for long-term growth. We look forward to partnering with the management team to accelerate development, scale the platform, and help build the infrastructure that will support the next generation of AI.”  The transaction is subject to customary conditions and approvals. It is expected to close by the end of 2026.  EQT Infrastructure VII is currently expected to be activated and begin charging management fees around year-end 2026. Upon activation, and with the acquisition of Copia Power, EQT Infrastructure VII is expected to be 0-5 percent invested (including closed and/or signed investments, announced public offers, if applicable, and less any expected syndication) based on target fund size and subject to customary regulatory approvals. EQT Infrastructure VI is currently 75-80 percent invested and continues to be in its commitment period, management fees will, following activation of EQT Infrastructure VII, be based on net invested capital. The information contained herein does not constitute an offer to sell, nor a solicitation of an offer to buy, any security, and may not be used or relied upon in connection with any offer or solicitation. Any offer or solicitation in respect of EQT Infrastructure VII will be made only through a confidential private placement memorandum and related documents which will be furnished to qualified investors on a confidential basis in accordance with applicable laws and regulations. The information contained herein is not for publication or distribution to persons in the United States of America. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold without registration thereunder or pursuant to an available exemption therefrom. Any offering of securities to be made in the United States would have to be made by means of an offering document that would be obtainable from the issuer or its agents and would contain detailed information about the issuer of the securities and its management, as well as financial information. The securities may not be offered or sold in the United States absent registration or an exemption from registration. ContactEQT Press Office, press@eqtpartners.com

Second quarter 2026 – Driving cost improvements and deleveraging

Oslo, 10 July 2026 Elkem reported an EBITDA of NOK 523 million for the second quarter 2026, a decline from NOK 645 million in the corresponding quarter last year. The reduction was mainly explained by lower sales prices for silicon. Elkem’s transformation continues to build momentum. The organisational streamlining is completed and cost reductions are on track and ahead of target. Measures to strengthen the balance sheet have been successfully concluded. Elkem raised NOK 1.8 billion in new equity and refinanced its main bank facilities. Elkem’s total operating income for the second quarter 2026 was NOK 3 708 million, which was down 4 per cent from the second quarter 2025. Earnings before interest, taxes, depreciation and amortisation (EBITDA) was NOK 523 million, down 19 per cent from the corresponding quarter last year. The Silicon Products division was impacted by low prices for silicon and ferrosilicon, yet the EBITDA improved quarter-on-quarter, partly as a result of production resuming at the Elkem Rana and Elkem Salten plants. The EU safeguard measures introduced on imports of ferroalloys in November 2025 have so far had limited impact on prices, reflecting weak demand and continued substitution risk. Prices are expected to gain as ferroalloy supply may tighten following the EU’s decision to decrease tariff-free steel quotas and double tariffs beyond the quotas as of 1 July 2026. Silicon Products reported a total operating income of NOK  2 946 million, a reduction of 4 per cent compared to the second quarter last year, while the EBITDA declined 28 per cent year-on-year. Carbon Solutions reported an EBITDA of NOK 172 million, down 29 per cent from the second quarter last year. The lower EBITDA was mainly due to lower sales volume and lower average sales prices. Elkem Iceland’s performance has been weak since 2024, driven by a structurally higher cost base compared to other Elkem plants. Strategic options are being assessed and Elkem Iceland has been reclassified as discontinued operations. Elkem initiated significant cost-reduction measures as of March 2026, to improve productivity and maintain a strong cost position. The initial target was to reduce the global workforce by approximately 300 FTEs. Once completed, the programme will have exceeded the target, nearing a reduction of 400 FTEs. The target is to deliver annual savings of more than NOK 600 million. In addition, Elkem is targeting a working capital reduction of NOK 1 000 million. By the end of the second quarter, working capital reductions amounted to NOK 841 million from year-end 2025. Investments will be capped at a maximum of NOK 1 000 million for the year. Total investments YTD-June stood at NOK 304 million. “Elkem’s transformation is gaining real momentum, with the organisational streamlining completed, cost reductions exceeding targets, and a successful refinancing demonstrating strong market confidence. We are actively pursuing strategic options across the portfolio while positioning for growth and margin improvements. Structural demand, driven by digitalisation, AI infrastructure, energy transition and defence, continues to strengthen our long-term outlook. This provides a solid foundation for sustainable value creation,” says CEO Helge Aasen. Elkem completed a NOK 1 800 million equity raise in the second quarter and refinanced its main bank facilities of EUR 1 000 million. In addition, Elkem has obtained a loan of NOK 750 million from the Nordic Investment Bank (NIB) on attractive conditions with a tenor of 10 years. Combined, these transactions have materially strengthened Elkem’s financial position Elkem equity as at 30 June 2026 amounted to NOK 12 628 million, which gave a ratio of equity to total assets of 44 per cent. Net interest-bearing debt was NOK 6 593 million, which gave a ratio of net interest-bearing debt to EBITDA of 3.2x. Elkem had cash and cash equivalents of NOK 4 876 million as at 30 June 2026, and undrawn credit lines of more than NOK 4 500 million. In the second quarter, Elkem and Statkraft signed a new long-term power purchase agreement (PPA). The PPA is for the 2031-2037 period, and the total contract volume is 1,534 GWh. The agreement secures competitive and predictable electricity supply for Elkem’s plant in Bjølvefossen, Norway. Elkem has a strong portfolio of long-term power contracts in Norway, and this agreement is a significant contribution to the extension of the portfolio. On 2 July 2026, Elkem announced the appointment of Dag Teigland as CEO by the board of directors, effective 3 August 2026. Aasen will step down from his role as CEO and assume the position of chairman of the board. Teigland brings over two decades of industrial and investment experience, and also has prior experience from Elkem, where he held several leadership roles between 1998 and 2002. Trade regulations and protective measures are expected to continue affecting Elkem’s markets, and could support a recovery in demand and prices in the EU. Elkem’s cost reduction programme will continue to contribute positively to the results from the third quarter and onwards. Silicon Products is still experiencing challenging market conditions. The underlying profitability is improving, but third quarter is expected to be impacted by seasonally lower activity. Carbon Solutions expects generally stable financial performance in the third quarter. From the third quarter 2026, Elkem will report on the new divisional structure, i.e. Elkem Silicon, Elkem Foundry Alloys and Elkem Carbon. For further information, please contact:Odd-Geir LyngstadVP Finance & Investor RelationsTel: +47 976 72 806Email: odd-geir.lyngstad@elkem.com Marianne StigsetVP Corporate Communications & Public AffairsTel: +47 411 88 482E-mail: marianne.stigset@elkem.com   About Elkem ASAWith a strong track record since 1904, Elkem is one of the world’s leading providers of advanced silicon-based materials shaping a better and more sustainable future. The company develops silicones, silicon products and carbon solutions by combining natural raw materials, renewable energy and human ingenuity. Elkem has been awarded top score of A on Forests and Water Security, and B on Climate Change from CDP. Elkem is listed on the Oslo Stock Exchange (ticker: ELK), where the company is also included in the ESG Index. www.elkem.com   

Besqab's interim report for January-June 2026 shows strong sales and rising profitability

Q2 2026 in brief (segment reporting)• Net turnover amounted to SEK 872.6 million (928.1)• Gross profit amounted to SEK 166.9 million (115.9) and the gross margin amounted to 19.1 percent (12.5)• Operating profit amounted to SEK 112.2 million (54.6) and the operating margin amounted to 12.9 percent (5.9)• Profit for the quarter amounted to SEK 102.5 million (58.2)• Earnings per share amounted to SEK 0.61 (0.35)• 146 (216) homes sold. 141 (31) homes booked in projects not yet in production• 1,721 (1,602) homes in ongoing production• The proportion of homes sold or booked in ongoing production was 65 percent (64)• Only 6 unsold homes in completed projects at the end of the period Magnus Andersson, CEO:“Besqab delivers a second quarter with strong sales, several production starts and a significantly improved result compared to the same period last year. The return on equity improved, which is partly a result of our focused work to shorten lead times in the projects and work more capital-efficiently. Activity in the housing market in Stockholm increased during the quarter with rising sales, lower supply and rising prices.” Period January–June 2026• According to the segment report, net sales amounted to SEK 1,341.4 million (1,439.6). Gross profit amounted to SEK 268.2 million (208.1) and the gross margin was 20.0 percent (14.5).• According to segment reporting, operating profit amounted to SEK 175.4 million (84.8) and the operating margin was 13.1 percent (5.9). Profit for the period amounted to SEK 163.3 million (73.1). Earnings per share before and after dilution amounted to SEK 0.99 (0.28).• According to IFRS, the equity ratio as of the balance sheet date was 46.8 percent (51.7), equity amounted to SEK 3,122.4 million (3,009.0) and total assets amounted to SEK 6,666.7 million (5,821.1).• According to IFRS, net sales amounted to SEK 1,439.9 million (179.7), operating profit amounted to SEK 164.1 million (–79.8). Profit for the period amounted to SEK 156.6 million (–91.6). Earnings per share before and after dilution amounted to SEK 0.92 (neg).• The number of homes sold during the period, in ongoing and completed projects, amounted to 229 (297).• The number of homes taken into possession by tenant-owner buyers during the period amounted to 229 (77). The number of homes recognized in profit according to IFRS amounted to 257 (77). Significant events during the reporting period• On April 13, it was announced that the Viggby Ängar development project in Täby was sold out. In total, the newly produced area includes 274 homes in the form of rental apartments and tenant-owner apartments. The entire project is expected to be completed in the fourth quarter of 2026.• On April 22, it was announced that Besqab has formed a joint venture with John Mattson Fastighetsföretagen AB for the development of two housing projects. One of the included projects includes approximately 89 apartments on Lidingö and the other approximately 250 apartments in Solna.• On May 12, Besqab announced an increase in ownership in Byggnadsfirman Erik Wallin AB to comprise 60 percent, which is thus consolidated into Besqab's consolidated financial statements.• On May 29, Besqab and ALFA Development, through a joint venture, took possession of building rights for approximately 400 new homes in Södra Hagalund, Solna. Production will take place in four stages, of which the start of production of the first stage is expected to take place in 2027. Significant events after the balance sheet date• Besqab handed over the first stage of the rental property project Femöringen in Solna with 157 rental homes and the third stage of the rental property project Inverness in Danderyd with 170 rental properties to the buyer Patrizia. The taking over is taking place according to schedule. For more infomation, please contact:Magnus Andersson, CEO, e: magnus.andersson@besqab.se, t: +46 8 409 415 58Magnus Sundell, CFO, e: magnus.sundell@besqab.se, t: +46 8 409 416 60 About BesqabBesqab AB (publ) develops sustainable, high-quality residential housing in sought-after locations in Greater Stockholm and Uppsala. The business also includes development of community services for external ownership or own management. The company is listed on Nasdaq Stockholm. More information at www.besqab.se

Archer awarded additional super-spec rig contract in Vaca Muerta

Hamilton, Bermuda (July 10, 2026) Archer is pleased to announce the award of an additional five-year contract, with two one-year extension options, from YPF for a super-spec drilling rig to its Vaca Muerta fleet. The contract has an estimated value of approximately USD 90 million over the firm contract period and further strengthens Archer's long-term position in one of the world's most active unconventional shale developments. The additional rig will be equipped with managed pressure drilling (“MPD”) technology, supporting improved drilling efficiency, operational reliability and safety. It will be leased from Patterson-UTI and represents the third additional super-spec rig added to Archer's Vaca Muerta fleet as part of the Company's ongoing strategic growth plan. The first of the three rigs commenced operations in late June 2026, the second is expected to mobilize during July 2026, and the third is expected to commence operations during the first quarter of 2027. Gerardo Molinaro, Vice President of Land Drilling at Archer, said: “YPF continues to lead the development of Vaca Muerta, and Archer is committed to support that growth. The additional rig further strengthens our long-standing relationship with YPV and reinforces our commitment to operational excellence. By expanding our super-spec fleet with MPD capabilities, we continue to enhance drilling performance while delivering safe, efficient and reliable operations.” For additional information, please contact: Espen Joranger, Chief Financial Officer — Mobile: +47 982 06 812, Email: espen.joranger@archerwell.com Joachim Houeland, Manager Treasury and Investor Relations — Mobile: +47 482 78 748, Email: joachim.houeland@archerwell.com This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Interim Report January – June 2026

A Quarter with Record Growth and Strategic Prioritisation January – June 2026 Compared to January – June 2025 · Loans to the public amounted to SEK 26,297 million compared to June 2025 the increase in local currencies was 21% · Operating profit increased by 31% to SEK 500.6 million · Earnings per share increased by 40% to SEK 6.14 · Adjusted earnings per share increased by 33% to SEK 5.87 · Cost/income ratio improved to 35.0% (37.5) · Return on equity amounted to 25.8% (21.7) · Adjusted return on equity amounted to 24.7% (21.9) · Total capital ratio amounted to 15.7% (16.1) compared to year-end April – June 2026 Compared to April – June 2025 · The loan portfolio amounted to SEK 26,297 million compared to June 2025 the increase in local currencies was 21% · Operating profit increased by 31% to SEK 255.9 million · Earnings per share increased by 33% to SEK 2.97 · Cost/income ratio improved to 34.6% (37.7) · Return on equity amounted to 24.2% (21.6) "The strong performance was primarily driven by high demand in the German credit card market, where previous investments in customer acquisition continue to generate results. Growth accelerated during the quarter and was record-high in June.”- Joakim Jansson, Group CEO January – As of 30 January – June 2026June 2026 June 20268.8 +30bp 3.5 540 +30% 1,002Risk Customers, Of which are app Revenue per customer, SEK-adjusted million -users, thousandmargin, % Key Takeaways · Strong customer engagement during the past year, the number of app-users increased by 30% to 540,163. · Everyday Finance has an organic loan portfolio growth of 38% to 17,070 MSEK and a significantly improved operating profit of 52% to 339 MSEK. · Consumer Lending is developing according to plan – the reduced new lending is an active strategic decision in favour of capital allocation to Everyday Finance. For further information, please contact:Mikael Meomuttel, Group CFOMobile: +46 (0) 70 626 95 33E-mail: ir@avarda.com This information is information that Avarda Bank AB (publ) is required to disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on 10 July 2026. About Avarda GroupAvarda Group simplifies how customers across Europe manage their personal finances. We have been listed on Nasdaq Stockholm since 2016. Rooted in our Swedish heritage, we combine a pragmatic and disciplined business mindset, with cutting-edge technology and innovation, always with a strong focus on cost-efficiency and profitability. Our proprietary, scalable platform and infrastructure enable efficient expansion across multiple markets. We move customers, partners and ourselves forward – towards new opportunities and evolving needs.

Valmet delivers board making line and lifecycle support to Sun Paper in China, enabling energy- and resource-efficient production

Sun Paper has selected Valmet to deliver a full board making line with automation and lifecycle support for their mill in Nanning, China. The customer’s target for the investment is to increase containerboard capacity and ensure reliable, energy- and resource-efficient operation of the board making line. The start-up is scheduled for fall of 2027. “The high-capacity machine concept and the selected advanced technologies support our targets for energy-efficient and stable production. We expect these solutions to deliver strong performance while reducing energy consumption and ensuring our capacity goals. We value the long-standing relationship we have built with Valmet and look forward to continuing our cooperation with this new project,” says Ying Guangdong, Vice General Manager and Chief Engineer of Sun Paper. “The machine, including the transformative Sleeve roll technology and compact dryer geometry, provides an excellent foundation for optimized and energy-efficient containerboard production. We are pleased to continue supporting Sun Paper with this unique board machine project with lifecycle services,” says Pekka Tolvanen, Sales Manager, Packaging and Paper Business Area, Valmet. The cutting-edge technologies, together with lifecycle support and automation, will secure the reliable high-capacity production of kraft and testliner while ensuring the efficiency targets of the machine are met. The delivery includes a full board machine from headboxes to winders with several technologies that are unique to the area. One of these technologies is the transformative Sleeve roll technology  for efficient dewatering in the forming section. It utilizes forming fabric compression to ensure smart usage of energy and excellent quality parameters. The board machine’s dryer section includes novel compact geometry  which ensures efficient drying of the board with superior runnability systems, securing high machine performance. The reliability and high-capacity targets, and excellent roll quality, are ensured with two winders . The order also includes services that will create a stable foundation for production and ensure consistent lifecycle performance of the board machine. These include spare parts , digital services,  and paper machine clothing . Improvements to other existing machinery of the customer are also included in the order. The extensive package of automation solutions  will secure production efficiency and machine safety while providing a solid foundation for the mill’s transition toward higher levels of autonomy. The order is included in Valmet's orders received for the second quarter of 2026. The value of the order will not be disclosed. About the customer Nanning Sun Paper is a wholly owned subsidiary of Shandong Sun Paper, based in Liujing Industrial Park, Hengzhou, Nanning. Leveraging its parent company’s cutting-edge technologies and fully integrated industrial chain, the company focuses on pulp manufacturing and paper production. Committed to a forest-pulp-paper integrated model, Nanning Sun Paper emphasizes smart manufacturing and environmentally responsible, low-carbon operations. As a leading paper manufacturer in Guangxi, it serves customers across Southwest China with products distributed nationwide and exported to ASEAN markets. VALMET Corporate Communications Further information:Petri Paukkunen, Vice President, Packaging and Paper Machines, Packaging and Paper Business Area, Valmet, tel. +358 40 744 8182 Xiangdong Zhu, Executive Vice President, China Chair, Valmet, tel. +86 21 39975000 (switchboard) Valmet is a global technology leader in serving process industries. We work with our customers throughout the lifecycle, delivering cutting-edge technologies and services, as well as mission-critical automation and flow control solutions. Backed by more than 225 years of industrial experience and a global team of 18,500 professionals close to customers, we are uniquely positioned to transform industries toward a regenerative tomorrow. In 2025, Valmet’s net sales totaled approximately EUR 5.2 billion. Our head office is in Espoo, Finland, and we have experts in approximately 40 countries around the world. Valmet’s shares are listed on Nasdaq Helsinki. Follow us on valmet.com  | X  | LinkedIn  | Facebook  | YouTube  | Instagram  | Instagram (IR)  Processing of personal data  

Akobo Minerals – Operational Update for June 2026

Oslo, Norway, 10 July 2026 – Akobo Minerals AB (publ) (“Akobo” or the “Company”) (Euronext Growth Oslo: AKOBO), the Scandinavian-based gold producer operating in Ethiopia, provides an operational update for June 2026. June concluded the Company's strongest quarterly production period since commencement of operations, with approximately 37 kg of doré gold produced during Q2 2026. Operations continued normally throughout the month, supported by stable mining and processing activities and no fuel-related disruptions. Development of the vertical shaft and sub-shaft also continued during June. Based on current observations, the Company believes the shaft is entering the final transition into hard rock, which is expected to support more efficient shaft development. Key highlights       Doré gold production in June: approximately 10 kg       Doré gold production in Q2 2026: approximately 37 kg       Cumulative doré production to date: approximately 134 kg       Lower-grade stockpile available for processing: approximately 650 tonnes For more information, contact Jørgen Evjen, CEO, Akobo Minerals Mob: (+47) 92 80 40 14 Mail: jorgen@akobominerals.com LinkedIn: www.linkedin.com/company/akobominerals  Web: www.akobominerals.com  About Akobo Minerals Akobo Minerals is a Scandinavian-based gold producer and explorer with more than 15 years of active operations in Ethiopia. The Company holds an exploration licence covering 182 km² and a mining licence covering 16 km² in the Gambela region, Dima Woreda. The Segele mine hosts an Indicated and Inferred Mineral Resource of approximately 69,000 ounces at an average grade of 22.7 g/t gold. The mineralised system remains open at depth, supporting further resource growth and potential mine life extension. In addition, the Company’s exploration licence hosts multiple high-quality targets with significant resource potential. Akobo Minerals places ESG principles at the core of its operations and maintains strong relationships with local communities and government authorities. The Company is committed to sound ethics, transparency and responsible mining practices. Akobo Minerals is headquartered in Oslo and listed on Euronext Growth Oslo and the Frankfurt Stock Exchange under the ticker AKOBO. In the United States, the Company’s shares trade on the OTC Pink Market under the symbol AKOBF. The Company complies with the JORC Code (2012) and places strong emphasis on internationally recognised industry standards.

Wetteri and Polestar expand their cooperation to the Helsinki Metropolitan Area – new Polestar showroom to open at Wetteri Airport

Wetteri Plc Media release10 July 2026 at 10:00 a.m. Wetteri and Polestar expand their cooperation to the Helsinki Metropolitan Area – new Polestar showroom to open at Wetteri AirportWetteri and Polestar are expanding their cooperation by opening a new Polestar showroom in late 2026 at Wetteri’s new location in the Helsinki Metropolitan Area, Wetteri Airport. Once completed, the new Polestar Airport will be the largest Polestar showroom in Finland.In addition to the Polestar model range, the premises will feature a comprehensive selection of high-quality, low-mileage used cars under Polestar’s Pre-owned concept. Polestar maintenance service is already available at the location. Through this expansion, Wetteri will be able to reach the rapidly growing electric vehicle market in the Helsinki Metropolitan Area even more effectively.“This is a major strategic step for us and, at the same time, a significant expansion into the new car market in the Helsinki Metropolitan Area. Polestar is a brand that is continuously gaining interest in the premium electric vehicle segment, and we already have good experience of its sales in Oulu and Kuopio. We are excited to be able to serve customers interested in electric motoring in the Helsinki Metropolitan Area at our new Wetteri Airport location. I warmly welcome everyone to visit the new Polestar showroom and test drive the impressive Polestar model range,” says Wetteri’s CEO Aarne Simula.“Polestar entered the Finnish market five years ago as a new and relatively unknown brand. Today, we have established a strong position among the most popular electric vehicle brands, and interest in the brand continues to grow. With the expanding model range and growing customer base, there is a need for a second location in the Helsinki Metropolitan Area. Wetteri has demonstrated strong expertise and commitment to our brand in Oulu and Kuopio, so I am confident they will be an excellent addition in serving customers in the Helsinki Metropolitan Area as well,” says Polestar Finland’s CEO Tommi Luopajärvi.Expansion of the cooperation is part of Wetteri’s strategyLaunching Polestar sales in the Helsinki Metropolitan Area is part of Wetteri’s Ohittamaton strategy, one of the objectives of which is to seek profitable growth from brand operations. In the future, full-service Polestar representation will be available in Kuopio, Oulu and the Helsinki Metropolitan Area. In addition, Wetteri serves as Polestar’s authorized maintenance service partner in Joensuu, Kajaani, Kemi, Kuusamo, Lempäälä, Pori, Rauma and Ylivieska.Wetteri Airport is Wetteri’s new location on Aamuruskontie alongside Ring Road III, which opened its doors in May 2026. In addition to Polestar sales and service, the location offers authorized service for several other brands as well as a used car showroom. Wetteri acquired the new location through a business transaction announced in April 2026. The opening ceremony of the Polestar showroom at the location will be held towards the end of 2026.Polestar aims for a more active sales modelSwedish Polestar, a manufacturer of premium performance electric vehicles, refined its global strategy last year to better respond to customers’ changing expectations and purchasing behaviour. The aim has been to bring the brand closer to customers and to offer more flexible and diverse ways to purchase a new car and explore the model range.Over the past year and a half, Polestar has significantly expanded its physical presence by opening new locations both in Finland and internationally. Customers now have the opportunity to order a car not only online but also directly from a Polestar showroom, and to experience the brand and its comprehensive model range in person. Physical locations play a key role in deepening the customer experience and providing personal service. Further information:WetteriHeidi Väkevä / Wetteri Communicationstel. +358 50 3369 785, viestinta@wetteri.fiPolestarJohanna Laune / PR & Communicationstel. +358 40 0440 301, johanna.laune@polestar.com Wetteri Plc – A car dealership from the north, across Finland Wetteri Plc is a full-service car dealership with more than 60 years of history in the Finnish car trade. Its business consists of three segments: passenger cars, maintenance services and heavy equipment. The company has grown from a local car dealership in Oulu into a national operator with 19 locations in Finland. Wetteri employs around 800 automotive professionals. Our goal is to deliver unrivalled car trade services and to be an excellent partner for our customers throughout the entire automotive life cycle. We are a key player in the Finnish car market on the journey towards zero-emission driving. Wetteri is listed on Nasdaq Helsinki. More information: sijoittajat.wetteri.fi/en/. About PolestarPolestar (Nasdaq: PSNY) is the Swedish electric performance car brand with a focus on uncompromised design and innovation, and the ambition to accelerate the change towards a sustainable future. Headquartered in Gothenburg, Sweden, its cars are available in 28 markets globally across North America, Europe and Asia Pacific.Polestar has four models in its line-up: Polestar 2, Polestar 3, Polestar 4, and Polestar 5. Planned models include the Polestar 7 compact SUV (to be introduced in 2028) and the Polestar 6 roadster. With its vehicles currently manufactured on two continents, North America and Asia, Polestar plans to diversify its manufacturing footprint further, with production of Polestar 7 planned in Europe.Polestar has an unwavering commitment to sustainability and has set an ambitious roadmap to reach its climate targets: halve greenhouse gas emissions by 2030 per-vehicle-sold and become climate-neutral across its value chain by 2040. Polestar’s comprehensive sustainability strategy covers the four areas of Climate, Transparency, Circularity, and Inclusion.

Acroud adopts financial targets for 2026–2028

Financial targets focus on sustained earnings growth and continued deleveraging The Board of Directors of Acroud AB (publ) has today adopted new financial targets for the three-year period 2026-2028. The financial targets are: · Compound annual growth in adjusted EBITDA of 12% · A net debt to adjusted EBITDA ratio below 1.25x by the end of 2028 The targets reflect Acroud’s continued transition from financial restructuring towards sustainable earnings growth, strong cash generation and disciplined capital allocation. Following a strong first quarter of 2026, where the net debt to adjusted  EBITDA ratio was reduced to 2.1x, the Board believes that Acroud has established a solid foundation for the coming three-year period. Acroud has historically allocated a significant share of its cash flow towards earnout obligations and other acquisition-related liabilities. Following the settlement of these legacy obligations, an increasing proportion of the Group’s future cash generation can be allocated more discretionarily between organic growth initiatives offering attractive returns and the continued reduction of financial leverage. The Board believes that Acroud’s scalable SaaS platform, the extensive project portfolio within the iGaming Affiliation Segment and the Group’s continued focus on operational efficiency provide a strong foundation for delivering on the new targets. “Following a good start to 2026, we are entering the next phase of Acroud’s development from a materially stronger position. Our focus is not solely on growing adjusted EBITDA, but on converting that growth into cash flow and using the cash generated in a disciplined manner. With the legacy earnout obligations behind us, we have greater flexibility to invest in the most attractive organic opportunities while continuing to reduce our financial leverage,” said Mikael Strunge, President and CEO of Acroud. The financial targets represent Acroud’s ambitions for the period as a whole and should not be interpreted as financial guidance for individual quarters or financial years. For further information, pleasecontact: Mikael Strunge, President andCEO +45 2092 0995 Andrzej Mieszkowicz,CFO +356 9911 2090 ACROUD AB(publ) Telephone: +356 9999 6019 E-mail:info@acroud.com Website:www.acroud.com Certified Adviser: FNCA Sweden AB, info@fnca.se From May 2024 (Q1 Report) Acroud has changed reporting and company language to English. This means that Interim Reports and the correlated press releases will be issued in English only. About ACROUDAB ACROUDis a global iGaming affiliate that operates and develops comparison and news sites within Sports Betting and Casino. Acroud also offers SaaS solutions for the iGaming affiliate industry. In past years, a number of companies have joined the ride and thus several experienced individuals in the industry leads Acroud's journey to fulfil our strategic goals. Our mission is to connect people, Content Creators (Youtubers, Streamers, Affiliates) and businesses. We remain a leading global player in the industry with our experts located in Malta, United Kingdom, Denmark, Sweden and Brazil. Acroud has been listed on the Nasdaq First North Premier Growth Market since June 2018.

Dampskibsselskabet NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO.163 - 10 JULY 2026 On 7 May 2026, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 7 May 2026 up to and including no later than 6 August 2026. For details, please see announcement no. 109 of 6 May 2026. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 25 million (approximately DKK 159 million). The following transactions have been made under the programme: Date Number Average purchase price (DKK) Transaction value (DKK) of sharesTotal, last 339,000 306.57 103,928,080announcement03/07/2026 7,000 308.16 2,157,12006/07/2026 7,000 303.05 2,121,35007/07/2026 7,000 310.27 2,171,89008/07/2026 6,000 322.25 1,933,50009/07/2026 6,000 319.96 1,919,760Accumulated 372,000 307.07 114,231,700 Since the share buy-back programme was initiated on 7 May 2026, the total number of repurchased shares is 372,000 at a total amount of DKK 114,231,700. With the transactions stated above, NORDEN holds a total of2,295,025 treasury shares, corresponding to 7.65 %. The total number of shares in NORDEN is 30,000,000. Adjusted for treasury shares, the number of shares is 27,704,975. During the same period (03/07-26 - 09/07-26), major shareholder, Motortramp A/S, has sold 9,999 shares. Please see announcement no. 110/2026 and daily reporting. Kind regards, Dampskibsselskabet NORDEN A/S Klaus Nyborg Chairman For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com

ABB Robotics collaborates with Roche to bring physical AI to laboratories

Zurich, Switzerland, July 8, 2026  ABB Robotics collaborates with Roche to bring physical AI to laboratories · Agreement lays the foundation for a new era of digitally connected labs enabled by intelligent robotics to provide significant efficiencies in laboratory workflows · First applications under collaboration will support pathology slide handling and autonomous connectivity in Core Lab intralogistics · Range of ABB Robotics’ technologies deployed, including autonomous mobile manipulation and fixed articulating robots ABB Robotics has announced a global collaboration with Roche Diagnostics to develop and bring to market new robotic solutions for clinical laboratories. The collaboration lays the foundation for a new era of connected labs that are flexible, fast and reliable to meet the growing demands of modern healthcare. “The collaboration is a major milestone in accelerating lab automation, introducing more autonomous and versatile robotics (AVR™) into clinical laboratories at scale,” said Marc Segura, President of ABB Robotics. “With Roche, we will be able to bring the latest physical AI to labs all around the world, addressing major challenges that are hindering labs from providing the best outcomes for patients.” The healthcare sector, where roughly 70 percent of treatment decisions rely on diagnostic testing[1], is under increasing strain, with laboratories facing workforce shortages as fewer professionals enter demanding and intensive lab roles. Coupled with aging populations and a growing shift toward personalized medicine, the need to accelerate testing and improve efficiency has never been greater. The collaboration with Roche will focus on creating automation solutions at scale, that will accelerate critical lab processes such as sample preparation and intra-logistics to help laboratories provide faster and more efficient diagnostics for improved patient care. The first applications under the collaboration are focused on two important laboratory areas. With Roche’s pathology business segment, ABB Robotics will develop solutions that support slide handling and organization, helping laboratories move toward more digital, connected workflows. In central diagnostics labs – Roche’s largest laboratory testing segment - ABB Robotics will use autonomous mobile manipulators to move samples and materials between instruments, providing greater connectivity, flexibility, and consistency for faster processing. These applications represent a strong opportunity to enhance efficiency in clinical diagnostics – robots can take on repetitive tasks, freeing lab staff to focus on more critical work, while adding flexibility to existing automation in the laboratory. “Partnering with ABB Robotics allows us to bring a new level of robotic automation to laboratories of all sizes - it's about vital flexibility and consistency in clinical diagnostics,” says Marc Boehm, Lifecycle Leader for Core Lab at Roche Diagnostics. “By automating repetitive tasks, we empower laboratory staff to focus on complex analysis, which directly accelerates the journey from diagnosis to critical treatment decisions for patients.”      ABB Robotics will be responsible for developing industrial-grade lab solutions, drawing on its automation expertise, global manufacturing presence and its broad AI-powered robotics portfolio, which is orchestrated by ABB Robotics’ software. Roche will bring in its leading diagnostic expertise and application knowledge to ensure the solutions are tailored to the needs of laboratories in real clinical settings. The collaboration with Roche reflects ABB Robotics’ broader strategy of working with partners across the laboratory ecosystem to address critical bottlenecks in lab operations. By leveraging physical AI - where robots learn from real-world data and adapt to dynamic environments - ABB Robotics is advancing scalable, flexible lab automation solutions that improve efficiency, support faster decision-making to help laboratories deliver more reliable patient outcomes. ABB Roboticsas one of the world’s leading robotics companies, is the only company with a comprehensive and integrated AI-powered portfolio covering robots, cobots and Autonomous Mobile Robots (AMRs), designed and orchestrated by our value-creating software. We help companies of all sizes and sectors - from automotive to electronics and logistics – to outperform by becoming more resilient, flexible and efficient. ABB Robotics is at the forefront of developing and commercializing a new generation of Autonomous Versatile Robotics (AVR), leading a global innovation ecosystem of partners in advancing efficient hardware and intelligent software with industrial-grade performance. The business employs approximately 7,000 people.go.abb/roboticsFor more information please contact:Media RelationsRory SmithEmail: rory.smith@gb.abb.com [1] ¹ U.S. Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS), FDA and CMS Statement: Americans Deserve Accurate and Reliable Diagnostic Tests, January 18, 2024.

Rikshem Half-Year Report Jan–Jun 2026: Positive performance and increased income from property management

“Rikshem’s most recent quarter, as well as the entire first half of the year, has been positive, with developments including new long-term leases for properties for public use, a major zoning plan in Lund that has taken legal effect, and the completion of renovation and new construction projects, which have generated strong demand in the rental market. During the first half of the year, both the net operating income and the income from property management increased, and the vacancy rates for our residential properties are lower than last year. We continue to have a strong financial position and maintain our key figures at a balanced level, says Anette Frumerie, Rikshem CEO. · Rental income was SEK 1,861 (1,833) million. Rental income for the like-for-like portfolio rose 1.9 percent. · Net operating income totaled SEK 1,059 (1,023) million, an increase of 3.5 percent. Net operating income for the like-for-like portfolio increased by SEK 6 million or 0.7 percent. · Income from property management rose to SEK 623 (613) million. · The change in value of investment properties was SEK 82.4 (-83.4) million. · Profit before tax for the period was SEK 577 (208) million. · The fair value of the properties, including Rikshem’s share in joint ventures, was SEK 58,807 (58,205) million. · The total return, including joint ventures (R12M), was 3.6 (3.3) percent. Read the half-year report at rikshem.se  or in the attached pdf. 

Ovako audit shows 59% CO₂ reduction since 2015 in new Sustainability Report

Nordic specialty steel producer Ovako has published its Sustainability Report for Financial Year 2025, its second report inspired by the European Sustainability Reporting Standards (ESRS) framework. The report is independently assured by KPMG and presents audited ESG performance data, at a time when many industrial companies are scaling back sustainability commitments in response to cost pressures. The findings show that Ovako's Imatra site recorded all-time low direct emissions of just 231 kg of CO₂ per tonne of sold steel goods. Since 2015, Ovako has reduced its Scope 1 & 2 CO₂ emissions per tonne by 59 percent. Recent decarbonization initiatives include a fossil-free hydrogen facility for heating steel prior to rolling and VTD (Vacuum Tank Degassing) in Hofors; the modernization of the rolling mill furnace in Boxholm, reducing energy consumption by 50 percent and cutting emissions by almost 60 percent; and a recently converted bloom furnace to oxyfuel technology in Imatra, further reducing CO₂ emissions and energy consumption. Key highlights from the FY2025 report include: Record-low emissions intensity: Ovako's steel products contain 97 percent recycled content, with Scope 1, 2, and 3 emissions at 0.35 tCO₂e per tonne of hot-rolled steel, representing a 51 percent reduction in CO₂e emissions since 2015. Looking only at Scope 1 & 2 emissions, the reduction is 59 percent per tonne of sold goods. Net-zero pathway: Ovako is committed to reducing its Scope 1, 2, and 3 emissions per tonne of hot-rolled steel by 25 percent by 2030 and by 75 percent by 2040 from a 2021 baseline, and ultimately to achieving net-zero emissions across the entire value chain by 2045. Industry-leading safety: With a Lost Time Injury Frequency Rate (LTIFR) of 0.7, a significant reduction of 94 percent since 2015, Ovako continues to set a high standard across its industry. Ovako's LTI rate is below the global steel industry average. Employer recognition: For the fourth year in a row, Ovako has been nominated as Career Company in Sweden of the Year. The Career Company Award is based on an extensive review of nearly 2,000 students and young professionals and is given to organizations that offer unique career and development opportunities. Ovako has repeatedly been highlighted for its inclusive culture, strong sense of purpose, and its ability to combine technology, sustainability, and human development. "With a clear strategy, engaged teams, and strong partnerships, we are well-positioned to lead the transformation to a sustainable steel industry — with a purpose to create steel for a decarbonized society," says Marcus Hedblom, President & CEO of Ovako Group. “Our ESG disclosure is a comprehensive overview of both our relentless productivity and ethical fibre. By communicating openly about actions and their impacts, we reinforce our commitment to responsible business practices and creating long-term value for stakeholders and the planet.” Read the FY2025 Sustainability Report here 

Musti and ICA start discussions on a long-term partnership following the transfer of ICA’s Gaston Stores to Musti Group

Musti Group plc         Press Release 10 July 2026 at 2.00 p.m. EEST Musti and ICA start discussions on a long-term partnership following the transfer of ICA’s Gaston Stores to Musti Group Following a strategic review, ICA is transferring the three Gaston stores in Uppsala, Västerås and Norrköping to Sweden’s largest pet retail chain, Arken Zoo, fully owned by Musti Group. At the same time, discussions have been initiated regarding continued cooperation. Gaston was launched in October 2024 as a pilot project to test a specialized retail concept and increase understanding of how ICA can best meet the needs of pet owners. Following the evaluation, ICA has decided not to continue operating the concept itself and will instead transfer the stores to Arken Zoo, an established player with extensive experience in the pet market. Arken Zoo will take over the Gaston stores in Uppsala, Västerås and Norrköping. At the same time, a dialogue is being initiated regarding a long-term collaboration between ICA and Arken Zoo, through which the companies can jointly develop the offering and explore additional locations where complementary pet retail concepts can be established near ICA stores, creating attractive shopping destinations. “We are pleased by the trust placed in us to take over the Gaston stores and look forward to further developing them under the Arken Zoo brand. Together with ICA, we see strong opportunities to strengthen the offering and make it even easier for pet owners to find products and services for their animals. We look forward to establishing a long-term partnership with ICA so that our customers can benefit from having more Arken Zoo stores close to them across Sweden,” says David Rönnberg, CEO at Musti Group. “The pilot project provided us with valuable insights and strengthened our understanding of what pet owners are looking for. The pet market remains important to ICA Gruppen. This is reflected in our overall offering – from pet food in ICA stores to pet insurance through ICA Insurance and prescription medicines and other products for animals through Apotek Hjärtat. We have previously had positive experiences with Arken Zoo, and our discussions have given us strong confidence in their ability to continue developing what we have built with Gaston,” says Peter Muld, Acting Chief Strategy Officer at ICA Gruppen. With this transaction, ICA concludes the Gaston pilot project. The Gaston stores and e-commerce operations will remain open during the transition period. ICA and Arken Zoo are working together to ensure a smooth handover for customers and employees. Additional information: Martin Svedholm Director, Treasury, Insurances and Investor Relations tel. +358 50579 0324, martin.svedholm@mustigroup.com Distribution:Principal mediawww.mustigroup.com Musti Group in brief Musti makes the life of pets and their owners easier, safer and more fun. We are the leading Nordic pet care company with an increasing footprint in the Baltic countries and Portugal. Our omnichannel business model caters the needs of pets and their owners across Finland, Sweden, Norway, Estonia, Latvia, Lithuania and Portugal. We offer a wide, curated assortment of pet products. We also provide pet care services such as grooming, training and veterinary services in selected locations. Musti Group’s net sales were EUR 509 million in 2025. At the end of year 2025, the company had almost 4,000 employees, 1.9 million customers and 497 stores.

DNB Bank ASA – status of share buy-back programme after week 28 2026

On 15 May 2026, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme comprising up to 1,0 percent of the company’s own shares, which represents a total of 14,406,648 shares. Up to 9,508,388 shares will be purchased on trading venues by 14 August 2026, and a proposal to cancel the shares will be submitted to the next Annual General Meeting. At the same meeting it will also be proposed to redeem the remaining shares – up to 4,898,260 shares – from the Norwegian Government, represented by the Ministry of Trade, Industry and Fisheries (“NFD”), so that NFD’s ownership interest of 34 percent remains unchanged. The total consideration paid for the shares purchased under the buy-back programme, including the shares that will be proposed redeemed from NFD, will not exceed NOK 4,755 million. During week 28 of 2026, DNB purchased 1,132,857 own shares at an average price of NOK 298.4963 per share. Following this, DNB has purchased a total of 9,508,388 own shares under the current buy-back programme, corresponding to 0.66 percent of the shares in the company. Below is a more detailed overview of the transactions carried out under the buy-back programme: +------------------------------+---------+--------+-------------+|Date: |Number of|Average |Total || |shares |price |transaction || | |(NOK) |value (NOK) |+------------------------------+---------+--------+-------------+|06.07.2026 |302,858 |298.0201|90,257,771 |+------------------------------+---------+--------+-------------+|07.07.2026 |319,053 |300.4205|95,850,062 |+------------------------------+---------+--------+-------------+|08.07.2026 |250,947 |297.5198|74,661,701 |+------------------------------+---------+--------+-------------+|09.07.2026 |199,999 |298.8386|59,767,421 |+------------------------------+---------+--------+-------------+|10.07.2026 |60,000 |297.6827|17,860,962 |+------------------------------+---------+--------+-------------+|Previously repurchased shares |8,375,531| |2,427,357,683||under the programme           | | | ||  | | | |+------------------------------+---------+--------+-------------+|Total shares repurchased under|9,508,388|290.8753|2,765,755,601||the programme          | | | |+------------------------------+---------+--------+-------------+ Please see the stock exchange announcement published on 15 May 2026, which is available at newsweb.oslobors.no, for more information about the buy-back programme.  For further information, please contact Rune Helland, Head of Investor Relations, on +47 23 26 84 00 or +47 97 71 32 50. This announcement contains information that is subject to disclosure requirements pursuant to the Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act. An overview of all buy-backs made this week is enclosed with this announcement and available at newsweb.oslobors.no. 

Buy-back of shares in Corem 6–9 July 2026

Corem Property Group AB (publ) (LEI code: 213800CHXQQD7TSS1T59) ("Corem") has during 6-9 July 2026 repurchased in total 3,300,000 own ordinary shares of Class B, 4,900 own ordinary shares of Class D and 4,509 own preference shares as part of the two parallel share buy-back programs which were initiated by the board of directors of Corem and announced by Corem on 27 April 2026, (“Share buy-back program”) and (“Share buy-back Safe Harbour”). The Safe Harbour share buyback program is thereby terminated, in accordance with the communicated end date 9 July 2026. The Safe Harbour share buy-back program is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). The ordinary share buyback program remains active. The share buy back program is made in accordance with the authorization granted by the Annual General Meeting and the cancellation of treasury shares at the Extraordinary General Meeting on 2 July 2026, which created renewed capacity for further share repurchases. The purpose of the repurchases is to optimize and improve Corem's capital structure and thereby create increased shareholder value. Through buybacks, Corem increases the earnings per Class A and B ordinary shares, as well as net asset value per Class A and B ordinary share. Own shares in Corem has been repurchased in accordance with the following: +----+----------+-----------------+-------------------+-----------------+|Date|Share |Aggregated daily |Weighted average |Total daily || |class |volume (number of|share price per day|transaction value|| | |shares) |(SEK) |(SEK) |+----+----------+-----------------+-------------------+-----------------+|2026|Class B |750,000 |2.3335 |1,750,125 ||-07 | | | | ||-06 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Class D |1,500 |228.6333 |342,950 ||-07 | | | | ||-06 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Preference|1,500 |231.4000 |347,100 ||-07 |shares | | | ||-06 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Class B |750,000 |2.3280 |1,746,000 ||-07 | | | | ||-07 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Class D |1,500 |228.0387 |342,058 ||-07 | | | | ||-07 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Preference|1,431 |230.7764 |330,241 ||-07 |shares | | | ||-07 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Class B |1,800,000 |2.2633 |4,073,940 ||-07 | | | | ||-08 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Class D |1,900 |226.9161 |431,141 ||-07 | | | | ||-08 | | | | |+----+----------+-----------------+-------------------+-----------------+|2026|Preference|1,578 |230.7782 |364,168 ||-07 |shares | | | ||-08 | | | | |+----+----------+-----------------+-------------------+-----------------+ No shares were repurchased on 2026-07-09. All acquisitions have been carried out on Nasdaq Stockholm by Carnegie Investment Bank AB (publ) on behalf of Corem. Following the above listed repurchases Corem's holding of own shares as per 9 July 2026 amounts to 25,000,007 own ordinary shares of Class B, 43,533 own ordinary shares of Class D and 43,762 own preference shares. The total number of shares in Corem amounts to 1,273,568,990 shares, of which 90,210,440 are ordinary shares of Class A, 1,163,750,254 are ordinary shares of Class B, 7,358,622 are ordinary shares of Class D and 12,249,674 are preference shares. A full breakdown of transactions pursuant to article 5.3 of MAR and article 2.3 of the Safe Harbour Regulation is attached to this announcement. Corem Property Group AB (publ)FOR FURTHER INFORMATION, PLEASE CONTACTRutger Arnhult, CEO, +46 70 458 24 70, rutger.arnhult@corem.seEva Landén, Deputy CEO, +46 10 482 76 50, eva.landen@corem.seCorem Property Group AB (publ)Address: P.O. Box 56085, SE-102 17 StockholmVisitors: Riddargatan 13 CReg.no: 556463-9440www.corem.seThis press release is in all respects a translation of the Swedish original press release. In the event of any discrepancies between this translation and the Swedish original, the latter shall prevail.

Reminder: Program for the publication of Yara International ASA second quarter 2026 results

Yara International ASA 2Q 2026 results will be published on Friday, 17 July 2026 at 08:00 CEST. Online quarterly results presentation will start at 13:00 CEST. The presentation will be held in English. The report, presentation and webcast will be available at the above-mentioned times at https://yara.com/investor-relations/latest-quarterly-report/. Following the presentation, management will host an online Q&A session that will start right after the results presentation.  To follow the presentation and the Q&A session without asking questions, you can stay in the webcast at https://yara.com/investor-relations/latest-quarterly-report/. To ask questions to Yara's management, please join the Teams Meeting by clicking this link after the presentation: https://teams.microsoft.com/meet/396728624398608?p=UIDwSLYm3htGYIgO0E  For those of you who want to dial in, please call +47 23 50 05 15.You can find other local numbers here: https://dialin.teams.microsoft.com/233db517-9857-4d27-b80e-7355f516cc62 Use conference call ID: 700 547 179# A replay of the 2Q 2026 presentation and Q&A session will be made available soon after the presentation. ContactMaria GabrielsenHead of Investor RelationsM: +47 920 900 93E: maria.gabrielsen@yara.com About Yara Yara is a global leader in crop nutrition and ammonia with a mission to responsibly feed the world and protect the planet. Yara operates a global, flexible production system that delivers a diversified portfolio of nitrogen-based products. With our extensive global market reach and more than a century of agronomic knowledge and continuous innovation, we partner across the value chain to improve crop yields, optimize resource use, and reduce environmental impact. Through diversified energy exposure and profitable decarbonization efforts, Yara is uniquely positioned to strengthen industrial competitiveness and create long‑term value for customers, shareholders, employees, and society at large. Founded in Norway in 1905, Yara operates in over 60 countries and serves more than 140 markets, employing about 15,700 people. In 2025, Yara reported revenues of USD 15.7 billion. For more information, visit yara.com  or follow us on LinkedIn , X , Facebook  or Instagram . This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Metso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the shareholding of BlackRock, Inc. On July 9, 2026, BlackRock's holding in Metso’s shares amounted to 41,182,340 shares or 4.96 percent of total shares and votes. BlackRock's holding through financial instruments in Metso amounted to 4,907,527 shares, which corresponds to 0.59 percent of the total amount of Metso’s shares. As a result, BlackRock's total position amounted to 46,089,867 or 5.55 percent of Metso’s shares and votes. Metso’s total number of shares and voting rights is 828,972,440.BlackRock, Inc.’s holdings according to the notification: % of % of shares and voting rights Total of both shares through financial instruments in % (7.A + and (total of 7.B) 7.B) voting rights (total of 7.A)Resulting 4.96% 0.59% 5.55%situation on thedate onwhich thresholdwas crossed orreachedPosition of 5.03% 0.49% 5.53%previousnotification A: Shares andvoting rightsClass/type of Number of % ofshares shares and shares and voting rights voting rightsISIN code Direct(SMA Indirect(SMA Direct(SMA Indirect(SMA 9:5) 9:6 and 9:7) 9:5) 9:6 and 9:7)FI0009014575 41,182,340 4.96%SUBTOTAL A 41,182,340 4.96%B: FinancialInstrumentsaccording toSMA 9:6aType of Expiration Exercise/ Physical or Number of % of sharesfinancial date Conversion cash shares and votinginstrument Period settlement and rights voting rightsAmerican N/A N/A Physical 106,918 0.01%DepositaryReceipt(US5926721094)Securities N/A N/A Physical 2,965,592 0.35%LentCFD N/A N/A Cash 1,835,017 0.22% SUBTOTAL B 4,907,527 0.59% Metso Corporation     Distribution:   Nasdaq Helsinki Ltd  Main media  www.mogroup.com  Metso is a frontrunner in sustainable technologies, end-to-end solutions and services for the aggregates, minerals processing and metals refining industries globally. We improve our customers’ energy and water efficiency, increase their productivity, and reduce environmental risks with our product and service expertise. We are the partner for positive change.   Metso is headquartered in Espoo, Finland. At the end of 2025 Metso had close to 18,000 employees in around 50 countries, and sales in 2025 were about EUR 5.3 billion. Metso is listed on the Nasdaq Helsinki. metso.com

Konecranes’ January–June 2026 half-year financial report will be published on July 24, 2026

KONECRANES PLC PRESS RELEASE July 10, 2026 at 15:30 PM EEST Konecranes’ January–June 2026 half-year financial report will be published on July 24, 2026 Konecranes will publish its January-June 2026 half-year financial report on Friday, July 24, 2026 at approximately 12:30 p.m EEST. The report will be available on the company’s website at www.konecranes.com after publishing. A live international webcast and telephone conference for analysts, investors and media will be arranged on the publishing day at 2:00 p.m. EEST. The event will be held in English. The half-year financial report will be presented by President and CEO Marko Tulokas and CFO Teo Ottola. Questions may be presented at the end of the conference. The conference will be recorded, and an on-demand version of the conference will be published on the company´s website later during the day. The webcast can be watched through the following link:https://konecranes.events.inderes.com/q2-2026/register To ask questions, the telephone conference can be joined by registering through the following link:https://events.inderes.com/konecranes/q2-2026/dial-in Phone numbers and the conference ID to access the conference will be provided after the registration. In case you would like to ask a question during the conference, please dial #5 on your telephone keypad to enter the question queue. KONECRANES PLCLinda HäkkiläVice President, Investor Relations FURTHER INFORMATIONLinda Häkkilä,Vice President, Investor Relations,tel. +358 (0) 20 427 2050 Konecranes is a global leader in material handling solutions, serving a broad range of customers across multiple industries. We consistently set the industry benchmark, from everyday improvements to the breakthroughs at moments that matter most, because we know we can always find a safer, more productive and sustainable way. That's why, with around 16,500 professionals in over 50 countries, Konecranes is trusted every day to lift, handle and move what the world needs. In 2025, Group sales totalled EUR 4.2 billion. Konecranes shares are listed on Nasdaq Helsinki (symbol: KCR). DISTRIBUTIONNasdaq HelsinkiMajor mediawww.konecranes.com

Half-year report January – June 2026

· Rental income amounted to SEK 2,634 million (2,554). · Profit from property management amounted to SEK 1,329 million (1,273). · Operating cash flow amounted to SEK 1,242 million (1,291). · Changes in the value of properties amounted to SEK -68 million (-487). · Changes in the value of financial instruments amounted to SEK -188 million (-64). · Profit after tax for the period amounted to SEK 888 million (607). · The market value of the properties amounted to SEK 89,734 million (85,875). · During the period, SEK 1,407 million (1,650) was invested in the existing property portfolio. · During the period, 8 properties (4) were acquired for SEK 539 million (60) and 3 properties (5) were divested for SEK 144 million (216). “Hemsö has had an active first half of the year. Tenant demand remains strong, and we have a substantial investment pipeline. In June and early July alone, Hemsö completed around 15 transactions and project investments. We have continued to grow in line with our strategy through both new and expanded partnerships, with transactions across all countries and segments in which Hemsö operates. At the same time, Hemsö’s financial and operational key metrics remain stable”, says Nils Styf, CEO of Hemsö. For more information, please contact: Nils Styf, CEO                                                                                 +46 8-501 170 00Rutger Källén, CFO and Deputy CEO                                           +46 8-501 170 35 This information is information that Hemsö Fastighets AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 15:30 CET on 10 July 2026.

Solution International Nordics AB (publ) carries out a directed set-off share issue of approximately SEK 7.3 million

Stockholm, 10 July 2026 The board of directors of Solution International Nordics AB (publ) (the "Company") has today, on 10 July 2026, pursuant to the authorisation granted by the annual general meeting on 16 June 2026, resolved to carry out a directed new share issue of SEK 7,314,674, divided into 1,828,668 shares at a subscription price of SEK 4.00 per share. The issue is directed to Iron Branch Invest AB. Background and resolutionThe purpose of the issue is to reduce the Company’s indebtedness and strengthen the Company’s balance sheet. Through the issue, where payment is made by way of set-off, the Company’s debt to Iron Branch Invest AB is settled in full. Subscription shall take place no later than 25 July 2026. The reason for the deviation from the shareholders’ pre-emption rights is to reduce the Company’s indebtedness in a time- and cost-efficient manner by way of set-off of an existing claim, without utilising the Company’s liquidity. Subscription priceThe subscription price of SEK 4.00 per share has been determined through negotiations between the Company and Iron Branch Invest AB, whereby the parties have jointly assessed that the price reflects the value of the Company. The subscription price represents a premium of approximately 37.9 per cent to the closing price of the Company’s share on 9 July 2026 of SEK 2.90. As the subscription price exceeds the market price, and the issue thereby results in lower dilution for existing shareholders than an issue at or below the market price, the board of directors considers the terms of the issue to be at market terms. Share capital and dilutionThrough the issue, the share capital increases by approximately SEK 253,335.56 to approximately SEK 6,370,794.56 and the number of shares by 1,828,668 to 45,986,706, corresponding to a dilution of approximately 4.0 per cent of the capital and votes. For further information, please contactMark McLoughlin, CEOSolution International Nordics AB (publ)ir@solutioninternational.com This information is information that Solution International Nordics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 10 July 2026 at 17:23 CEST.

Citycon Oyj: Managers' Transactions – G City Ltd.

Person subject to the notification requirementName: G City Ltd.Position: Closely associated person(X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer Name: Chaim KatzmanPosition: Member of the BoardIssuer: Citycon OyLEI: 549300P8N0P6KDGTJ206Notification type: INITIAL NOTIFICATIONReference number: 165710/6/8 ____________________________________________Transaction date: 2026-07-06Venue: CEUXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 1 Unit price: 2.895 EUR (2): Volume: 70 Unit price: 2.895 EUR (3): Volume: 58 Unit price: 2.895 EUR (4): Volume: 307 Unit price: 2.895 EUR (5): Volume: 237 Unit price: 2.895 EUR (6): Volume: 534 Unit price: 2.895 EUR (7): Volume: 665 Unit price: 2.895 EUR  Aggregated transactions (7): Volume: 1872 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-06Venue: TQEXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 590 Unit price: 2.895 EUR  Aggregated transactions (1): Volume: 590 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-07Venue: CEUXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 425 Unit price: 2.895 EUR (2): Volume: 3 Unit price: 2.895 EUR (3): Volume: 63 Unit price: 2.895 EUR (4): Volume: 18 Unit price: 2.895 EUR (5): Volume: 316 Unit price: 2.895 EUR (6): Volume: 357 Unit price: 2.895 EUR (7): Volume: 20 Unit price: 2.895 EUR (8): Volume: 25 Unit price: 2.895 EUR (9): Volume: 38 Unit price: 2.895 EUR (10): Volume: 82 Unit price: 2.895 EUR (11): Volume: 455 Unit price: 2.895 EUR (12): Volume: 49 Unit price: 2.895 EUR (13): Volume: 85 Unit price: 2.895 EUR (14): Volume: 45 Unit price: 2.895 EUR (15): Volume: 86 Unit price: 2.895 EUR (16): Volume: 287 Unit price: 2.895 EUR (17): Volume: 90 Unit price: 2.895 EUR (18): Volume: 47 Unit price: 2.895 EUR (19): Volume: 77 Unit price: 2.895 EUR (20): Volume: 8000 Unit price: 2.895 EUR  Aggregated transactions (20): Volume: 10568 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-07Venue: TQEXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 428 Unit price: 2.895 EUR (2): Volume: 763 Unit price: 2.895 EUR (3): Volume: 106 Unit price: 2.895 EUR  Aggregated transactions (3): Volume: 1297 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-08Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 798 Unit price: 2.895 EUR (2): Volume: 133 Unit price: 2.895 EUR (3): Volume: 546 Unit price: 2.895 EUR (4): Volume: 202 Unit price: 2.895 EUR (5): Volume: 133 Unit price: 2.895 EUR (6): Volume: 133 Unit price: 2.895 EUR (7): Volume: 1796 Unit price: 2.895 EUR (8): Volume: 76 Unit price: 2.895 EUR (9): Volume: 9 Unit price: 2.895 EUR (10): Volume: 689 Unit price: 2.895 EUR (11): Volume: 720 Unit price: 2.895 EUR (12): Volume: 133 Unit price: 2.895 EUR (13): Volume: 33 Unit price: 2.895 EUR (14): Volume: 798 Unit price: 2.895 EUR (15): Volume: 313 Unit price: 2.895 EUR (16): Volume: 769 Unit price: 2.895 EUR (17): Volume: 6 Unit price: 2.895 EUR (18): Volume: 251 Unit price: 2.895 EUR (19): Volume: 600 Unit price: 2.895 EUR (20): Volume: 2 Unit price: 2.895 EUR (21): Volume: 190 Unit price: 2.895 EUR (22): Volume: 133 Unit price: 2.895 EUR (23): Volume: 1713 Unit price: 2.895 EUR (24): Volume: 613 Unit price: 2.895 EUR (25): Volume: 260 Unit price: 2.895 EUR (26): Volume: 614 Unit price: 2.895 EUR (27): Volume: 601 Unit price: 2.895 EUR (28): Volume: 356 Unit price: 2.895 EUR (29): Volume: 4 Unit price: 2.895 EUR (30): Volume: 25 Unit price: 2.895 EUR (31): Volume: 19934 Unit price: 2.895 EUR (32): Volume: 13126 Unit price: 2.895 EUR (33): Volume: 10553 Unit price: 2.895 EUR (34): Volume: 500 Unit price: 2.895 EUR (35): Volume: 100 Unit price: 2.895 EUR (36): Volume: 150 Unit price: 2.895 EUR (37): Volume: 199 Unit price: 2.895 EUR (38): Volume: 187 Unit price: 2.895 EUR (39): Volume: 190 Unit price: 2.895 EUR (40): Volume: 500 Unit price: 2.895 EUR (41): Volume: 48 Unit price: 2.895 EUR (42): Volume: 200 Unit price: 2.895 EUR (43): Volume: 5000 Unit price: 2.895 EUR (44): Volume: 5000 Unit price: 2.895 EUR (45): Volume: 4800 Unit price: 2.895 EUR (46): Volume: 5000 Unit price: 2.895 EUR (47): Volume: 5000 Unit price: 2.895 EUR (48): Volume: 5000 Unit price: 2.895 EUR (49): Volume: 5000 Unit price: 2.895 EUR (50): Volume: 5000 Unit price: 2.895 EUR (51): Volume: 5000 Unit price: 2.895 EUR (52): Volume: 5000 Unit price: 2.895 EUR (53): Volume: 1428 Unit price: 2.895 EUR (54): Volume: 5000 Unit price: 2.895 EUR (55): Volume: 3572 Unit price: 2.895 EUR  Aggregated transactions (55): Volume: 118136 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-08Venue: CEUXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 17 Unit price: 2.895 EUR (2): Volume: 422 Unit price: 2.895 EUR (3): Volume: 942 Unit price: 2.895 EUR (4): Volume: 390 Unit price: 2.895 EUR (5): Volume: 1376 Unit price: 2.895 EUR (6): Volume: 67 Unit price: 2.895 EUR (7): Volume: 16 Unit price: 2.895 EUR (8): Volume: 17 Unit price: 2.895 EUR (9): Volume: 23 Unit price: 2.895 EUR (10): Volume: 37 Unit price: 2.895 EUR (11): Volume: 73 Unit price: 2.895 EUR (12): Volume: 1 Unit price: 2.895 EUR (13): Volume: 55 Unit price: 2.895 EUR (14): Volume: 3 Unit price: 2.895 EUR (15): Volume: 92 Unit price: 2.895 EUR (16): Volume: 23 Unit price: 2.895 EUR (17): Volume: 138 Unit price: 2.895 EUR (18): Volume: 341 Unit price: 2.895 EUR (19): Volume: 468 Unit price: 2.895 EUR (20): Volume: 448 Unit price: 2.895 EUR (21): Volume: 734 Unit price: 2.895 EUR (22): Volume: 229 Unit price: 2.895 EUR (23): Volume: 153 Unit price: 2.895 EUR (24): Volume: 73 Unit price: 2.895 EUR (25): Volume: 599 Unit price: 2.895 EUR (26): Volume: 439 Unit price: 2.895 EUR (27): Volume: 714 Unit price: 2.895 EUR (28): Volume: 176 Unit price: 2.895 EUR (29): Volume: 684 Unit price: 2.895 EUR (30): Volume: 340 Unit price: 2.895 EUR (31): Volume: 559 Unit price: 2.895 EUR (32): Volume: 1 Unit price: 2.895 EUR (33): Volume: 981 Unit price: 2.895 EUR (34): Volume: 99 Unit price: 2.895 EUR (35): Volume: 467 Unit price: 2.895 EUR (36): Volume: 61 Unit price: 2.895 EUR (37): Volume: 502 Unit price: 2.895 EUR (38): Volume: 427 Unit price: 2.895 EUR (39): Volume: 1785 Unit price: 2.895 EUR (40): Volume: 3 Unit price: 2.895 EUR (41): Volume: 365 Unit price: 2.895 EUR (42): Volume: 4341 Unit price: 2.895 EUR (43): Volume: 8501 Unit price: 2.895 EUR (44): Volume: 2018 Unit price: 2.895 EUR (45): Volume: 1078 Unit price: 2.895 EUR (46): Volume: 8501 Unit price: 2.895 EUR (47): Volume: 6483 Unit price: 2.895 EUR (48): Volume: 2339 Unit price: 2.895 EUR (49): Volume: 2932 Unit price: 2.895 EUR (50): Volume: 74 Unit price: 2.895 EUR (51): Volume: 176 Unit price: 2.895 EUR (52): Volume: 119 Unit price: 2.895 EUR (53): Volume: 4700 Unit price: 2.895 EUR (54): Volume: 1093 Unit price: 2.895 EUR  Aggregated transactions (54): Volume: 56695 Volume weighted average price: 2.895 EUR ____________________________________________Transaction date: 2026-07-08Venue: TQEXInstrument type: SHAREISIN: FI4000369947Nature of transaction: ACQUISITION  Transaction details(1): Volume: 73 Unit price: 2.895 EUR (2): Volume: 39 Unit price: 2.895 EUR (3): Volume: 1 Unit price: 2.895 EUR (4): Volume: 1 Unit price: 2.895 EUR (5): Volume: 1 Unit price: 2.895 EUR (6): Volume: 352 Unit price: 2.895 EUR (7): Volume: 429 Unit price: 2.895 EUR (8): Volume: 977 Unit price: 2.895 EUR (9): Volume: 1499 Unit price: 2.895 EUR (10): Volume: 19934 Unit price: 2.895 EUR (11): Volume: 466 Unit price: 2.895 EUR (12): Volume: 56 Unit price: 2.895 EUR  Aggregated transactions (12): Volume: 23828 Volume weighted average price: 2.895 EUR CITYCON OYJ For further information, please contact:Anni TorkkoDirector, Group Corporate Analysis & IRTel. +358 45 358 0570anni.torkko@citycon.com 

Establishment of At-the-Market Equity Offering Programme

10 July 2026 ZENITH ENERGY LTD. ("Zenith" or the "Company") Establishment of At-the-Market Equity Offering Programme Zenith Energy Ltd. (LSE: ZEN; OSE: ZENA; XSAT: ZENA SDR), the listed international energy production and development company, is pleased to announce that it has entered into an “At-the-Market” equity offering facility agreement (the "Facility") to raise up to £2,000,000 (before expenses) over the next 12 months. Under the terms of the Facility, market sales of new common shares of no-par value ("Shares") will be made from time to time at the Company’s discretion (“Facility Sales”), who will establish the parameters such as minimum price, maximum volume and period of time under which Facility Sales of Shares may be made. Facility Sales of Shares will only be made to investors trading on the London Stock Exchange (LSE: ZEN). The Facility has been established as an additional financing tool following the £2,000,000 unsecured convertible loan facility announced on 28 April 2026. The Company is under no obligation to utilise the Facility, either in whole or in part, and it may never be utilised. The Company is announcing the establishment of the Facility only. No Common Shares are being issued pursuant to the Facility as at the date of this announcement, and the execution of the Facility does not itself result in any dilution to existing shareholders. At-the-market equity programmes are widely utilised by listed companies in the United States and have become an established capital markets financing tool, enabling issuers to access equity capital efficiently, at lower transaction costs and with greater flexibility than traditional marketed offerings by issuing shares incrementally into the market at prevailing market prices. Any use of the Facility will be subject to the Board's discretion and will only occur where it considers such sales to be in the best interests of the Company and its shareholders. Andrea Cattaneo, Chief Executive Officer, commented: "We are pleased to have secured this flexible, efficient and cost-effective equity capital raising capability. The Facility provides Zenith with the ability to access capital selectively and at prevailing market prices, allowing the Company to benefit from the strong liquidity in its shares while retaining a high degree of control over the timing, pricing and size of any issuances, thereby helping to minimise dilution for existing shareholders. The Company is under no obligation to utilise the Facility, either in whole or in part, and it may never be used. The Board will only elect to utilise the Facility where it believes doing so is in the best interests of the Company and its shareholders." Further Information: +----------------------------------------+------------------------+|Zenith Energy Ltd |Tel: +1 (587) 315 1279 || | ||Andrea Cattaneo, Chief Executive Officer|E:  info@zenithenergy.ca|+----------------------------------------+------------------------+ Notes to Editors: Zenith Energy Ltd. is a revenue generating, independent energy company with energy production, exploration and development assets in North Africa, the US and Europe. The Company is listed on the London Stock Exchange Main Market (LSE: ZEN), the Euronext Growth of the Oslo Stock Exchange (OSE: ZENA) and on the Spotlight Stock Market in Sweden (XSAT: ZENA SDR). Zenith's strategic focus is on pursuing development opportunities through the development of proven revenue generating energy production assets, as well as low-risk exploration activities in assets with existing production. For more information, please visit: www.zenithenergy.ca Twitter: @zenithenergyltd LinkedIn: https://bit.ly/3A5PRJb Market Abuse Regulation (MAR) Disclosure The information contained in this announcement is information that the Company is required to disclose under the EU Market Abuse Regulation (Regulation (EU) No 596/2014) (“MAR”), as applicable in Sweden and to companies listed on Spotlight Stock Market. The information was submitted for publication, through the agency of the contact person listed above, at the time this announcement was made public. Following publication, this information is now considered to be in the public domain.

Correction regarding previous press release: Missing MAR statement

BiBB signs exclusive distribution agreement with Palex Medical Spain BiBBInstruments AB ("BiBB" or the "Company"), developer of EndoDrill[®] – the world's first market-cleared powered biopsy instrument for endoscopy – announces today that the Company has signed its first European commercial distribution agreement for EndoDrill[®] GI with Palex Medical S.A.U. ("Palex Spain"). Under the agreement, Palex Medical Spain receives exclusive rights to market, sell and commercialize EndoDrill[®] GI in Spain. The agreement is intended to serve as a foundation for further commercial expansion within additional European regions of the Palex network. Preparations for the European launch are taking place in parallel with the ongoing U.S. commercialization, which began in 2025 in collaboration with TaeWoong Medical USA. Comment from Fredrik Lindblad, CEO of BiBB:"Signing our first European commercial distribution agreement represents an important milestone for BiBB. Palex Medical Spain combines a strong commercial organization with extensive experience in advanced endoscopy and a well-established presence in the Spanish healthcare market. We look forward to introducing EndoDrill[®] GI together with Palex and to supporting clinicians with a new approach to tissue acquisition through high-quality core tissue samples.” The agreement includes exclusivity rights and mutually agreed commercial targets. The agreement covers EndoDrill[®] GI only and does not include other products within the EndoDrill[®] portfolio. Additional EndoDrill[®] products may be added to the agreement as they become commercially available. Palex Group is one of Europe's leading healthcare distribution groups, operating across 11 European regions. The Group employs more than 2,100 people and is headquartered in Barcelona, Spain. Palex Spain is the Group's largest operating company, employing close to 1,000 people and serving healthcare providers throughout Spain. Commercial launch preparations in Spain have commenced. EndoDrill[®] GI has already been successfully used in patient cases at several leading EUS centers in Madrid and Valladolid together with Palex. The positive clinical experience generated through these procedures has provided an important foundation for the commercial launch. The parties have subsequently initiated market development activities, including clinical engagement, target account identification and launch planning. María Jesús Barrenechea , CBO Spain of Palex:”The introduction of BiBBInstruments’ EndoDrill[®] technology represents an important step forward in our commitment to advanced, patient-centred care. By enabling high-quality core biopsies through a powered, rotating tissue acquisition system, this state-of-the-art technology has the potential to improve the reliability of tissue sampling and support more accurate diagnosis and treatment planning. For patients, this may translate into better-informed clinical decisions and a more efficient diagnostic pathway. For healthcare professionals, EndoDrill[®] provides an innovative tool designed to enhance precision and confidence in endoscopic tissue acquisition procedures.” Spain represents an important European market for endoscopic ultrasound, with approximately 100 hospitals performing EUS procedures. The agreement with Palex Medical Spain is intended to support further commercial expansion within the Palex network. BiBB is currently engaged in discussions regarding additional European territories. About Palex Group and Palex Medical SpainPalex Group is a leading European healthcare and medical technology distribution group providing advanced solutions and services to hospitals, healthcare professionals and research institutions. The Group operates through a network of specialized companies with expertise spanning endoscopy, surgery, interventional medicine and hospital solutions. Palex Spain is the largest operating company within Palex Group, one of Europe's leading healthcare distribution groups. The company employs close to 1,000 people and maintains a dedicated endoscopy organization serving leading hospitals throughout Spain. About EndoDrill® GIEndoDrill[®] GI is the world's first market-cleared powered biopsy instrument for endoscopic ultrasound (EUS), with both FDA 510(k) clearance and CE marking. Unlike conventional manual biopsy needles, EndoDrill[®] uses a powered rotating needle tip designed to obtain intact core tissue samples to facilitate histopathology and molecular analysis. The system is currently being commercialized in the United States through distribution partner TaeWoong Medical USA. The European commercial launch is scheduled to commence in Spain during 2026 through distribution partner Palex Medical Spain, representing the first step in BiBB's planned expansion across Europe. For more information, please contact:Fredrik Lindblad, CEOEmail: fredrik.lindblad@bibbinstruments.comPhone: +46 70 899 94 86www.bibbinstruments.com  This is a translation of the Swedish press release. In the event of any discrepancy, the Swedish language version shall prevail. This information is information that BiBBInstruments AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU) No 596/2014. The information was submitted for publication, through the agency of the contact person set out above, at the time stated by the Company's news distributor upon publication of this press release. About BiBBInstruments AB BiBBInstruments AB is a cancer diagnostics company developing and manufacturing EndoDrill®, the world’s first series of market-cleared powered endoscopic biopsy instruments. EndoDrill® is designed to obtain core tissue samples (core needle biopsies, CNB) with high diagnostic accuracy and aims to improve the diagnosis of cancers in organs such as the stomach, pancreas, liver, lungs, and urinary bladder. The product portfolio targets the global market for ultrasound-guided endoscopic biopsy instruments (EUS/EBUS), one of the most advanced and fastest-growing segments within modern endoscopy. BiBB received FDA 510(k) clearance for its first instrument, EndoDrill® GI, in 2023 and CE marking under the European Medical Device Regulation (MDR) in 2024 for all three product variants – EndoDrill® GI, EndoDrill® EBUS, and EndoDrill® URO. As such, EndoDrill® is the first powered biopsy system cleared in both the United States and Europe. The U.S. launch of EndoDrill® GI commenced during the second half of 2025 in collaboration with TaeWoong Medical USA. The EndoDrill® system consists of sterile single-use instruments and a proprietary drive system. BiBB was founded in 2013 by Dr. Charles Walther, cancer researcher at Lund University and senior consultant pathologist at Skåne University Hospital. The Company is headquartered at Medicon Village in Lund, Sweden, and its shares are listed on Spotlight Stock Market (ticker: BIBB).

New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer’s disease

Key findings: The data were presented during the Developing Topics session, “Lecanemab Subcutaneous Formulation in Early Alzheimer’s Disease: Emerging Clinical Evidence and Practical Use Considerations” (Session #1-32-FRS-C). The session highlighted findings from the lecanemab SC-AI development program in early Alzheimer’s disease, including pharmacokinetic (PK), pharmacodynamic (PD), efficacy, safety and real-world patient and care partner experience data. Results showed that once-weekly 500 mg SC-AI achieved drug exposure similar to the approved IV initiation regimen (10 mg/kg every two weeks), supporting the expectation of similar clinical efficacy and safety, regardless of the route of administration. The subcutaneous dosing option may offer a convenient at-home alternative to IV infusion, with the potential to expand treatment access and support more flexible care delivery across healthcare settings. Data showed: · Bioequivalence achieved: Once-weekly 500 mg SC-AI demonstrated bioequivalence to the IV initiation regimen (10 mg/kg every two weeks), with an exposure ratio of 104% (90% confidence interval [CI]: 99.1%–109%). Exposure remained consistent across body weight quartiles, demonstrating a stable pharmacokinetic profile in a broad patient population. · Efficacy driven by exposure, not route of administration: Amyloid removal measured by amyloid PET, clinical efficacy measured by CDR-SB, and the incidence of ARIA-E were driven by lecanemab exposure rather than the route of administration. The 500 mg SC-AI initiation regimen achieved exposure comparable to the IV initiation regimen, supporting the expectation of a comparable efficacy and safety profile despite the different route of administration. · Consistent results across patient populations: The 500 mg SC-AI initiation regimen demonstrated consistent exposure, amyloid clearance as measured by amyloid PET, clinical efficacy and safety across body weight groups. Amyloid clearance and clinical outcomes were not meaningfully affected by body weight, supporting the use of a fixed-dose regimen. · Flexible administration options: Patients may switch between IV and SC administration as needed, and if a dose is missed, treatment can be administered the following day or up to six days later, providing greater flexibility and convenience in Leqembi administration. Safety profile of subcutaneous Leqembi aligned with the IV formulation: · Overall safety profile of SC-AI was generally consistent with that observed for the IV formulation.  · Incidence of ARIA-E with the 500 mg SC-AI initiation regimen was predicted to be similar to that observed with the IV initiation regimen.  · Injection-related reactions were observed with subcutaneous Leqembi, most of which were localized, while systemic reactions were less frequently observed.  · The incidence of anti-drug antibodies was low, at 1.4% in the 500 mg SC-AI group. No neutralizing antibodies were observed, confirming that the low immunogenicity profile was maintained with the SC-AI formulation. Clinical trial perspectives and real-world evidence: sustained clinical benefit with SC-AI Data from two US Alzheimer’s treatment centers (Alzheimer’s Research and Treatment Center, and First Choice Neurology and Visionary Investigators Network) provide early insight into clinical trial and real-world use of subcutaneous Leqembi: · At Alzheimer’s Research and Treatment Center, 28 patients receiving SC administration demonstrated slower cognitive decline as measured by CDR-SB[1] over 36 months relative to a matched Alzheimer’s Disease Neuroimaging Initiative (ADNI) natural history cohort. The cohort included 25 patients newly initiated on SC administration and 3 patients who transitioned from IV administration.  · In a separate case series from First Choice Neurology and Visionary Investigators Network, 10 of 11 evaluable patients (91%) showed improvement or remained stable on MMSE[2] compared with baseline before maintenance therapy. At this center, patients who had received maintenance therapy with SC administration for at least 6 months were included in the analysis. · Patient and care partner surveys conducted at these two sites demonstrated high satisfaction with subcutaneous Leqembi administration, with satisfaction rates ranging from 75% to 97%, convenience ratings from 83% to 97%, and willingness to recommend treatment ranging from 92% to 100%. Results presented in this session further reinforce the importance of early and continuous treatment, highlighting how Leqembi SC initiation and maintenance administration provides greater optionality for long-term disease management.  --- This release discusses investigational uses of an agent in development and is not intended to convey conclusions about efficacy or safety. There is no guarantee that such investigational agents will successfully complete clinical development or gain health authority approval. The information was released for public disclosure, through the agency of the contact person below, on July 12, 2026, at 5:30 pm CEST.For further information, please contact:Oskar Bosson, VP Communications and Investor Relations E-mail: oskar.bosson@bioarctic.com Telephone: +46 704 107 180Jenny Ljunggren, External Communications and Investor Relations Manager E-mail: jenny.ljunggren@bioarctic.com Telephone: +46 76 013 86 08About Leqembi® (lecanemab) Leqembi is the result of a strategic research alliance between BioArctic and Eisai. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Leqembi is approved in 53 countries and is under regulatory review in 6 countries. Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks is approved in 8 countries, including the United Kingdom, China, the US and Japan, and applications have been filed in 12 countries and regions. In the US, Leqembi Iqlik™ is approved for subcutaneous dosing with an autoinjector for maintenance treatment of early Alzheimer’s disease. In November 2025, a new drug application for subcutaneous formulation of Leqembi was submitted in Japan. In December 2025, Leqembi was included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China. In January 2026, Eisai’s supplemental Biologics License Application (sBLA) regarding a subcutaneous starting dose with Leqembi Iqlik was granted Priority Review by the US FDA. The sBLA has been assigned an extended PDUFA date of August 24, 2026. In January 2026, the Biologics License Application for subcutaneous formulation of Leqembi was accepted in China and in February, the application was designated for priority review. Since July 2020, Eisai’s Phase 3 clinical study (AHEAD 3-45) with lecanemab in individuals with preclinical Alzheimer’s disease meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. The study was fully recruited in October 2024. AHEAD 3-45 is a four-year study conducted as a public-private partnership between Eisai, Biogen and the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in Alzheimer’s disease and related dementias in the US, funded by the National Institute on Aging, part of the National Institutes of Health. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited Alzheimer’s disease (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy. About the collaboration between BioArctic and Eisai Since 2005, BioArctic has a long-term collaboration with Eisai regarding the development and commercialization of drugs for the treatment of Alzheimer’s disease. The most important agreements are the Development and Commercialization agreement for the lecanemab antibody, which was signed 2007, and the Development and Commercialization agreement for the antibody lecanemab back-up for Alzheimer’s disease, which was signed 2015. In 2014, Eisai and Biogen entered into a joint development and commercialization agreement for lecanemab. Eisai is responsible for the clinical development, application for market approval and commercialization of the products for Alzheimer’s disease. BioArctic has the right to commercialize lecanemab in the Nordic region and is currently preparing for commercialization in the Nordics together with Eisai. BioArctic has no development costs for lecanemab in Alzheimer’s disease and is entitled to payments in connection with sales milestones as well as royalties on global sales. About BioArctic AB BioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with BioArctic’s partner Eisai, who are responsible for regulatory interactions and commercialization globally. In addition to Leqembi, BioArctic has a broad research portfolio with antibodies against Parkinson's disease and ALS as well as additional projects against Alzheimer's disease. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For further information, please visit www.bioarctic.com. [1] Clinical Dementia Rating–Sum of Boxes (CDR-SB) is a standard scoring system used to quantify the severity of dementia in Alzheimer's disease. [2] Mini-Mental State Examination (MMSE) isa 30-point questionnaire used to assess cognitive impairment and screen for Alzheimer's disease.

Interim Report April–June 2026

· Net sales increased by 9 (-9) percent, to SEK 7,629 (6,974) million, of which organic growth 9 percent · The order intake increased by 44 (9) percent, to SEK 11,691 (8,109) million · EBITA increased by 51 (10) percent, to SEK 570 (378) million, with a positive impact of SEK 118 million from non-recurring items · The EBITA margin increased to 7.5 (5.4) percent, adjusted for non-recurring items the margin was 5.9 percent · Profit after tax increased by 59 (12) percent, to SEK 429 (269) million · Cash flow from operating activities was SEK 96 (123) million · Basic and diluted earnings per share were SEK 2.10 (1.31) CEO statementBravida delivers strong organic growth, improved margins and a significantly larger order backlog in the second quarter of 2026. Our established and resilient business model, strong financial position and high customer confidence, not least for our expertise in large, advanced projects, increase our attractiveness to both customers and employees. Together, this provides a stable platform for continued profitable growth and increased shareholder value. Strong organic growth in all business segmentsBravida delivered a strong second quarter and first half of 2026, in a world that continues to be characterised by economic and geopolitical uncertainty and, to some extent, a cautious attitude regarding making investments in Bravida's traditional core area of business.  Net sales increased by 9 (-9) percent during the second quarter, to SEK 7,629 (6,974) million. Organic growth was 9 (-8) percent. Acquisition-related growth amounted to 0 (1) percent, with the divestment of ABEKA El och Kraftanläggningar AB (ABEKA) offsetting the quarter's acquisition-driven growth. The currency effect was 0 (-3) percent. In the first half of the year, net sales increased by 6 (-7) percent, to SEK 14,674 (13,862) million. Organic growth was 6 (-7) percent, with the divestment of ABEKA somewhat offsetting acquisition-related growth during the half-year period as well. The currency effect was negative, at -1 (-2) percent. Improved profitability as a result of growth and a focus on marginsThe underlying profitability improved during both the second quarter and the first half of 2026, driven by increased activity and a well-adjusted cost structure. The measures we have carried out to adapt our operations to the current market situation, combined with a consistent focus on costs and operational efficiency, are now yielding clear results.  EBITA for the second quarter increased by 51 percent to SEK 570 (378), corresponding to an EBITA margin of 7.5 (5.4) percent. For the first half of the year, EBITA amounted to SEK 895 (685) million and the EBITA margin improved to 6.1 (4.9) percent.  Earnings for the second quarter were positively impacted by SEK 158 million from the divestment of ABEKA but were at the same time reduced by restructuring costs of SEK -40 million, so the net effect was SEK 118 million. For the first half of the year, the net effect was SEK 98 million, due to restructuring costs totalling SEK -60 million.  Due to our continued volume growth, good cost control and a selective project portfolio, my assessment is that Bravida is in a good position to gradually strengthen our margins and achieve my goal of emerging from the current recession as a much stronger company than when we entered it. Significant data centre orders securedBravida's order backlog increased significantly during the second quarter and amounted to SEK 20,372 (16,854) million at the end of the period. The order intake improved in general during the quarter, but the increase is primarily due to one particular order for a data centre outside Stavanger in Norway. The assignment, which is a Joint Venture in which Bravida's share amounts to just over SEK 4.3 billion, will run until 2028/2029. I am proud that Bravida has once again been entrusted with delivering installation solutions for a data centre. Since 2009, Bravida has served as a technology partner to customers building data centres, and has established a leading position in the Nordic region in this segment. As specialists in technical systems and advanced projects, we can take responsibility for the entire chain – from design and project management to installation, service and retrofitting. After the end of the period, we have signed two additional major orders relating to data centres in Sweden and Finland, with these being worth SEK 650 million and SEK 2.2 billion respectively. Financial strength creates shareholder valueBravida's cash conversion was 77 (80) percent for the rolling twelve months as of the balance sheet date. Cash conversion outcomes are affected by contract structures and payment patterns in larger projects, where cash flow may vary between periods as a result of advance payments being made. Over a longer timeline, our cash conversion is approximately 100 percent, which better reflects the underlying cash flow capability of the business. Cash flow was impacted positively by SEK 208 million during the second quarter as a result of the divestment of ABEKA.  Bravida’s strong balance sheet and low debt put us in a good position to carry out value-creating acquisitions, which include both platform acquisitions and complementary add-on acquisitions. At the same time, we have the capacity to maintain our dividend policy of distributing at least 50 percent of annual net profit. The year's dividend corresponded to 63 (73) percent of net profit.  To further strengthen returns to our shareholders, we recently completed our first share repurchase programme of SEK 100 million. After the end of the period, the Board of Directors decided to implement an additional repurchasing programme for a maximum of SEK 100 million. Stable and exciting platform for continued profitable growthThere is good growth in all markets, with a high level of activity and a growing demand relating to larger and more advanced projects, such as data centre and infrastructure projects. This all provides a well-balanced business mix and a stable and very exciting platform for continued growth. In summary, Bravida is financially strong, and has good capacity to invest in continued growth and create long-term value for our shareholders. Mattias JohanssonCEO and Group PresidentStockholm, July 2026 The report will be presented at 13:00 CEST by CEO and Group President Mattias Johansson and CFO Petra Vranjes. The presentation will be held in English and can be followed online or by phone.  Link to webcasthttps://bravida.events.inderes.com/q2-report-2026 Telephone conference To participate in the conference call, please register via this link:https://events.inderes.com/bravida/q2-report-2026/dial-in After registration, you will be provided with telephone numbers and a conference ID to access the conference. There will be room for questions in the telephone conference. The report and presentation will be available at: https://www.bravidagroup.com/en/investors/reports-and-presentations For further information, please contact:Ann-Charlotte Johansson, Interim Head of Investor RelationsTelephone: +46 70 751 98 31E-mail: ann-charlotte.johansson@bravida.se This disclosure contains information that Bravida Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, at 12:00 am CEST on 13 July 2026.

Studsvik convenes Extraordinary General Meeting to elect Mats Ladeborn to the Board

Nyköping, July 13, 2026 - Studsvik AB (Nasdaq Stockholm: SVIK) today announces that its Board of Directors has resolved to convene an Extraordinary General Meeting on 18 August 2026. The principal items of business are the proposed election of Mats Ladeborn to the Board, the issuance of Hurdle Shares to him, and a new long-term incentive sleeve linked to exceptional, long-term value creation. Studsvik has spent close to 80 years at the technical core of the nuclear industry, serving reactor operators worldwide. In 2026 it acquired Kärnfull Next, a Swedish developer of new nuclear projects, extending its work across the full lifecycle of a nuclear power plant. Kärnfull Next runs Studsvik’s ReFirm programme, which is developing a portfolio of SMR parks in southern Sweden; in June 2026 Studsvik applied for state support for up to approximately 1,400 MWe of new fossil-free baseload across its two most advanced sites, Valdemarsvik and Nyköping. Ladeborn’s election adds operational and new-build leadership to the Board as that work advances. The election of Mats Ladeborn Mats Ladeborn has more than four decades of senior international experience in the nuclear energy sector. He has served as Enterprise Chief of Nuclear Operations at the Emirates Nuclear Energy Corporation (ENEC), with responsibility for overseeing operations of the four-unit Barakah Nuclear Energy Plant – among the largest new nuclear programmes commissioned anywhere in the world in recent years – as well as for fuel management, radioactive waste management and research and development. Prior to ENEC, he was Vice President of Fleet Development at Vattenfall in Sweden, with responsibility for nuclear oversight across the group’s reactor fleet in Sweden and Germany. He has also served as President of FORATOM, the European nuclear industry association, as a member of the governing board of the World Association of Nuclear Operators (WANO) Paris Centre, on a safety committee for new nuclear power in the United Kingdom, and as Chairman of a high-level working group of the International Atomic Energy Agency (IAEA). He holds a Master of Technology and is a qualified nuclear operator. As a member of the Board, Mats Ladeborn will take a leading role in supporting Studsvik’s portfolio of new nuclear projects developed through Kärnfull Next (KNXT). His operational experience across the construction, commissioning and safe operation of large nuclear fleets will be a direct asset to the ReFirm programme as it advances site development, partner selection and regulatory engagement. Mats Ladeborn joins a Board that already holds significant new-build expertise: Board member Julia Pyke CBE led Sizewell C – the largest British fossil-fuel-free energy project in a generation – to its £38 billion final investment decision in 2025, and previously helped develop and finance Hinkley Point C. Ladeborn also strengthens the Board’s relationships with the operating fleet at the core of Studsvik’s established business. Having overseen nuclear operations in Europe and the Middle East and served on WANO’s governing board, he brings longstanding relationships across the global operator community and firsthand insight into what utilities need as they extend plant lifetimes, increase output and modernise their operations. Conditional on his election, the Nomination Committee also proposes that Mats Ladeborn invest alongside shareholders through a board incentive programme on terms equivalent to the Board LTIP 2026/2029 adopted at the 2026 Annual General Meeting, in which two Board members currently participate. Ladeborn would be allocated up to 7,500 newly issued Hurdle Shares, compared with up to 5,000 each for the two existing participants. Under that programme, the Hurdle Shares are acquired at market value and convert into ordinary shares only if demanding share-price hurdles are met. Further, the Board of Directors proposes to amend the remuneration guidelines so that Board members may enter into consultancy agreements with Studsvik to ensure that Studsvik can remunerate work carried out by board members outside of their board role. “Mats Ladeborn brings invaluable operational experience to the Board as Studsvik accelerates its transformation and takes a greater role in supporting the existing global nuclear fleet and enabling its expansion,” says Daniel S. Aegerter, Chair of the Nomination Committee, Founder & CEO of Armada Investment and Studsvik’s largest shareholder. “We are looking forward to working with Mats – very few people have brought a major new nuclear programme into operation, and he is one of them,” says Adam Rodman, Studsvik Board member and Founder & Chief Investment Officer of Segra Capital. “Studsvik has a unique position in the nuclear industry – combining decades of technical expertise with the potential to make a real difference at scale,” says Mats Ladeborn. “I am excited by that opportunity, and I look forward to working with the Board and leadership team to help realise it.” A long-term incentive sleeve aligned to exceptional value creation In addition, the Board proposes that the Extraordinary General Meeting adopts a focused long-term incentive sleeve based on a new class of Hurdle Shares. The hurdle is set above even the highest performance hurdle in the company’s existing LTIP 2026/2029 – a deeply out-of-the-money structure under which value accrues to a limited number of designated individuals only if Studsvik delivers exceptional, long-term value for shareholders. Participants invest their own capital at market value, determined by an independent valuation institute using the Black & Scholes model, with no acquisition-cost subsidy from the company. Adoption requires a corresponding amendment to the Articles of Association to introduce the new share class. Full terms, including participants, hurdle levels, dilution and estimated cost, are set out in the complete proposal. The Extraordinary General Meeting The complete notice, including the full proposals and instructions for participation, and the Nomination Committee’s motivated statement will be published separately and made available at www.studsvik.com. For more information, please contact: Jan BardellChairman of the Board, Studsvik AB (publ)jan.bardell@studsvik.com About StudsvikStudsvik offers a range of advanced technical services to the global nuclear power industry. Studsvik’s business focus areas are fuel and materials technology, reactor analysis software, decontamination and radiation protection as well as technical platforms for handling, conditioning and volume reduction of radioactive waste. The company has more than 75 years’ experience of nuclear technology and radiological services. Studsvik has approx. 540 employees in 6 countries and the company’s shares are listed on Nasdaq Stockholm.www.studsvik.com https://www.linkedin.com/company/studsvik/ This information is information that Studsvik AB (publ.) is obliged to disclose pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was released for public disclosure, through the agency of the contact person above, on July 13, 2026, at 18:45 pm (CEST).

Ericsson reports second quarter results 2026

Strategic highlights – disciplined execution and margin resilience · Adjusted gross margin of 48.4%, supported by solid operational execution and improved margins in Mobile Networks. · Strong net cash position supporting continued investments and capital returns, with SEK 8.2 b. returned to shareholders in Q2. · Demonstrated AI-enabled drone sensing and tracking using existing cell towers at a Texas stadium during a major global sporting event. Financial highlights – solid financial performance · Reported sales were SEK 52.7 (56.1) b. Organic* sales decreased by -1%* YoY primarily due to lower IPR licensing revenues, reflecting a non-recurring benefit from a partial settlement in the prior year period. Organic* sales grew in three out of four market areas. · Adjusted [1] gross income was SEK 25.5 (27.0) b., with solid operational execution partly offset by currency headwinds. Reported gross income was SEK 24.1 (26.6) b. · Adjusted [1] gross margin was 48.4% (48.0%). Networks and Cloud Software and Services adjusted gross margin increased. Reported gross margin was 45.8% (47.5%). · Adjusted [1] EBITA was SEK 6.9 (7.4) b. with a 13.1% (13.2%) margin, benefiting from continued strong margin expansion in Cloud Software and Services. Reported EBITA was SEK 6.3 (6.8) b., with an 11.9% (12.0%) margin. · Net income was SEK 4.1 (4.6) b. EPS diluted was SEK 1.22 (1.37). · Free cash flow before M&A was SEK 0.4 (2.6) b. · Capital returns to shareholders were SEK 8.2 b. in Q2, including SEK 3.2 b. of share repurchases Comment from Börje Ekholm, President and CEO: "Our Q2 results underscore the strength of our portfolio and disciplined execution. Adjusted gross margin was 48%, up by 2 percentage points after normalizing for the one-off benefit of the IPR settlement last year. In Q2, we took action to mitigate component cost inflation. As the impact builds in the coming quarters, we will continue to pursue internal measures and pricing actions to help offset the effect. We also expect some pressure on Networks adjusted gross margin in Q3 due to higher volumes of network rollout projects. Ericsson enters the next phase from a position of strength. Over recent years, we have strengthened our portfolio to capture the next wave of AI-driven connectivity. Building on our technology leadership in mobile networks, we have expanded into attractive growth areas, positioning Ericsson to capitalize as AI increasingly moves into the physical world." +--------------+------+------+------+------+-------+-------+-------+-------+|SEK b. |Q2 |Q2 |YoY |Q1 |QoQ |Jan-Jun|Jan-Jun|YoY || |2026 |2025 |change|2026 | change|2026 |2025 | change|+--------------+------+------+------+------+-------+-------+-------+-------+|Net sales |52.691|56.132|-6% |49.332|7% |102.022|111.157|-8% |+--------------+------+------+------+------+-------+-------+-------+-------+| Organic sales|- |- |-1% |- |- |- |- |2% ||growth*[2] | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Gross income |24.122|26.649|-9% |23.299|4% |47.421 |53.186 |-11% |+--------------+------+------+------+------+-------+-------+-------+-------+|Gross |45.8% |47.5% |- |47.2% |- |46.5% |47.8% |- ||margin[2] | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|EBIT |5.919 |6.391 |-7% |1.443 |- |7.362 |12.322 |-40% |+--------------+------+------+------+------+-------+-------+-------+-------+|EBIT margin[2]|11.2% |11.4% |- |2.9% |- |7.2% |11.1% |- |+--------------+------+------+------+------+-------+-------+-------+-------+|EBITA[2] |6.277 |6.763 |-7% |1.788 |- |8.065 |13.415 |-40% |+--------------+------+------+------+------+-------+-------+-------+-------+|EBITA |11.9% |12.0% |- |3.6% |- |7.9% |12.1% |- ||margin[2] | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Net income |4.076 |4.626 |-12% |0.887 |- |4.963 |8.843 |-44% |+--------------+------+------+------+------+-------+-------+-------+-------+|EPS diluted, |1.22 |1.37 |-11% |0.27 |- |1.48 |2.61 |-43% ||SEK | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Free cash flow|0.385 |2.581 |-85% |5.921 |-93% |6.306 |5.285 |19% ||before M&A[2] | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Net cash, end |59.839|36.040|66% |68.141|-12% |59.839 |36.040 |66% ||of period[2] | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Adjusted ||financial ||measures[1][2] |+--------------+------+------+------+------+-------+-------+-------+-------+|Adjusted gross|25.481|26.958|-5% |23.734|7% |49.216 |53.653 |-8% ||income | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Adjusted gross|48.4% |48.0% |- |48.1% |- |48.2% |48.3% |- ||margin | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Adjusted EBIT |6.520 |7.048 |-7% |5.211 |25% |11.731 |13.259 |-12% |+--------------+------+------+------+------+-------+-------+-------+-------+|Adjusted EBIT |12.4% |12.6% |- |10.6% |- |11.5% |11.9% |- ||margin | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+|Adjusted EBITA|6.878 |7.419 |-7% |5.556 |24% |12.433 |14.352 |-13% |+--------------+------+------+------+------+-------+-------+-------+-------+|Adjusted EBITA|13.1% |13.2% |- |11.3% |- |12.2% |12.9% |- ||margin | | | | | | | | |+--------------+------+------+------+------+-------+-------+-------+-------+ *Sales adjusted for the impact of acquisitions and divestments and effects of foreign currency fluctuations.[1] Adjusted metrics are adjusted to exclude restructuring charges.[2] Non-IFRS financial measures are reconciled at the end of this report to the most directly reconcilable line items in the financial statement. NOTES TO EDITORS You find the complete report with tables in the attached PDF or on https://www.ericsson.com/en/investors/financial-reports/interim-reports Video webcast for analysts, investors and journalists President and CEO Börje Ekholm and CFO Lars Sandström will comment on the report and take questions at a video webcast at 9:00 AM CEST (8:00 AM BST London, 3:00 AM EDT New York). Join the webcast  or please go to www.ericsson.com/investors To ask a question: Access dial-in information here  The webcast will be available on-demand after the event and can be viewed at www.ericsson.com/investors. FOR FURTHER INFORMATION, PLEASE CONTACT InvestorsDaniel Morris, Head of Investor RelationsPhone: +44 7386657217E-mail: investor.relations@ericsson.com Lena Häggblom, Director, Investor RelationsPhone: +46 72 593 27 78E-mail:  lena.haggblom@ericsson.com Alan Ganson, Director, Investor RelationsPhone: +46 70 267 27 30E-mail: alan.ganson@ericsson.com MediaRalf Bagner, Head of Media RelationsPhone: +46 76 128 47 89E-mail: ralf.bagner@ericsson.com Media relationsPhone: +46 10 719 69 92E-mail: media.relations@ericsson.com This is information that Telefonaktiebolaget LM Ericsson is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on July 14, 2026.

AQ Group updates financial targets

AQ Group's Board of Directors has decided on updated financial targets. New financial targets (previous targets in brackets): Financial standing: equity ratio >40% (>40%) Profitability: profit margin before tax (EBT) >10% (>8%) Growth: annually >15% (>15%) Product quality: 100% (100%) Delivery precision: >98% (>98%) "Our strategy has for a long time been to increase technology content and sales of more complex components and systems. Today, we take greater responsibility for design, especially in our business area inductive components. During the last 13 quarters, we had a profit margin before tax above our target of 8%. It therefore feels natural to raise the ambition and our new target is thus 10%. Other targets remain challenging and relevant to keep unchanged." comments James Ahrgren, CEO. "The Board is focused on creating shareholder value and we believe that this is best done by AQ Group continuing to grow profitably. It is important that we have challenging targets to strive towards and therefore the time was right to update the profitability target now." comments Åsa Landén Ericsson, Chairman of the Board. ___________________________________________________________ For further information, please contact:CEO and IR, James Ahrgren, + 46 76 052 58 88 orCFO, Christina Hegg, + 46 70 318 92 48 This disclosure contains information that AQ Group is obliged to make public pursuant to the EU Market Abuse Regulation. The information was released for publication by James Ahrgren on 14-07-2026 07:45 CEST. ____________________________________________________________ AQ is a global manufacturer of components and systems to demanding industrial customers and is listed on Nasdaq Stockholm’s main market. The Group consists mainly of operating companies each of which develop their special skills, and in cooperation with other companies, striving to provide cost effective solutions in close cooperation with the customer. The Group headquarter is in Västerås, Sweden. AQ has 8,000 employees in Bulgaria, Poland, Lithuania, Sweden, China, Estonia, Hungary, Mexico, Finland, India, Canada, USA, Germany, Italy, Brazil, Great Britain and Czech Republic. In 2025 AQ had net sales of SEK 9 billion, and the Group has since its start in 1994 shown profit every quarter. www.aqgroup.com

AQ Group AB (publ), interim report January-June, 2026

Second quarter, April-June 2026 in brief · Net sales increased by 10% to SEK 2,577 m (2,344)  · Operating profit (EBIT) increased by 17% to SEK 255 m (218)  · Profit before tax (EBT) increased by 13% to SEK 256 m (228)  · Profit margin before tax (EBT %) was 9.9% (9.7)  · Profit after tax amounted to SEK 202 m (189) · Cash flow from operating activities amounted to SEK 23 m (232) · Earnings per share before dilution amounted to SEK 2.20 (2.06) Six months, January-June 2026 in brief · Net sales increased by 6% to SEK 4,934 m (4,634)  · Operating profit (EBIT) increased by 11% to SEK 480 m (433)  · Profit before tax (EBT) increased by 11% to SEK 479 m (432)  · Profit margin before tax (EBT %) was 9.7% (9.3)  · Profit after tax amounted to SEK 382 m (355) · Cash flow from operating activities amounted to SEK 362 m (477) · Earnings per share before dilution amounted to SEK 4.16 (3.87) · Equity ratio was 67% (65) Significant events after the end of the period · Updated financial target, profit margin before tax 10% (8%) A word from the CEO     Good net sales and earningsIn the second quarter, we had the highest net sales and profit in a single quarter in the company's history. We increase net sales by 10% and had organic growth of 9%. It is as planned. A large proportion of deliveries and invoicing took place at the end of the quarter. During the quarter, we invested in more capacity for the production of inductive components for data centers. During the quarter, complete systems were delivered from Hungary, Finland and the US. At the same time, our transformer factories in China are growing towards the same market segment at a rapid pace. Inductive components for data centers alone accounted for 6% of AQ's total sales in the quarter. We are also continuing our expansion into the defense industry. We are investing SEK 60 m in additional production equipment and premises in northern Sweden to meet current and future demand. Finally, we acquired Time 24 in the quarter. There, we have integrated the company at rocket speed to get components and systems out to Time 24's demanding customers, and in the quarter, sales amounted to SEK 20 m. AcquisitionOur growth through acquisitions during the quarter was 1% through the acquisition of Time 24. Time 24 manufactures systems for demanding industrial customers in the UK. Their customers operate primarily in the semiconductor and railway industries. We continue to have a strong balance sheet and are continuing to work on several potential acquisitions to reach our target for 2026 of acquired growth above 5%. We have seen improvements in the profitability of several newly acquired companies compared to the corresponding quarter last year.  Market and investmentsOur deliveries increased to the defense industry in Europe and to data centers in the US. Several of our factories in China, Europe and the US are running at full speed. We have therefore continued to invest in new winding machines, vacuum impregnation and test equipment for inductive components to increase our manufacturing capacity of transformers. We have also invested in machinery and premises to meet the high demand for mechanics and electrical systems from the defense industry and electrification customers. We are prepared for growth and can invest more if necessary.  Cash flow, balance sheet, margin and increased financial target For 13 quarters, our profit margin before tax was above our target of 8%. In recent years, we have increased the complexity and technology content of our delivery and therefore the Board of Directors has decided to raise the target to a profit margin above 10%. This is reasonable as we today take greater responsibility for design, especially in our business area inductive components. Our profit margin before tax (EBT) in the quarter was 9.9%. Our cash flow from operating activities in the quarter was SEK 23 m (232), impacted by increased inventories and trade receivables due to growth. However, we can continue to be opportunistic and grow organically and through acquisitions as we have a net cash position. Thank youI am grateful that I have the opportunity to work with so many fantastic employees, customers and suppliers. During the quarter and year, we won orders in exciting growth segments. It may sound simple. But as difficult as it is to win new customer contracts, it is to deliver them at the required pace. I am incredibly impressed by the dedication and tenacity we show to make our customers and ultimately their customers happy. It is with pride that we close the second quarter with the highest sales and earnings in the company's history. Thank you! James AhrgrenCEO  _________________________________________________________________ This disclosure contains information that AQ Group is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was released for publication by James Ahrgren on 14-07-2026 08:00 CEST. For further information, please contact:James Ahrgren, CEO and IR, telephone +46 76 052 58 88  orCFO, Christina Hegg, telephone +46 70 318 92 48__________________________________________________________________ AQ is a global manufacturer of components and systems to demanding industrial customers and is listed on Nasdaq Stockholm’s main market. The Group consists mainly of operating companies each of which develop their special skills, and in cooperation with other companies, striving to provide cost effective solutions in close cooperation with the customer. The Group headquarter is in Västerås, Sweden. AQ has 8,000 employees in Bulgaria, Poland, Lithuania, Sweden, China, Estonia, Hungary, Mexico, Finland, India, Canada, USA, Germany, Italy, Brazil, Great Britain and Czech Republic. In 2025 AQ had net sales of SEK 9 billion, and the Group has since its start in 1994 shown profit every quarter. www.aqgroup.com